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Abstract 
(I123)FP-CIT imaging is used for differential diagnosis of clinically uncertain Parkinsonian 
Syndromes. Conventional reporting relies on visual interpretation of images and analysis of 
semi-quantification results. However, this form of reporting is associated with variable 
diagnostic accuracy results. The first half of this thesis clarifies whether machine learning 
classification algorithms, used as computer aided diagnosis (CADx) tool, can offer improved 
performance. 
 
Candidate machine learning classification algorithms were developed and compared to a 
range of semi-quantitative methods, which showed the superiority of machine learning tools 
in terms of binary classification performance. The best of the machine learning algorithms, 
based on 5 principal components and a linear Support Vector Machine classifier, was then 
integrated into clinical software for a reporting exercise (pilot and main study). 
 
Results demonstrated that the CADx software had a consistently high standalone accuracy. 
In general, CADx caused reporters to give more consistent decisions and resulted in 
improved diagnostic accuracy when viewing images with unfamiliar appearances.  
 
However, although these results were undoubtedly impressive, it was also clear that a 
number of additional, significant hurdles remained, that needed to be overcome before 
widespread clinical adoption could be achieved.  
 
Consequently, the second half of this thesis focuses on addressing one particular aspect of 
the remaining translation gap for (I123)FP-CIT classification software, namely heterogeneity 
of the clinical environment. Introduction of new technology, such as machine learning, may 
require new metrics, which in this work were informed through novel methods (such as the 
use of innovative phantoms) and strategies, enabling sensitivity testing to be developed, 
applied and evaluated. 
 
The pathway to acceptance of novel and progressive technology in the clinic is a tortuous 
one, and this thesis emphasises the importance of many factors in addition to the core 
technology that need to be addressed if such tools are ever to achieve clinical adoption. 
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1 Introduction 
This work aims to assess the effectiveness of automated classification algorithms for 
assisted radiological reporting of clinical (I123)FP-CIT nuclear medicine scans. The major 
focus is on evaluation of algorithms in a clinical reporting context. The following sections set 
out the clinical and technical background to (I123)FP-CIT imaging and associated disease 
processes. An overview of current standard of care image analysis techniques (semi-
quantification) is necessarily provided, along with a summary of machine learning 
classification algorithms and their history of application in (123I)FP-CIT imaging. This is the 
basis for a series of investigations which seek to establish the performance of developed 
classification algorithms, as compared to semi-quantification, and for evaluating the impact 
of such software tools on human reporter performance. 
1.1 (123I)FP-CIT imaging 
(123I)FP-CIT (DaTSCAN) imaging is a Single Photon Emission Computed Tomography 
(SPECT) brain scan technique used for differential diagnosis of patients with clinically 
uncertain Parkinsonian Syndrome (PS). In a clinical context it is used to detect the loss of 
dopaminergic neuron terminals associated with idiopathic Parkinson‘s Disease (PD), Multiple 
System Atrophy (MSA) and Progressive Supranuclear Palsy (PSP). It is also used to help 
distinguish between Dementia with Lewy Bodies (DLB) and other forms of dementia and to 
differentiate patients with presynaptic Parkinsonism from those with other forms of 
Parkinsonism (6). In a research context (123I)FP-CIT is increasingly used for monitoring 
progression of disease in patients suffering from PS. 
1.1.1 Parkinsonian Syndromes 
Parkinsonian Syndrome refers to a collection of movement disorders with similar clinical 
features but different pathologies. It includes, in addition to rarer causes of Parkinsonism: 
 
 Parkinson‘s Disease (PD) 
 Multiple System Atrophy (MSA) 
 Progressive Supranuclear Palsy (PSP) 
 Corticobasal degeneration (CBD) 
 Vascular Parkinsonism (VaP) 
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 Drug induced Parkinsonism (DIP) 
 
The most significant clinical symptom exhibited by all PS patients is bradykinesia, which is 
defined as ‗‗slowness of initiation of voluntary movement with progressive reduction in speed 
and amplitude of repetitive action‖ (7). PS is also typically associated with rest tremors, 
extrapyramidal rigidity and postural instability (8). 
 
The most common form of PS is PD, affecting approximately 1% of people over the age of 
65 (9). Diagnosis is predominately guided by clinical features. A number of guidelines have 
been published to assist with diagnosis, in particular the UK Parkinson‘s Disease Society 
Brain Bank Diagnostic Criteria (10). Other forms of Parkinsonism may display subtly different 
features, which can guide differential diagnosis. For example, MSA is often associated with 
early, progressive autonomic dysfunction whilst PSP patients will typically present with eye 
movement problems (8). 
 
However, differentiating between different forms of PS remains challenging. In addition, the 
progressive motor deficits typically displayed by PS patients are similar to those experienced 
by patients with essential tremor, which is a condition associated with involuntary limb or 
head movement. Other diseases such as multiple sclerosis and Huntington‘s disease may 
also present as movement disorders. 
 
In the UK and elsewhere patients presenting with motor deficits may be referred to experts in 
movement disorders or to clinicians with more general expertise, such as general 
neurologists. Given the subtle differences in the features of different PS sub-types it is 
perhaps unsurprising that clinical diagnosis of PD is often associated with disappointing low 
accuracy figures. A recent systematic review and meta-analysis by Rizzo and colleagues 
(11) identified 11 studies comparing clinical diagnosis of Parkinson‘s Disease with pathologic 
diagnosis post-mortem (the gold standard). Clinical diagnosis by ‗non-experts‘ (such as 
general neurologists) was associated with an accuracy of only 74% and a specificity of just 
49% as compared to neuropathology results (experts in movement disorders achieved a 
higher accuracy of approximately 80%).  
 
Similar accuracy results for general neurologists were found in a large Finnish study with 
1362 patients (12).  A study conducted in a specialised centre for movement disorders, 
where one might expect relatively high diagnostic accuracy, showed that 36% of patients 
were reclassified within a mean time window of 3.4 years following initial clinical diagnosis, 
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suggesting that clinical features may not be a reliable indicator of disease in the early stages 
(13). Indeed, it appears that there is a tendency to over diagnose PD in early disease stages 
(14). Similarly, studies have demonstrated that clinical diagnosis of DLB is associated with 
low sensitivity (15). Although the accuracy of diagnosis by clinical features alone is likely to 
increase over time as the disease progresses and symptoms evolve (13,16,17), these 
findings suggest that there is a need for other tests, particularly in the early stages of 
disease, which can highlight differences in disease pathology and increase diagnostic 
accuracy and certainty.  
 
Getting diagnosis correct early on can be extremely important for decisions on patient 
management. For example, patients with PD will typically be prescribed with Levodopa to 
reduce symptoms. However, the drug is associated with significant side effects such as 
nausea and vomiting. In patients with essential tremor Levodopa offers no benefit but may 
reduce quality of life. 
1.1.2 Dementia with Lewy Bodies 
DLB is a progressive brain disease associated with the presence of cortical Lewy bodies 
(abnormal aggregates of protein) inside nerve cells. DLB presents with similar symptoms to 
both Alzheimer‘s Disease (AD) and PD. There is still uncertainty in regards to prevalence, 
largely due to difficulties in diagnosing the condition. However, a recent systematic review 
has estimated that DLB accounts for approximately 1 in 25 dementia cases diagnosed in the 
community and 1 in 13 cases diagnosed in secondary care (18). DLB patients suffer from 
typical dementia symptoms, including attention deficits and substantial memory impairment. 
However, damage to cells in the substantia nigra can also give rise to movement deficits, 
similar to those seen in PS. 
 
Differential diagnosis between DLB and other forms of dementia is important as patient 
management is different for each disease. In particular, DLB patients often have severe 
sensitivity to neuroleptics, but these antipsychotic drugs are commonly prescribed for 
Alzheimer‘s patients to reduce disruptive behaviour.   
1.1.3 Tracer uptake and differential diagnosis 
The radioactive tracer (I123)FP-CIT targets just one protein involved in the nigrostriatal 
dopaminergic pathway, one of the four main dopamine pathways of the brain. In order to 
understand how imaging relates to disease it is necessary to appreciate the basic steps 
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involved in neurotransmission, whereby signals are passed from one neuron to the next. As 
shown by Figure 1-1 the neurotransmitter (dopamine) is held within vesicles in the pre-
synaptic neuron. Action potentials passing along this neuron cause vesicles to release their 
dopamine into the synaptic cleft. Some of the released dopamine binds to and activates the 
receptors of the post-synaptic neuron, causing an action potential to be generated and thus 
allowing the signal to be passed from one neuron to the next. Unbound dopamine is 
reabsorbed from the synapse back into the pre-synaptic neuron by Dopamine active 
transporters (DaT). 
 
 
Figure 1-1 Schematic of two dopaminergic neurons and their synapse. The neurotransmitter 
dopamine is released from vesicles into the synaptic cleft 
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It has been shown in-vitro that FP-CIT binds reversibly to DaT (19). Human brain slices 
recovered post-mortem from individuals without a Parkinsonian Syndrome, following FP-CIT 
administration, have shown high concentrations of the tracer within the putamen and 
caudate (19,20). This area of the brain, known as the striatum, contains a large number of 
nigrostriatal axon terminals. Thus, by radiolabelling FP-CIT with I123, and administering to 
the patient, it is possible to image DaT function in-vivo within the striatum.  
 
Some movement disorders cause dopaminergic neurons to die. The concentration of DaT in 
the striatum reduces as the number of healthy dopaminergic neurons decreases. Therefore, 
by examining the density of administered (123I)FP-CIT within the striatum, through SPECT 
imaging, an assessment can be made of the function of the pre-synaptic dopaminergic 
pathway and whether disease processes associated with certain conditions are present. 
Table 1-1 summarises which of the previously described disorders is associated with 
reduced DaT density, and which causes no significant change. For patients where 
differential diagnosis between these diseases is unclear, a positive or negative (123I)FP-CIT 
test can therefore help to identify the likely cause of a patient‘s symptoms.  
 
Disease Impact on pre-synaptic DaT density 
Idiopathic Parkinson‘s Disease Reduced (21) 
Multiple System Atrophy Reduced (21) 
Progressive Supranuclear Palsy Reduced (21) 
Essential Tremor Not affected (21,22) 
Alzheimer‘s Disease Not affected (21,23) 
Drug-Induced Parkinsonism Not affected (24) 
Vascular Parkinsonism Reduced or unaffected (25,26) 
Corticobasal Degeneration Reduced or unaffected (27) 
Dementia with Lewy Bodies Reduced in most cases (28–31) 
Table 1-1 Summary of the effects of different brain disorders on pre-synaptic DaT density, 
according to current research 
 
(123I)FP-CIT is just one of a range of radiopharmaceuticals that have been developed to 
enable imaging of both the pre- and post-synaptic dopaminergic pathway. However, this 
work focuses on clinical imaging. In the UK the majority of dopaminergic scans conducted in 
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the NHS are carried out with (123I)FP-CIT, and so all other radiopharmaceuticals are 
considered out of scope.  
1.1.4 Clinical SPECT imaging 
(123I)FP-CIT imaging is carried out using SPECT, where multiple planar projections are 
acquired from a gamma camera, which are then reconstructed into a 3D volume. 
Recommended clinical image acquisition parameters are set out in the ―information for the 
physician‖ leaflet supplied by the manufacturer of (123I)FP-CIT. In addition, both the 
European Association of Nuclear Medicine (EANM) and Society of Nuclear Medicine (SNM) 
have produced guidelines for this test (6,32).  
 
Typically, reporters will view reconstructed axial slices from the centre of the brain, 
encompassing the whole striatal area. In some cases a summed image will also be 
examined, created by adding together voxel intensities from consecutive slices. 
1.1.5 Accuracy and variability of unaided visual analysis 
In this study it is hypothesised that automated classification algorithms are a useful 
diagnostic aid, providing an objective, independent assessment of image appearances, 
which the clinician may use as part of his / her considerations in image reporting. Before 
developing tools for this purpose it is important to understand the performance of human 
observers alone in detecting abnormal tracer uptake patterns.  
 
A number of studies have considered the accuracy of (I123)FP-CIT imaging. However, these 
have been conducted in different settings with different groups of patients (at different stages 
of disease), using different gold standard methods with different acquisition and 
reconstruction parameters. Results must therefore be interpreted in light of any potential 
biases.  
 
Many modern studies consider the accuracy of (I123)FP-CIT imaging in conjunction with 
semi-quantificationa, and these are excluded from the following discussion in order to focus 
purely on the reporter‘s ability to visually interpret an image. In addition, the following 
                                               
a
 Semi-quantification: relative quantitative measures of uptake within a region of interest. See section 
1.2 
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discussion mainly focuses on larger scale studies. Results from studies with small or limited 
datasets are largely excluded. 
 
Although post-mortem pathological examination of the brain is generally considered the gold 
standard method for diagnosing parkinsonisms, this is not practical in many studies. Clinical 
diagnosis with long term follow-up (covering disease progression, results of other tests and 
assessment of response to treatment) is the most commonly used reference standard, 
despite the possible limitations this places on interpretation of results. One of the main 
limitations of clinical follow-up, particularly for retrospective studies is that the results of 
(I123)FP-CIT imaging itself may have a significant impact on the final diagnosis. 
 
Use of clinical diagnosis as a gold standard may appear counter-intuitive at first sight given 
that (I123)FP-CIT imaging was primarily introduced to clinic in order to overcome limitations 
associated with diagnosis by clinical features alone. However, (I123)FP-CIT imaging is 
mostly used in early stages of disease where clinical data is limited and uncertain. To 
emphasise the time-limited justification for carrying out a (I123)FP-CIT scan, de-La Fuente-
Fernandez measured the diagnostic accuracy of clinical diagnosis using SPECT data as the 
reference standard for 322 PS and non-PS patients (33). He showed that accuracy was 84% 
in the early stages of disease but 98% for patients with established clinical diagnosis (i.e. the 
two tests were identical in latter stages of disease). 
 
Table 1-2 summarises the main research articles focusing on measurement of the diagnostic 
performance of (I123)FP-CIT imaging (with interpretation through visual analysis only)
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Summary of the evidence for diagnostic performance of (I123)FP-CIT imaging (visual image analysis only) 
 
Source Method Results 
O‘Brien et al. 
(21) 
Pooled analysis of three phase three and one 
phase four prospective clinical trials, covering 
928 participants. Visual interpretation was 
conducted by both on-site reporters and a panel 
of experts. Data was based on a gold standard 
diagnosis provided by clinical follow-up. 
In the differentiation of patients with a striatal dopaminergic deficit 
disorder (SDDD), such as a PS or DLB, from patients without a SDDD, 
overall sensitivity was 91.9% and specificity 83.6% when interpretation 
was performed locally. The expert panel achieved a sensitivity of 88.7% 
and specificity of 91.2%. Inter-reporter agreement was generally good 
between members of the expert panel (Cohen‘s kappa varied from 0.81 
to 1.00). However, greater variability was seen between the expert panel 
and local on-site reporters 
O‘Brien et al. 
(23) 
Visual analysis of 164 scans by 5 reporters 
(consensus reporting), as compared to clinical 
diagnosis 
Sensitivity of 78% and specificity 85% in classification of DLB vs. AD. 
Kappa values on inter-reporter agreement varied from 0.91 to 0.94  
Benamer et al. 
(34) 
Multi-centre study. 158 patient scans were read 
by local reporters and then by a central panel of 
5 experts. 
Local reporters achieved an accuracy of 98% in the binary diagnostic 
task of distinguishing between Parkinsonisms and ET / healthy 
volunteers, whilst the expert panel gave a correct interpretation in 95% of 
cases. 
Marshall et al. 
(14) 
Visual analysis of 99 SPECT images, as 
compared to clinical interpretation (via video 
recording) at 3 year follow up 
(I123)FP-CIT had a sensitivity of only 78% in diagnosing degenerative 
Parkinsonism from non-degenerative tremor, but 97% specificity. Here, 
Inter-reporter agreement on SPECT image interpretation was high 
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(kappa statistic varied from 0.94-0.97). 
 
Tolosa et al. 
(35) 
Follow-up study of 85 patients with clinically 
uncertain PS. SPECT findings were compared 
to clinical diagnosis established over 2 
subsequent years.  
(I123)FP-CIT findings agreed with a conclusive clinical diagnosis in 90% 
of cases 
Kemp et al. (36) Retrospective study of 80 patients, comparing 
visual analysis by a single observer against 
clinical diagnosis 12-24 months after SPECT 
imaging was completed.  
 
(I123)FP-CIT imaging findings were in agreement with clinical diagnosis 
in 95% of cases  
Thomas et al. 
(31) 
Retrospective study of 55 research patients. 
Diagnosis confirmed by autopsy. Accuracy of 
(I123)FP-CIT imaging determined through 
consensus reporting 
 
Accuracy of (I123)FP-CIT was 86% in differentiating DLB from 
Alzheimer‘s disease, which was greater than the accuracy measured 
from clinical diagnosis (79%)  
Table 1-2 Summary of research articles measuring the ability of (I123)FP-CIT scans, with interpretation by human reporters, to distinguish 
between patient groups. Studies are listed in descending order according to the number of patient datasets included in the analysis
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Most of the studies listed in Table 1-2 have relied upon data from large hospitals, with 
relatively high patient throughput. However, (I123)FP-CIT is a routine test that is often 
carried out in smaller institutions where the level of experience and expertise may be lower. 
A recent audit conducted by the British Nuclear Medicine Society (BNMS) provides some 
insight into the level of reporting performance on a wider scale in the NHS (37). It was shown 
that, for 86 different UK centres (each contributing 6 anonymised scans), independent 
reviewers agreed the original image report in 88% cases. In the remainder there were 
discordant findings, which suggests that visual analysis in the wider clinical community is 
perhaps more significant than that suggested by most research articles.  
 
Overall, it appears that visual interpretation of (I123)FP-CIT images is associated with 
variable but relatively high accuracy, sensitivity and specificity figures (in the region of 80-
90%) for differentiation of dopaminergic deficit disorders from those without such conditions. 
These relatively impressive performance figures are perhaps unsurprising given the size of 
impact that PS has on dopaminergic function. As shown in previous research on post-
mortem brains, early stage dopaminergic disease is associated with a 70-80% reduction of 
dopamine in the striatum (38). Given that patients are only referred for (I123)FP-CIT imaging 
when clinical features have become apparent, it can be inferred that the classification task 
for visual analysis is to distinguish between two very different functional states. 
 
The available data on inter-reporter agreement indicate that there are generally only small 
differences between performances of interpreting clinicians. However, importantly, there was 
a greater level of variability seen between reports by assigned ‗experts‘ and locally 
performed visual analysis. Although there are a number of differences in the studies 
examined that may have affected results and may limit applicability of findings (particularly in 
terms of the case mix, reconstruction method and reference standard used), there does 
appear to be some potential for improving diagnostic accuracy of (I123)FP-CIT tests and for 
reducing inter-reporter variability. It is this that provides justification for new techniques (for 
example, machine learning) as described in this thesis. 
1.1.6 Conclusion 
Parkinsonisms affect a relatively large proportion of the population and although clinical 
diagnosis remains the dominant diagnostic method, the approach is associated with 
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somewhat disappointing accuracy figures, particularly in the early stages of disease. 
(123I)FP-CIT is a SPECT imaging test that enables clinicians to evaluate function in the pre-
synaptic nigrostriatal dopaminergic pathway. Visual analysis of these images can help to 
distinguish between PS and other conditions such as essential tremor, with relatively high 
accuracy. 
 
Although (123I)FP-CIT imaging appears to be a useful diagnostic tool within the appropriate 
clinical context, there is some variability in reported accuracy figures and there is evidence of 
differences in performance between human reporters. Consequently, there may be scope for 
improving upon the accuracy of (123I)FP-CIT imaging with assistive software based on 
machine learning.  
 
A form of assistive software is already in use in many clinical departments for (123I)FP-CIT 
imaging, namely semi-quantification. This is recommended by EANM guidelines for routine 
image reporting (6) and is therefore a potential competitor to any machine learning tools 
developed during this work. The following section describes semi-quantification and 
considers its advantages and disadvantages to establish whether there is scope for machine 
learning to further increase clinical diagnostic performance. 
1.2 Semi-quantification 
Semi-quantification enables an objective assessment of an image to be performed, which is 
designed to help clinicians better and more consistently assess nigrostriatal dopaminergic 
function. Numerous commercial software solutions are available, including DaTQUANT (GE 
Healthcare) and BRASS (Hermes Medical). 
 
Semi-quantification involves measurement of tracer uptake within regions of interest, placed 
over organs that are key to differential diagnosis (i.e. the striatum or subsections of the 
striatum such as the putamen and caudate, see Figure 1-2 for a typical example). The 
average voxel intensity (and hence tracer uptake concentration) within these regions is 
usually compared to another region of the brain, with low uptake, which represents non-
specific uptake of the tracer. The ratio of the two values gives the specific to non-specific 
uptake ratio or striatal binding ratio (SBR). In this thesis SBR is calculated according to: 
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  Eq 1.1 
 
Where CS refers to the mean count level within a striatal region (or sub-region), which may 
be defined on a full 3D volume or summed 2D slices, and CB refers to the mean count level 
within a background region, such as the occipital lobe. In addition, other ratios are often 
calculated as part of semi-quantitative analysis, such as left to right asymmetry ratios and 
caudate to putamen ratios. The regions of interest used to define the boundaries of striatal 
uptake are often small and are often defined on a chosen template image. Each test image 
is then usually registered to the template in order that regions of interest can be applied 
automatically. Alternative methods have also been proposed. For example, the Southampton 
method (39) applies a wide region of interest around the individual striata, using manual 
placement. Background, non-specific uptake is estimated from the remainder of the brain.  
 
 
Figure 1-2 Example of the regions of interest used in the calculation of SBR. Caudate 
regions are shown in white, putamen regions in yellow and the region covering the occipital 
lobe in green 
 
Whichever particular method is used to define and place regions of interest, the calculated 
SBRs (and other ratios) are usually provided to the clinician alongside data on expected 
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values for ‗normal‘ (and possibly ‗abnormal‘) patients, where ‗normal‘ refers to either healthy 
controls or patients without dopaminergic deficit and ‗abnormal‘ covers any patients with pre-
synaptic dopaminergic deficit. This gives some context to the SBR figures.  
 
One of the major reasons why interpretation of (I123)FP-CIT images can be difficult through 
visual analysis alone, and why semi-quantification is recommended, is that normal striatal 
tracer uptake is known to decline naturally with increasing patient age (40). It is difficult for a 
human to visualise precisely how images appearances should change with patient age and 
so it can be challenging to appreciate how the tolerances on normal appearances should be 
adjusted for each patient. For this reason normal ranges reported with SBR results are often 
age-matched, for example only considering SBRs from reference patients that are within +/- 
5 years of the test patient. 
 
Another justification often presented for the use of semi-quantification software in clinic is 
that in a minority of cases nigrostriatal deficit can manifest as balanced loss of DaT 
throughout the striatum, as mentioned previously, maintaining comma-shaped striatal 
appearances on reconstructed images even at advanced stages of disease. In these cases 
reporters must examine the contrast between voxel intensities within striatal structures, as 
compared to non-specific uptake in the rest of the brain, in order to identify that disease is 
present. Appreciating the exact intensity threshold (and hence display colour) of background 
tissues that indicates abnormality can be difficult. The fact that striatal tissues maintain a 
classic normal shape could be sufficient to distract the reporter from making the correct 
interpretation. Semi-quantification is easily able to highlight these ‗balanced loss‘ cases as 
SBRs are simply a ratio of counts within striatal regions as compared to non-specific uptake 
regions. 
1.2.1 Impact on clinical performance 
A number of studies have previously sought to estimate the added value that semi-
quantification brings. This data gives a useful indication as to the level of performance gain 
that may be possible with image analysis tools, and may provide some justification for 
pursuit of more sophisticated machine learning solutions. 
 
Albert and colleagues (41) examined 62 historical patient datasets, where SPECT imaging 
had originally been reported as inconclusive. Reference diagnosis was established from 
clinical follow-up. Following re-reconstruction with different parameters each image was 
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reported visually by 2 reporters and then semi-quantification was performed using BRASS. 
Any study where SBR figures were less than 2 standard deviations from the mean of an age-
matched normal comparison set was considered abnormal. The accuracy of visual analysis 
alone was found to be 89%, in line with many of the studies highlighted in section 1.1.5. 
Accuracy from semi-quantification alone was 85%. Where semi-quantification and visual 
analysis were in concordance the accuracy was 94%, evidence that, if in agreement, semi-
quantification may add confidence to visual analysis.  
 
Along similar lines, Ueda and colleagues (42) and Suarez-pinera and colleagues (43) 
examined retrospective clinical data to compare the performance of semi-quantitative 
software with that of visual analysis alone, and then examined results from the two 
approaches combined. Ueda found that visual analysis had a higher sensitivity but equal 
specificity to semi-quantification, and that a combined approach (where results agreed) gave 
an even higher sensitivity (96.7%) than either in isolation (42). Suarez-pinera found no 
significant difference between semi-quantification and visual analysis, and found no added 
performance benefit from combining the two approaches (43). However, the dataset used in 
this case was small (32 cases), limiting the chances of measuring significant differences 
between approaches. In both of these studies, the optimum cut-off for the semi-quantification 
classification was defined from the same data to which it was applied to measure 
classification performance. Therefore, performance figures are likely to represent an 
overestimate. 
 
Focusing on studies where reporters were exposed to semi-quantitative output there is again 
a collection of relatively small scale investigations in the literature. The largest such study 
included 304 cases from previous clinical trials, using clinical diagnosis as the reference 
standard. Each case was read by 5 reporters with limited clinical experience, first using 
visual analysis alone and then repeated with semi-quantification results available (44). It was 
found that sensitivity was almost identical between the two approaches and that the 
introduction of semi-quantification increased mean specificity slightly (87.9% vs 89.9%). 
Interestingly, the mean confidence score of the reporters increased significantly when the 
semi-quantification results were available as compared to when performing visual analysis 
alone, apparently an advantage of semi-quantification may be in decreasing diagnostic 
uncertainty. 
 
Two other studies of semi-quantification performance were carried out based on similar 
assumptions. Soderlund and colleagues (45) and Pencharz and colleagues (46)  examined 
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the variability in reporting both with and without the assistance of semi-quantification 
software. Soderlund, using a dataset of 54 historical cases, found that mean inter-reporter 
variability was kappa = 0.8 for visual analysis alone. This is similar to the variability results 
found in 1.1.5. When reporters were given access to SBR results kappa increased to 0.86. 
When both SBR results and caudate-to-putamen ratios were provided to reporters the 
variability between them reduced further (kappa = 0.95) (45). Pencharz, using 109 historical 
patient cases, found that there was no difference in accuracy between visual analysis and 
visual + semi-quantification combined. However, they also found that the mean number of 
cases per reporter that were reported as equivocal reduced from 10.6 to 3.6 after 
introduction of semi-quantification results (46). 
 
These results, taken together, confirm that semi-quantification offers some benefit in clinical 
practice (its usefulness in clinical trials is not considered). There is no compelling evidence 
of a significant increase in sensitivity or specificity as a result of introducing semi-
quantification to the reporting process. However, it does appear that when semi-
quantification and visual analysis agree, the diagnostic accuracy of the combined results is 
likely to be very high. When used by image reporters, semi-quantification seems to increase 
confidence in image reports and there is evidence that inter-observer variability reduces as a 
result. These findings may partly explain why semi-quantification continues to be in routine 
clinical use, particularly in Europe. Conversely, the relatively modest gains achievable with 
semi-quantification may explain why SNM guidelines suggest that semi-quantification is not 
an absolute necessity (32). 
 
Semi-quantification is an imperfect tool for assisted image reporting. Firstly, due to the small, 
tight regions of interest that are often used, results usually rely on accurate registration of the 
test image to a template. Small errors in registration can cause big differences in the 
quantities measured. Secondly, semi-quantification results are usually provided to clinicians 
in the form of multiple SBR results (and possibly other ratio figures), each with an associated 
normal range or suggested normal / abnormal cut-off value. The clinician must interpret each 
of the SBR scores in light of normal ranges to come to an overall decision on patient 
diagnosis. Therefore, there is still a significant amount of interpretation required by the 
reporter after image analysis. Thirdly, semi-quantification is a relatively crude classification 
tool. It takes no account of the shape of striatal uptake or the distribution of voxel values, or 
any other image features which could be affected by disease processes. Finally, it is well 
known that semi-quantification is highly sensitive to differences in gamma camera 
equipment, scanning protocols and reconstruction methods (47–50). This is likely to be more 
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pronounced than the effects on visual analysis (as humans are less likely to be distracted by 
a slight difference in noise, for example). This dictates that individual hospitals may need to 
define their own normal ranges for SBR figures.  
 
For these reasons there are benefits to be obtained from improved (I123)FP-CIT reporting 
software. Machine learning algorithms may be able to overcome some or all of the limitations 
associated with conventional semi-quantification methods and, given the industrious activity 
in this area, it is hypothesised that established machine learning technology is already 
sufficiently mature to offer improved performance in clinic. This work focuses on selection, 
implementation and evaluation of machine learning software to establish whether such 
systems offer effective diagnostic support to reporters. To this end, the following sections 
give an overview of machine learning algorithms along with a summary of the techniques 
applied to (I123)FP-CIT SPECT imaging in the recent literature, before setting out the aims 
of this work. Although the focus of much of the following section is on machine learning, 
there is no aspiration to develop a completely new algorithm, the main goal is to critically 
evaluate existing techniques in a clinical reporting scenario. 
1.3 Machine Learning 
Machine learning is a wide, rapidly evolving field. It is increasingly used in a variety of 
practical applications, from controlling driverless cars to computer game development. In 
research, machine learning is often applied to large datasets in order to identify complex 
patterns, which can then be used to inform future decisions. In this thesis machine learning 
is used as a tool for developing a whole-image automated classification system, to perform a 
reporting task in a similar manner to a radiologist. Specifically, the goal is to implement and 
evaluate a system, which when presented with a previously unseen image, is able to classify 
it as belonging to one of two patient groups (dopaminergic deficit and non-dopaminergic 
deficit groups). The intention is not to replace the radiologist but to provide an independent 
check of the likely differential diagnosis associated with an image. This independent reading 
will be presented to the clinician with the aim of improving his/her reporting performance. 
Software performing this task is often referred to as Computer Aided Diagnosis (CADx) 
software. This is very similar to but distinct from Computer Aided Detection (CADe) software, 
which identifies the locations of possible abnormalities within an image to a clinician. 
 
Given that the focus of the thesis is not on development of a new machine learning algorithm 
per se, the following section provides only a high level introduction to machine learning 
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theory. It is not intended to provide an in depth technical review of all aspects of machine 
learning technology. This introductory section is followed by details of specific recent 
examples in the literature related to (I123)FP-CIT imaging, which have previously produced 
promising results. In chapters 2 and 3 a selection of these tools will be adapted and critically 
evaluated to identify a candidate algorithm for use in a reporting exercise. These later 
sections offer a focused insight into the chosen machine learning theory. 
1.3.1 Overview 
Fundamentally there are two main types of machine learning algorithm, supervised and 
unsupervised. Supervised algorithms use databases of labelled training data in order to 
define a mapping from the features of the training data to their pre-defined label. Thus, the 
chosen algorithm learns to associate a particular grouping of training data with a particular 
set of feature values. This is the form of machine learning most often applied in medical 
imaging and is typically used for regression and classification problems. For example, based 
on historical data, a supervised algorithm could be trained to predict organ size given a 
particular age value. Alternatively, machine learning could be used to create a model that 
learns to differentiate between tumours and healthy tissue based on the pixel intensity 
values. The general concept of supervised learning is depicted in Figure 1-3. 
 
 
Figure 1-3 Supervised learning concept represented as a workflow 
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Conversely, unsupervised learning is applied to data where no pre-defined label (or ‗ground 
truth‘ is available). The goal here is to model the underlying structure of the data. Typical 
applications include clustering, where the algorithm tries to find inherent groupings in the 
training set. Another potential application is in dimensionality reduction, where the goal is to 
find a more compact representation of the same data.  
 
In this work only supervised algorithms are considered, in line with the majority of medical 
imaging research. As previously mentioned, the task is to classify (I123)FP-CIT images as 
belonging to one of two different patient groups. In classical machine learning theory the way 
to approach this problem would be to first define the likely image features that would offer 
the best chance of accurate classification. This may simply be the raw voxel intensity values, 
or could be derived features obtained from analysis of the shape of segmented structures, 
for example. Often, a large number of image features are first presented to the classifier and 
those features contributing little to the overall performance are removed. In recent years 
however, ‗hand-crafting‘ features in this way has become less popular, largely due to the 
recent dominance of deep learning algorithms, such as convolutional neural networks 
(CNNs) in image analysis research (51). With CNNs a hierarchy of features is derived by the 
neural network itself as part of the overall training process, the advantage being that the 
classification algorithm finds the best features for the task and particular set of data it is 
presented with. 
 
In the following section some of the techniques previously applied to (I123)FP-CIT 
classification will be highlighted, to give an indication of the tools that are currently available 
for use in CADx systems. A subset of these techniques will be adopted in this thesis for 
initial evaluation. Clinical tests of CADx software, in a simulated reporting scenario, will be 
based on the best performing algorithm from these initial results. 
1.3.2 Automated classification for (I123)FP-CIT: a summary 
Automated classification tools for (I123)FP-CIT imaging, based on machine learning 
methods, have been investigated by numerous authors. Details on the techniques applied in 
the available literature since 2010, to distinguish between patients with and without pre-
synaptic dopaminergic deficit, are summarised in Table 1-3. Also included are details of the 
image features extracted, reported performance metrics, details of the data upon which the 
performance figures were derived and information related to the chosen cross-validation 
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technique. The table includes algorithms where training data is based on SPECT images 
only, multimodality inputs are excluded.  
 
 
  
 
 
2
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Summary of automated classification research for (I123)FP-CIT imaging since 2010 (articles ordered according to accuracy) 
Authors Image features (if applicable) Classifier Validation data + method Results 
Augimeri, Cherubini, 
Cascini et al., 2016 (52)  
Mean ellipsoid uptake, dysmorphic 
index (ellipsoid orientation) 
Support Vector 
Machine (SVM) 
43 local images (12 normal, 31 
Parkinson‘s Disease (PD)), no 
cross validation mentioned 
Up to 100% accuracy, 
specificity and sensitivity 
Bhalchandra, Prashanth, 
Roy et al., 2015 (53) 
Analysis of 42nd slice only. Striatal 
binding ratios in both caudates and 
putamena, radial features and 
gradient features. Features are 
tested for statistical significance 
(wilcoxon rank) before use in the 
classifier 
SVM and SVM 
with Radial Basis 
Function (RBF) 
kernel, Linear 
Discriminant 
Analysis (LDA) 
350 images from Parkinson‘s 
Progression Markers Initiative 
(PPMI) database (187 healthy 
controls (HC), 163 PD). 5 fold 
cross-validation (CV), repeated 
100 times 
Linear SVM. Maximum of: 
Accuracy = 99.4% 
RBF kernel. Maximum of: 
Accuracy = 99.4% 
LDA. Maximum of: 
Accuracy = 99.4% 
Choi, Ha, Im et al., 2017 
(54)  
All voxels within the image CNN – PD net 701 images from the PPMI 
database (431 PD, 193 HC, 77 
scans without evidence of 
dopaminergic deficit (SWEDD)). 
 
82 local images (72 PD, 10 non-
parkinsonian) 
Maximum of: 
Accuracy = 98.8% 
Sensitivity  = 98.6% 
Specificity = 100.0% 
Oliveira, Faria, Costa et 
al., 2017 (55) 
Binding ratios in the putamen, 
caudate and striatum, striatal 
volume and length in both brain 
SVM, k-nearest 
neighbour (k-NN), 
logistic regression 
652 images from the PPMI 
database (209 HC, 443 PD). 
Leave-one-out CV 
Maximum of: 
Accuracy = 97.9% 
Sensitivity  = 98.0% 
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hemispheres Specificity = 97.6% 
Oliveira, Castelo-Branco, 
2015 (56) 
Image voxels within striatal region 
of interest 
SVM 654 images from PPMI 
database (209 HC, 445 PD). 
Leave-one-out CV 
Maximum of: 
Accuracy = 97.9% 
Sensitivity = 97.8% 
Specificity = 98.1% 
Prashanth, Dutta Roy, 
Mandal et al., 2017 (57) 
16 shape and 14 surface fitting 
features of selected slices, 
following thresholding. Striatal 
binding ratios of both caudates and 
putamena and asymmetry indices 
were also considered. Features are 
tested for statistical significance 
(wilcoxon rank) before use in the 
classifier 
SVM with RBF 
kernel, boosted 
trees, random 
forests, naive 
bayes 
715 images from PPMI 
database (208 HC, 427 PD, 80 
SWEDD). 10 fold CV, repeated 
100 times. Hyperparameters for 
SVM chosen through 10 fold CV 
SVM: 
Accuracy = 97.3 ± 0.1% 
Sensitivity = 97.4 ± 0.1% 
Specificity = 97.2 ± 0.2% 
Boosted trees: 
Accuracy = 96.8 ± 0.2% 
Sensitivity = 97.1 ± 0.3% 
Specificity = 96.3 ± 0.4% 
Random forests: 
Accuracy = 96.9 ± 0.2% 
Sensitivity = 97.2 ± 0.2% 
Specificity = 96.5 ± 0.3% 
Naive Bayes: 
Accuracy = 96.9 ± 0.1% 
Sensitivity = 96.4 ± 0.1% 
Specificity = 96.5 ± 0.2% 
Tagare, DeLorenzo, Voxel intensities within a region of Logistic lasso 658 images from PPMI Maximum of: 
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Chelikani et al., 2017 (58) interest database (210 HC, 448 PD). 3 
fold CV for performance 
assessment. Parameters 
chosen through 10 fold CV 
(nested within outer 3 fold CV). 
Accuracy = 96.5 ± 1.3% 
 
Palumbo, Fravolini, 
Buresta et al., 2014 (59) 
Striatal binding ratios for both 
caudates and putamena (and a 
subset of these 4 features), patient 
age 
SVM with RBF 
kernel 
90 local images from patients 
with ‗mild‘ symptoms (34 non-
PD, 56 PD). Leave-one-out and 
5 fold CV 
Maximum of: 
Accuracy = 96.4% 
Prashanth, Dutta Roy, 
Mandal et al., 2014 (60) 
Striatal binding ratio for both 
caudates and putamena 
SVM, linear and 
with RBF kernel. 
493 images from PPMI 
database (181 HC, 369 early 
PD), 10 fold CV, no repeats 
RBF kernel:  
Accuracy = 96.1%, 
Sensitivity = 96.6%, 
Specificity = 95.0% 
Linear SVM: 
Accuracy = 92.3%, 
Sensitivity = 95.3%, 
Specificity = 84.0% 
Martinez-Murcia, Gorriz, 
Ramirez et al., 2013 (61)  
12 Haralick texture features within 
a brain region of interest 
SVM ‗Whole‘ PPMI database. Leave-
one-out CV 
Maximum of: 
Accuracy = 95.9%, 
Sensitivity = 97.3%, 
Specificity = 94.9% 
Zhang, Kagen, 2016 (62) Voxel intensities from a single axial Single layer 1513 images from PPMI Maximum of: 
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slice, repeated for 3 different slices Neural network database (baseline and follow-
up, 1171 PD, 211 HC, 131 
SWEDD). 1189 images for 
training, 108 for validation, 216 
for testing. 10 fold CV 
Accuracy = 95.6 ± 1.5% 
Sensitivity = 97.4 ± 4.3% 
Specificity = 93.1 ± 3.6% 
 
Rojas, Gorriz, Ramirez et 
al., 2013 (63) 
 
Voxel intensities, independent 
component analysis (ICA) & 
principal component analysis 
(PCA) decomposition of voxel data 
(after applying empirical mode 
decomposition) within regions of 
interest 
SVM 80 local images (39 non-pre-
synaptic dopaminergic deficit 
(non-PDD), 41 PDD). Leave-
one-out CV 
Raw voxels: 
Accuracy = 87.5%, 
Sensitivity = 90.2%, 
Specificity = 84.6% 
ICA features. Maximum of: 
Accuracy = 91.2%, 
Sensitivity = 91.8%, 
Specificity = 92.9% 
PCA features. Maximum 
of: 
Accuracy = 95.0%, 
Sensitivity = 95.1%, 
Specificity = 94.9% 
Martinez-Murcia, Gorriz, 
Ramirez et al., 2018 (64) 
Downsampled voxel intensities CNNs – modified 
versions of 
ALEXNET and 
LENET5 
642 images from PPMI 
database (194 HC, 448 PD). 10 
fold stratified CV 
LENET5. Maximum of: 
Accuracy = 94.9 ± 2.5% 
Sensitivity = 94.0 ± 4.6% 
Specificity = 96.9 ± 5.1% 
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ALEXNET. Maximum of: 
Accuracy = 94.1 ± 4.5% 
Sensitivity = 96.7 ± 2.9% 
Specificity = 96.9 ± 7.2% 
Towey, Bain, Nijran, 2011 
(65) 
PCA decomposition of voxels 
within striatal region of interest 
Naïve-Bayes, 
Group prototype 
116 local images (37 non-PDD, 
79 PDD). Leave-one-out CV 
Naïve-Bayes: 
Accuracy = 94.8%, 
Sensitivity = 93.7%, 
Specificity = 97.3% 
Group prototype: 
Accuracy = 94.0%, 
Sensitivity = 93.7%, 
Specificity = 94.6% 
Segovia, Gorriz, Alvarez, 
2012 (66) 
Partial least squares 
decomposition of voxels within 
striatal regions 
SVM applied to 
hemispheres 
separately. RBF 
kernel 
189 local images (94 non-PDD, 
95 PDD). Leave-one-out CV 
Features varied from 1 to 
20. Maximum of: Accuracy 
= 94.7%, Sensitivity = 
93.2%, Specificity = 93.6% 
Martinez-Murcia, Gorriz, 
Ramirez et al., 2014 (67) 
ICA decomposition of selected 
voxels 
SVM, linear and 
with RBF kernel 
208 local images (100 non-PDD, 
108 PDD), 289 images from 
PPMI database (114 normal, 
175 PD). 30 fold CV 
RBF kernel. Maximum of: 
Accuracy = 94.7% 
Sensitivity = 98.1% 
Specificity = 92.0% 
Linear SVM. Maximum of: 
Accuracy = 92.8% 
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Sensitivity = 98.2% 
Specificity = 93.0% 
Kim, Wit, Thurston, 2018 
(68) 
Image voxel intensities in a single 
axial slice 
CNN – Inception 
v3 network 
108 local images for training, 45 
for hold out testing 
Maximum of: 
Accuracy = 84.4% 
Sensitivity = 96.3% 
Specificity = 66.7% 
Illan, Gorriz, Ramirez et 
al., 2012 (69) 
Image voxel intensities & image 
voxels within striatal region of 
interest 
Nearest mean, 
linear SVM 
208 local images (108 non-PDD, 
108 PDD). 30 random 
permutations CV, with 1/3 data 
held out for testing  
SVM. Maximum of: 
Sensitivity = 89.0%, 
Specificity = 93.2% 
Nearest mean. Maximum 
of: 
Sensitivity = 90.7%, 
Specificity = 84.0% 
k-NN. Maximum of: 
Sensitivity = 88.6%, 
Specificity = 86.9% 
Palumbo, Fravolini, Nuvoli 
et al., 2010 (70) 
 
Striatal binding ratios for caudates 
and putamena on 3 slices 
Probablistic 
Neural network 
(PNN), 
Classification tree 
(CT) 
216 local images (89 non-PDD, 
127 PD). Two fold CV, repeated 
1000 times 
PNN: 
For patients with essential 
tremor mean probability of 
correct classification = 
96.6 ± 2.6% 
CT: 
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For patients with Essential 
tremor mean probability of 
correct classification = 
93.5 ± 3.4% 
 
Table 1-3 Summary of machine learning algorithms applied to (I123)FP-CIT image classification in the literature since 2010, including reported 
performance figures. Articles are listed in order of accuracy. Where accuracy values are not available these are grouped towards the bottom of 
the table. Table is adapted from (1)
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A number of trends are immediately apparent from examination of Table 1-3. Firstly, the 
reported performance figures are universally high. Most accuracy values are greater than 
90%, with some authors reporting almost perfect performance. This contrasts with accuracy 
figures previously summarised for visual image analysis (see section 1.1.5), and for semi-
quantification (see section 1.2.1), which were typically in the 80-90% range. These results 
clearly show that established machine learning algorithms are a promising technology for 
creating CADx software. As in previous discussions however, these figures should be 
treated with a degree of caution. Not only is performance likely to be strongly related to the 
particular case mix in the database but the method of cross validation can also have a 
significant impact on results (71–73).  
 
The Parkinson‘s Progression Markers Initiative (PPMI) database of SPECT data (www.ppmi-
info.org/data) is cited by most authors as a source of validation data. This is perhaps 
unsurprising as the data is freely available to researchers, without the need to apply for 
ethical approval or to go through other lengthy governance processes. As patients were 
recruited prospectively, following a battery of other tests and screening stages, the 
diagnostic coding is likely to be relatively reliable. The other advantage of using the PPMI 
data is that it allows greater comparability between research studies. However, this research 
database is unlikely to reflect the patient cohorts seen in clinical nuclear medicine. The 
patient groups included are healthy controls, Parkinson‘s Disease and scans without 
evidence of dopaminergic deficit (SWEDD). In clinic, a range of atypical Parkinsonisms are 
seen, as well as DLB and other diseases which do not affect nigrostriatal pathways. 
Furthermore, patients were only included in the PD group if their SPECT scan showed DaT 
deficit (74), which may have excluded any patients for which signs of disease were subtle. 
The strict controls on imaging protocols, camera calibration steps and image reconstruction 
(75,76) also do not reflect clinical reality. 
 
The range of classifiers used by researchers is wide, although support vector machines 
(SVM), either in conventional linear form, or with a radial basis function (RBF) kernel, appear 
to dominate. This is likely to be because SVM was considered as a ‗state-of-the-art‘ 
algorithm up until relatively recently and had been successful in numerous classification 
problems. The image features extracted and used as input to the classifiers are varied. 
However, in most cases relatively simple features are chosen (such as raw voxel intensities 
and SBRs). This suggests that complex pre-processing is not required to achieve good 
classification performance. In general the most recent articles gave the highest accuracy 
figures, with some exceptions. This may be because authors have built upon the findings of 
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previous research work and sought to address limitations that were previously identified. The 
two-class classification paradigm dominates recent research, where the classifier is trained 
to separate out two different groups of data. Alternatively, the problem could be considered 
as a one-class system, where the classifier is trained to find the boundaries of one class 
within feature space, without explicit reference data from other diagnostic classes. 
 
Overall, analysis of previous literature on automated binary classification of (I123)FP-CIT 
images confirms that existing machine learning algorithms are associated with high 
accuracy, which is generally in excess of accuracy figures reported for human observers 
alone, and human observers assisted by semi-quantification software. However, given the 
differences in patient datasets, acquisition protocols and analysis methods direct comparison 
between these different approaches to diagnosis is associated with significant uncertainty.  
 
To date there has not been a direct, comprehensive comparison between semi-quantification 
methods and machine learning in terms of accuracy or any other performance metrics. 
Towey (65) did provide a comparison between two automated classifiers and a limited 
number of commercial semi-quantification tools. However, the dataset used was relatively 
small and there was a fundamental bias in the findings in that results for the semi-
quantification approaches were reported from the training data rather than from an 
independent test set. Furthermore, no machine learning algorithm has yet been tested in the 
clinic under realistic reporting conditions (e.g. in support of a human reporter).  
 
If CADx systems based on machine learning algorithms are to be used to benefit patient 
care these gaps in knowledge need to be filled, which is the main focus of this work. 
1.4 Discussion and objectives 
The introductory sections have laid out the clinical and technical background to Parkinsonian 
Syndromes and (I123)FP-CIT SPECT imaging. It was shown that image results can help to 
differentiate between patients with nigrostriatal dopaminergic deficit and those without, which 
is particularly useful in the early stages of disease. It is apparent that visual analysis of 
SPECT images is associated with relatively high but variable accuracy, sensitivity and 
specificity and that there is evidence of some discrepancies between reporters in some 
studies. In recent years the use of semi-quantification software as a diagnostic aid has 
become routine in clinical practice. There are numerous different ways of conducting semi-
quantification analysis and there are several commercial products available. The evidence 
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for clinical impact of semi-quantification is relatively limited, with no significant increase in 
reporting accuracy seen. However, results from the literature do suggest that greater 
concordance between reporters and increased confidence in diagnosis is possible when 
these tools are adopted in the clinic.  
 
There is evidence that machine learning algorithms are already sufficiently mature to offer 
high accuracy in the binary classification of (I123)FP-CIT images. One of the main 
advantages of such tools over semi-quantification is that the entire image can be distilled 
into a single classification metric, rather than a series of SBR figures and normal ranges, 
which, in an assisted reporting context, greatly simplifies the decision-making process for the 
reporting clinician and may lead to increased diagnostic performance. However, no direct 
comparison has yet been conducted against semi-quantification approaches and no tests 
have yet been conducted to assess the likely impact of existing machine learning algorithms 
on clinical reporting in a CADx scenario. 
 
Consequently, the main research question for this thesis is: 
 
How effective is a CADx tool, based on established machine learning algorithms, for 
assisted (I123)FP-CIT image reporting? 
 
Effectiveness will be measured in terms of independent classification accuracy and in terms 
of the impact upon human reporter accuracy, sensitivity, specificity and inter-reporter 
reliability. Studies will be conducted utilising realistic clinical data where possible and 
considering standard-of-care competing technologies (semi-quantification). 
 
In order to meet this research question a number of key objectives are proposed. These are 
summarised below. Figure 1-4 demonstrates how these objectives fit within the overall thesis 
workflow. 
 
Objectives: 
 
1) Select and implement machine learning classification tools. A limited number of 
promising machine learning algorithms will be selected and implemented in software 
for further evaluation 
2) Collect a database of (I123)FP-CIT images. Data will be extracted from the 
archives at Sheffield Teaching Hospitals NHS Foundation Trust following ethical 
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approval. All patient identifiable information will be removed. Gold standard diagnosis 
will be established from patient records. This ―local‖ database will be supplemented 
by data from the PPMI repository. All images will be pre-processed to enable further 
analysis  
3) Compare the performance of machine learning algorithms with semi-
quantification. A comprehensive range of semi-quantification methods will be 
selected and implemented. Cross validation will be carried out on the Sheffield data 
and the PPMI database to quantify the standalone effectiveness of machine learning-
based classification algorithms as compared to semi-quantification methods. This will 
provide an indication as to whether machine learning offers added benefits over 
existing assistive reporting technology, and will help to identify a single algorithm for 
use in the reporting exercise 
4) Develop software for testing of human reporters. Software will be created to 
enable measurement of human observer performance in reporting (I123)FP-CIT 
images. The software will mimic the interface used clinically for reporting patient 
data.  
5) Assess the impact of an automated classification tool, implemented as a CADx 
system, on reporting. After selecting the best performing machine learning 
algorithm from cross-validation results, studies will be conducted to assess the 
magnitude of impact of a CADx system on reporter performance, both quantitatively 
and qualitatively. This will be carried out via an initial, smaller-scale pilot study, 
followed by a larger scale clinical evaluation. 
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Figure 1-4 Thesis workflow 
 
In line with objectives 1 and 2, the next chapter in this thesis focuses on implementing 
algorithms and gathering data, laying the groundwork for chapter 3, where the standalone 
performance of machine learning algorithms and semi-quantification methods is compared. 
Chapter 4 then addresses objectives 4 and 5 through a reporting exercise, using a selected 
machine learning tool implemented as a CADx system. 
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2 Algorithms and data 
2.1 Machine learning algorithms 
Objectives addressed by this section (in black, bold): 
 
1) Select and implement machine learning classification tools 
2) Collect a database of (I123)FP-CIT images 
3) Compare the performance of machine learning algorithms with semi-quantification 
4) Develop software for testing of human reporters 
5) Assess the impact of an automated classification tool, implemented as a CADx 
system, on reporting 
Table 2-1 Objectives addressed in section 2.1 
 
This section focuses on identifying machine learning approaches from the literature that are 
likely to give the highest classification performance, and implementing them in software in 
preparation for a direct comparison with semi-quantification methods and a reporting study. 
As shown previously, classical machine learning algorithms require selection of both image 
features and a classifier. 
 
From Table 1-3 it is clear that SVMs (with and without RBF kernel) are the most prevalent 
classifiers from recent research and are associated with the highest classification scores. 
These classifiers were therefore chosen for implementation and evaluation. Further 
theoretical justification for selecting SVMs is provided in the following background sections. 
 
A number of different image features have been used as inputs to SVMs in previous work 
and there is no observable trend highlighting the particular suitability of one feature over 
another. This is largely due to the fact that most previous studies have involved selection 
and comparison of relatively few different feature types.  
 
Therefore, the features extracted for this thesis had to be selected according to different 
criteria. Features are chosen with the aim of reducing the image pre-processing required, 
maximising the potential for automation and minimising algorithm complexity. This will 
reduce the risk of unforeseen errors occurring in the reporting exercise and will reduce the 
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potential for increased uncertainties in pre-processing. If, for example, a more complex 
derived feature related to shape were chosen, image segmentation may be required, which 
is an imperfect process that can itself be affected by issues such as image noise.  
 
From the list of previously used features the following were chosen for initial evaluation: 
image voxels in the reconstructed image, SBRs and principal components of image voxels. 
These features have the added advantage that they have been investigated by multiple 
authors using different approaches and have all been associated with promising results. It 
was decided that features would not be combined but would be considered separately, as is 
largely the case in the recent literature. 
 
Diagnostic input features from other modalities were not included, as development of a 
CADx tool that does not rely on results of other tests being available, is likely to be more 
amenable to clinical translation. However, due to the known age dependency of tracer 
uptake, patient age was used as an added input to the classification algorithm in all cases. 
This ensured that the classifier modelled the relationship between age and other features.   
 
A summary of the different features and classifiers chosen for implementation and evaluation 
is shown in Figure 2-1. 
 
 
Figure 2-1 Summary of the feature – classifier combinations selected for implementation and 
evaluation 
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The following two sub-sections give a brief technical summary of Principal Component 
Analysis and Support Vector Machines respectively, two of the main methodologies chosen 
to form automated classification tools. The goal here is not to provide an exhaustive critique 
or in-depth mathematical analysis but to give enough information that the major advantages 
(and disadvantages) of the selected technologies used in this work can be demonstrated. 
These background sections are followed by details of the implemented machine learning 
pipelines. 
2.1.1 Technical background – Principal Component Analysis 
PCA is primarily used for dimensionality reduction, enabling representation of data with very 
large numbers of variables by a much smaller number of common components. One of the 
main benefits of PCA is that it can dramatically reduce computational time for classifier 
training. It is a technique that was established in the early 1900s and has been applied to 
numerous varied applications in the intervening years (77). 
 
PCA takes a set of observations (i.e. images) and projects them to a new subspace whose 
axes are orthonormal (78). PCA attempts to maximise the variance of the data along each 
projected axis. Thus, the majority of the variance in the original dataset can be described by 
the first few axes or principal components of the new space, thereby achieving a significant 
reduction in the number of dimensions required to adequately reconstruct the data. The 
magnitude of the linear components (which when combined reconstruct the object) uniquely 
characterises the object in PCA space. A simple example of PCA is demonstrated 
graphically in Figure 2-2. Here, PCA is applied to a set of two dimensional points. The first 
principal component (PC1) is placed along the line of highest variance. As can be seen, if 
the data points were to be described only by their position along PC1 they would be 
relatively well represented in the space, with little residual error. Thus, the same data can be 
well characterised using half the number of original variables. Given that PCA does not 
consider the labels of a particular class of data it is an unsupervised technique. 
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Figure 2-2 Example of PCA applied to a two dimensional dataset 
 
In mathematical terms PCA is a linear transformation of the form: 
 
      Eq 2.1 
  
Where   is the input sample matrix (whose rows represent variables and columns represent 
observations),   is the projection matrix and   is the transformed output. In image 
processing research the input matrix is often composed of separate vectors, each of which is 
a collection of pixel values from separate training images that have been concatenated into a 
1 dimensional form.  
 
The variance-covariance matrix of   defines the extent to which each of the variables within 
  are linearly associated with each other (i.e. covariance), and also the spread along each 
axis (i.e. variance). Variances occupy the diagonal matrix positions and co-variances occupy 
all other off-diagonal positions. For a sample of data taken from a larger population, 
covariance and variance can be calculated according to: 
 
 
   (   )   
(    ̅)(    ̅)
   
 
 
   
 (   ̅)  (   ̅)   Eq 2.2 
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Where   ,    represent individual values associated with two different variables within the 
sample,  ,  are vectors of all values associated with the two variables, and  ̅,  ̅ represent 
the variable means. The number of data points in the sample is defined by  . From the 
above it can be shown that the covariance of data with itself, i.e.    (   ) or    (   ), 
reduces to a statistic which is simply the variance of that data. It also follows that    (   ) = 
   (   ). 
 
If Y is a two dimensional system containing 4 samples, i.e.   (
        
      
 
    
    
), the 
variance-covariance matrix,   , can be written as: 
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Eq 2.3 
 
 
Where    ( ) and    ( ) are the variances of the two variables. If all the variables are 
mean centred (i.e. mean = 0) then the variance-covariance matrix simplifies to: 
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    Eq 2.4 
  
In most practical applications, such as in medical image processing, the matrices   and   
are likely to contain many more than 2 variables and 4 samples. Substituting the output 
matrix   in Eq 2.4 for the input matrix   (from Eq 2.1), and expanding for an unspecified 
number of variables, the following relationship is obtained: 
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   Eq 2.5 
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where each xi is a vector containing all the values or observations for one particular input 
variable (i.e. each row of X). PCA attempts to maximise the variance of the data along each 
projected axis (and consequently to minimise the co-variance between axes). The role of the 
projection matrix   is therefore to ensure that the co-variances of the transformed matrix   
are as close to zero as possible and the variances as large as possible. In effect PCA 
attempts to diagonalise CY. One method for achieving matrix diagonalization is to perform 
eigen-decomposition, which for the square, symmetric matrix XXT is defined as: 
 
         
         
Eq 2.6 
 
Where E is an orthonormal matrix containing the eigenvectors of XXT and D is a diagonal 
matrix containing the (real) eigenvalues. See Figure 2-3 for an illustrative example of this 
eigen-decomposition concept. 
 
 
Figure 2-3 Illustration of the eigen-decomposition concept as applied to the variance-
covariance matrix XXT 
 
If the rows of the projection matrix P are chosen to equal the eigenvectors (columns of E), 
such that     , then the equation for the variance-covariance matrix becomes: 
 
 
   
 
   
  (    )  
 
   
  Eq 2.7 
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Thus, the variance-covariance matrix of the output has been reduced to a diagonal matrix (of 
eigenvalues), which was the original goal of PCA. The principal components are the rows of 
P and are equal to the eigenvectors of XXT. There are as many principal components (with 
non-zero eigenvalues) as there are observations in the training data. In image processing 
research this is likely to be far fewer than the number of variables (i.e. number of voxels). 
The principal components are usually stated in order of reducing variance such that the first 
component describes the largest amount of variance in the data.  
 
In image processing and classification it is common to only use a small selection of derived 
principal components, often by choosing those which together represent a certain 
percentage of the overall variance in the data (77). This is because lower components with 
lower variance are often more likely to be made up of noise. In SPECT, where image noise 
is significant in comparison to other modalities, using only the first few principal components 
can help to remove the confounding effects of noise from algorithm training processes (78), 
which may help to improve the accuracy and robustness of the trained machine learning 
tool. 
 
The above eigen-decomposition is a common method for deriving principal components. 
However, other techniques are available. Singular value decomposition (SVD) is a 
computationally efficient method for deriving components that has been used in many 
applications (77). SVD theory states that the matrix X can be decomposed as follows: 
 
        Eq 2.8 
 
Where U and V are orthonormal matrices and ∑ is a diagonal matrix containing the singular 
values of X.  
 
If the variance-covariance matrix, XXT, is expanded according to the SVD definition, the 
following equation is obtained: 
 
      (    )(    )
 
       Eq 2.9 
   
Comparison of Eq 2.9 with the eigen-decomposition in Eq 2.6 demonstrates that the (non-
zero) singular values of XXT are equivalent to the square roots of the (non-zero) eigenvalues 
of XXT. It is also apparent that U is a matrix containing the eigenvectors of XXT. Thus, by 
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calculating the singular value decomposition of X it is possible to derive the principal 
components (and eigenvalues).  
 
In the following chapters SVD is used to compute principal components from training data. 
Test data are projected on to these components by matrix multiplication. For example, a test 
image, f (in vector form), can be projected on to the basis represented by U through the 
following equation:       , where c is a vector of coefficients describing the position of the 
image in the principal component (PC) subspace. The distribution of test image coefficients 
is used as an input to SVM classification in the following investigations. Unless otherwise 
stated it is always assumed that training and test data are mean centred (i.e. a mean image 
is subtracted from each case). 
 
PCA is a linear technique and as such its ability to represent systems where the underlying 
interactions between variables (or features) are non-linear is limited. Thus, more recently 
kernel PCA was introduced, whereby PCA is applied in a modified space dictated by a 
kernel function (79). Conventional PCA as a precursor to classification is also limited by its 
unsupervised nature. Choosing components according to the largest variance is not 
necessarily the best method for choosing a basis on to which to apply a classifier. However, 
due to its simplicity and wide-ranging, successful application in previous tasks (including for 
the task at hand) only conventional, linear PCA is applied as a dimensionality reduction 
method in this work.  
2.1.2 Technical background – Support Vector Machines 
A conventional SVM classifier is a supervised learning approach which attempts to draw a 
discrimination boundary between two classes of data. The boundary is created in such a 
way as to maximise the width of the margin between the samples in each class (a maximum-
margin approach). SVM has been successfully used in numerous diverse applications. For 
example, recent reviews provide an insight into its contribution to the fields of computational 
biology, remote sensing, bioinformatics and hydrology (80–83). It is perhaps unsurprising 
therefore, that SVM has become a popular choice for classification of (I123)FP-CIT images 
(see section 1.3.2). 
  
SVM is a type of linear classifier. This group of functions can be described as follows: 
 
  ( )        Eq 2.10 
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Where w represents a vector of weightings, x represents the (multidimensional) inputs, b is a 
bias term and f(x) is the algorithm output or the ‗decision‘ of the classifier. The goal of the 
classifier is to learn the model parameters (i.e. w and b) that are most appropriate for 
separating groups in the space defined by the inputs. SVM achieves this by focusing on the 
samples that are closest to the opposite class, on the edge of each group. These are the 
‗support vectors‘, as represented graphically in Figure 2-4.  
 
 
Figure 2-4 Graphical representation of classical SVM theory, where the goal is to define a 
maximal separating margin between class one (blue stars) and class 2 (red circles) 
 
In SVM         defines the separating plane between classes (  ). Since  ( 
    )  
  defines the same plane there is a free normalisation parameter, c, which can be selected. 
SVM normalises the linear equation such that there are 2 separate equations for the support 
vectors of each class: 
 
                     (  ) Eq 2.11 
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                        (  ) Eq 2.12 
 
Here, y indicates the binary class label. For linearly separable data any samples which are 
not support vectors will give  ( ) values of less than -1 or greater than 1, depending on 
class membership (see Figure 2-4). Noting that for any two arbitrary points along H0, a1 and 
a2: 
 
   (     )      Eq 2.13 
 
It is clear that the vector w is always normal to the surface of H0 (and to H1 and H2, which 
share the same gradient). The separation between the support vector planes    and    is 
the margin between the classes, which SVM attempts to maximise. The width of this margin 
can be calculated by recalling that the perpendicular distance (d) between a point (p0,q0) and 
a line (kx1 + lx2 + m = 0) is: 
 
 
  
|         |
√     
 Eq 2.14 
 
Therefore, taking an arbitrary point on H0, the perpendicular distance to H1, can be 
calculated from: 
 
 
  
|    |
√  
    
 
 
 
‖ ‖
 
Eq 2.15 
 
Where w1 and w2 are the individual components of the vector w and ‖ ‖ is the magnitude or 
norm of w. The total separation between H1 and H2  is double this length. The goal of SVM is 
therefore to maximise 
 
‖ ‖
. Inverting this expression, the objective function of SVM becomes 
the minimisation of ‖ ‖.  
 
This optimisation problem is subject to the following constraints, derived from Eq 2.11 and 
Eq 2.12: 
 
   ( 
     )                    Eq 2.16 
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Unfortunately, real world classification problems often involve data that are not linearly 
separable as shown in the simple example in Figure 2-4. However, SVM classifiers can still 
be useful in these circumstances if the objective function is modified to include additional 
terms. By introducing a slack variable (ε) to the constrained optimisation problem (see Eq 
2.17) samples are permitted to lie beyond the support vector margin of their particular class 
(see Figure 2-5).  
 
 
Figure 2-5 Graphical representations of soft-margin SVM, where complete linear separation 
between classes is not possible 
 
 
   
     
 
 
 
‖ ‖   ∑  
 
 
 
 
Eq 2.17 
 Subject to:    ( 
     )                                
 
The regularisation parameter C determines the relative contribution of the slack variable to 
the optimisation and balances the need for a large margin with that of maintaining the 
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constraints. In effect, the penalty for each margin violation is equal to   . A small value for C 
allows the constraints to be easily ignored such that many data points can violate the margin 
between classes, with outliers exerting less influence on the decision boundary. A large 
value for C ensures that the optimisation considers the constraints as more of a hard limit 
such that the optimal solution is likely to be a smaller margin hyperplane, which minimises 
the number of samples violating the margin. 
  
SVM with slack variables is the ‗soft margin‘ version of SVM (84), and is the approach used 
in this thesis as it provides a more robust approach to classification.  
 
One further alteration can be applied to this problem formulation to widen its potential scope 
of application. Input data may not be linearly separable in the input space and classification 
performance may be poor, even with the addition of slack variables. However, if data can be 
mapped to a higher dimensional space then linear separation may become feasible. This 
idea is highlighted in the simple example shown in Figure 2-6. In the left image two variables 
are displayed, taken from two different populations (described by either blue circles or red 
crosses). In this case linear discrimination will be ineffective. On the right is the same data 
but with the addition of a z-axis which is the sum of squares of the original variables. This 
graph shows a clear separation between the groups, with linear separation possible in the z-
axis. 
 
  
Figure 2-6 Illustration of the how mapping to a higher dimensional space can enable linear 
separation 
Mapping all points to a higher dimensional space before performing the classifier 
optimisation can be very computationally expensive. Therefore, researchers often employ 
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the ‗kernel trick‘ such that this mapping does not need to be performed directly. This involves 
taking the Lagrangian of the optimisation problem (Eq 2.17), examining the dual formulation 
and recognising that a kernel (similarity function) can be used in place of an inner product of 
data points that have been transformed to a higher dimensional space. The mathematics of 
these operations are not reproduced here as such steps are relatively unimportant in terms 
of demonstrating the broad concepts behind SVMs. 
 
There are a number of different kernels that can be used when training SVMs. Their main 
benefit is that the derived separating plane between classes, when projected onto the 
original data axes, can be non-linear. This greatly extends the scope of application of SVMs 
and is likely to be one of the main reasons why they have been so popular in the literature.  
 
One of the most commonly used kernels is the Gaussian kernel or Radial Basis Function 
(RBF) kernel (see Eq 2.18), the use of which is equivalent to implicitly applying the SVM in 
an infinitely large dimensional space. 
 
 
 (     )      ( 
‖     ‖
 
   
) Eq 2.18 
 
Where σ is a hyperparameter which controls the width of the Gaussian function. Smaller 
values of σ tend to make the SVM decision boundary (in the input feature space) more 
flexible with greater curvature, which means that the algorithm can be trained on highly non-
linear data but at the increasing risk of overfitting (i.e. high variance, lower bias). Larger 
values of σ lead to a smoother decision boundary with reduced curvature, which is less 
prone to overfitting (i.e. low variance, higher bias).  
 
The main disadvantage of introducing kernels into SVM algorithms is that there are 
additional hyperparameters that need to be selected, which if not chosen carefully could 
produce a classification function that is too highly tuned to training data (with subsequent 
lower performance on independent test data). It is not clear from the literature whether linear 
or non-linear forms of SVM are likely to be the most successful for (I123)FP-CIT 
classification, and so both approaches are implemented. 
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2.1.3 Algorithm pipelines 
For this work the well-established libSVM package (version 3.18, 
https://www.csie.ntu.edu.tw/~cjlin/libsvm/) (85) was adopted for training and implementing 
the SVM algorithms, utilised from within Matlab scripts. Prior to training each SVM algorithm 
all variables were normalised by subtracting the mean value and dividing by the standard 
deviation (available from training data). This was performed such that all variables are 
treated with equal weight during training. 
 
When using principal components as input features to SVM, images were first examined to 
establish which side of the brain had the lowest uptake within the striatum. This was 
achieved through examination of SBR figures (see 2.2.5 for details on how these were 
extracted from the data). The images were mirrored about the central axis, if necessary, in 
order to ensure that the striatum of lowest tracer uptake was always on the left side. This 
approach, as implemented by Towey (65), was performed in order that the effects of 
unilateral disease are not ameliorated in the projection on to principal component axes. The 
image reorientation process was also conducted when raw voxel intensities were used as 
features, in order that abnormal data had more similar appearances and would be clustered 
closer together in the classification space.  
 
When using image voxels or principal components as algorithm inputs, only the central 
portion of the image was of interest, containing the striata. The majority of the remaining 
brain, the skull and image background were not diagnostically significant. Thus, a loose 
region of interest was applied to all images. Voxel intensities outside of this region were 
masked out. Three different sized masks were investigated for each set of features and for 
each SVM model as it was unclear a-priori what size / volume would give the best 
performance. Different mask sizes were achieved by dilating the original mask different 
numbers of times. Dilating the mask once was equivalent to expanding the boundary of the 
mask by one voxel in all directions. Three different numbers of mask dilations were 
considered: 0, 2 and 4. As previously stated, patient age was also used as a separate input 
to the SVM classifiers, to force the algorithm to model the effects of this confounding variable 
on the classification result. 
 
An overall summary of the different machine learning algorithms that were implemented 
(including different input features) is shown in Figure 2-7.  
 
  
46 
 
 
 
Figure 2-7 Summary of the different machine learning algorithms that were implemented 
(adapted from (1)) 
In total, considering all the different input features and both linear and non-linear SVM 
classifiers, there were 47 distinct machine learning approaches that were implemented in 
software. These are summarised in Table 2-2. 
 
Machine 
learning 
algorithm 
Input 
feature 
No. of 
PCs 
Dilate 
(times) 
SVM 
Kernel 
ML 1, 2, 3 PCs 1 0, 2, 4 Linear 
ML 4, 5, 6 PCs 2 0, 2, 4 Linear 
ML 7, 8, 9 PCs 3 0, 2, 4 Linear 
ML 10, 11, 12 PCs 5 0, 2, 4 Linear 
ML 13, 14, 15 PCs 10 0, 2, 4 Linear 
ML 16, 17, 18 PCs 15 0, 2, 4 Linear 
ML 19, 20, 21 PCs 20 0, 2, 4 Linear 
ML 22, 23, 24 PCs 1 0, 2, 4 RBF 
ML 25, 26, 27 PCs 2 0, 2, 4 RBF 
ML 28, 29, 30 PCs 3 0, 2, 4 RBF 
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ML 31, 32, 33 PCs 5 0, 2, 4 RBF 
ML 34, 35, 36 PCs 10 0, 2, 4 RBF 
ML 37, 38, 39 PCs 15 0, 2, 4 RBF 
ML 40, 41, 42 PCs 20 0, 2, 4 RBF 
ML 43, 44, 45 Pixels - 0, 2, 4 Linear 
ML 46 SBR - - Linear 
ML 47 SBR - - RBF 
Table 2-2 List of the distinct machine learning algorithms developed and implemented in 
Matlab software. For each algorithm patient age was used as an additional input feature to 
the classifier (adapted from (1)) 
2.2 Patient data 
Objectives addressed by this section (in black, bold): 
 
1) Select and implement machine learning classification tools 
2) Collect a database of (I123)FP-CIT images 
3) Compare the performance of machine learning algorithms with semi-quantification 
4) Develop software for testing of human reporters 
5) Assess the impact of an automated classification tool, implemented as a CADx 
system, on reporting 
Table 2-3 Objectives addressed in section 2.2 
Two types of patient data were collected and used throughout this work, clinically-acquired 
retrospective data and prospective research data acquired from a clinical trial (the PPMI 
database). The former is key for ensuring that findings from all the investigations in this 
study are relevant to the clinic. The latter is likely to be associated with fewer confounding 
variables, as all data were acquired according to a tight research protocol, which will add 
certainty to any trends identified in clinical data. Furthermore, inclusion of the PPMI data 
enables results to be compared with those of other authors, giving context to the methods 
employed here. 
 
The following sub-sections provide more details on the characteristics of these two datasets, 
and the additional image processing that was carried out in preparation for performance 
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tests of machine learning algorithms and semi-quantification methods. Many of the details of 
these datasets are also discussed in a peer-reviewed publication (1). 
2.2.1 Clinical images and reference classification (“local data”) 
Approval was sought and granted by City and East Research Ethics Committee 
(15/LO/0736) to extract all (I123)FP-CIT images from the archives at Sheffield Teaching 
Hospital NHS Foundation Trust (acquired up until June 2015). All these images were 
acquired under standard conditions (see Table 2-4), other than the stopping conditions 
which were set a constant 30s per projection, rather than acquiring according to counts. Four 
scanners were used to acquire the data, namely three GE Infinia cameras and one GE 
Millenium scanner (all manufactured by GE Healthcare). No specific inter-scanner calibration 
was conducted so it is likely that there may be small systematic differences in semi-
quantification results between systems. Reconstruction was conducted on the same system 
in all cases with the same settings: GE Xeleris v2.1 with 2 iterations, 10 subsets and 
Butterworth post-filter (order 10 cut-off 0.7). 
 
Parameter Value 
Administered activity 167-185 MBq 
Injection-to-scan delay 3-6 hours 
Acquisition time 30 minutes 
Acquisition pixel size 3.68 mm 
Number of projections 60 per head (over 180o) 
Energy window 159 keV ± 10% 
Acquisition matrix size 128 x 128 
Table 2-4 Summary of clinical data acquisition parameters 
 
Cases where image quality was very poor, as highlighted by the image report, were 
excluded from the database. In addition, cases where significant previous vascular disease 
had been highlighted in the image report were excluded. This ensured that the pattern of 
dopaminergic function was unaffected by infarcts at or near the striatum. 
 
Once extracted, each image required a ‗gold-standard‘ diagnostic classification. It was 
intended that this information would be derived from examination of clinical notes over an 
extended period of time following SPECT imaging by expert neurologists. This would bring 
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the study in to line with other literature examining the accuracy of (I123)FP-CIT imaging. 
However, due to resource constraints, only a subset of the available images could be 
classified in this way (subset A). As an additional, alternative method (and consistent with 
subset B), the image reports for each patient were examined. The overall conclusion of the 
reporting radiologists was used to provide a 3 level classification, using a scoring system 
from 1-5 to reflect the level of confidence that the radiologists had in their findings. The 
scoring system was as follows: 
 
 1 = definitely abnormal appearances 
 2 = more likely abnormal than normal 
 3 = equivocal 
 4 = more likely normal than abnormal 
 5 = definitely normal appearances 
 
At Sheffield (I123)FP-CIT images are all reported by two radiologists together, with 
additional contribution from a trained Clinical Scientist. In recent years semi-quantification 
results have also been provided to the reporting team, although very few patients in the 
cohort were reported with this additional information. Reporting radiologists have access to 
the patient‘s previous imaging results and relevant clinical information (such as presenting 
symptoms). This comprehensive approach to reporting should ensure that results are 
reflective of the best performance achievable from visual image analysis. Patients for whom 
only an image report was available for generating the reference diagnosis are considered to 
be part of subset B. 
 
Results 
 
In total 389 images were extracted from the archives. There were 55 cases where clinical 
follow-up by 2 neurologists had established a diagnosis with high confidence (subset A). The 
mean time of follow-up post SPECT imaging was 31 months, with a minimum of 15 months 
and maximum 51 months. There were 34 male and 21 female patients in this subset. At the 
time of scanning their mean age was 66 years (SD = 11 years) with a maximum of 80 and 
minimum 29 years. The patient characteristics of subset A are highlighted in Table 2-5. 
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Subset A 
 
Diagnosis Classification group Number of 
patients 
Parkinson‘s 
Disease 
Patients with pre-
synaptic dopaminergic 
deficit (abnormal 
appearances) 
29 
Dementia with Lewy 
Bodies 
4 
Drug induced 
Parkinsonism 
Patients without pre-
synaptic dopaminergic 
deficit (normal 
appearances) 
5 
Hydrocephalus 1 
Multiple Sclerosis 1 
Essential tremor 10 
Dystonia 3 
Alzheimer‘s 
Disease 
2 
Table 2-5 Diagnostic categories and patient numbers for the 55 patients where diagnosis 
could be confirmed through long term follow-up, with high confidence (subset A) 
 
The other 306 images were classified into ‗normal appearances‘, ‗abnormal appearances‘ 
and ‗equivocal‘ groups using the image report only (subset B). Of these, the majority were 
reported with high confidence. As shown by Table 2-6, only one patient had an equivocal 
report, dictating that the classification was essentially binary. For this larger subset the mean 
age was 69 years (SD = 13 years), with a maximum of 92 years and minimum of 18 years. 
There were 194 males and 112 females. 
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Subset B 
 
Score Classification group Number of 
patients 
1 Patients with pre-synaptic 
dopaminergic deficit (abnormal 
appearances) 
174 
2 17 
3 equivocal 1 
4 Patients without pre-synaptic 
dopaminergic deficit (normal 
appearances) 
29 
5 84 
Table 2-6 Patient numbers and classification grouping for patients with no clinical diagnosis 
(subset B) 
 
To assess the likely discrepancy between the two methods of classification, the clinical 
diagnosis of the 55 patients in subset A was compared to their image reporting scores in 
terms of accuracy. For the 31 patients with a reporting score of 1, there was 1 discrepancy 
with clinical follow-up results. For the 2 patients with a score of 2 there was also 1 
discrepancy. For patients with a score of 4 or 5 there was complete agreement with the 
clinical follow-up results. Thus, if patients with scores of 1 and 2 are lumped together into an 
abnormal group, and those with scores of 4 and 5 lumped together into a normal group, the 
overall error in binary classification is only 3.6% between conventional image reporting and 
clinical follow-up. The specificity is 100% and sensitivity 94%. This suggests that the current 
clinical reporting system is relatively cautious, keeping the false negative rate low at the 
expense of slightly reduced sensitivity. However, overall, results provide a level of 
reassurance as to the reliability of radiologists‘ reports. Moreover, this level of error is 
smaller than that seen in the previous literature review on the accuracy of visual analysis 
(where error was generally 10-20%, see section 1.1.5). This may be due to the influence of 
other imaging data and clinical feature information that was available to radiologists, but 
which is generally excluded from previous studies on (I123)FP-CIT accuracy. It could also be 
because this particular cohort of patients was relatively easy to classify. Whatever the 
underlying causes, these results provide evidence that for the larger patient group (subset 
B), the impact of non-gold standard classification is likely to be relatively small.  
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Discussion 
 
Given the two-tiered nature of the clinical data acquired from Sheffield, careful consideration 
was given to how each subset should be used. Subset A, with the more dependable 
diagnostic information, was kept aside for the most critical investigations in this study, where 
reliability of results was of highest importance. For this thesis, these investigations were 
considered to be the examinations of impact on radiologist performance, as evidence of 
impact in a real reporting scenario is likely to be key to judging the overall success of 
machine learning algorithms.  
 
It was decided that subset B (without the singular equivocal case) would be used for cross-
validation investigations, where the goal was to compare the standalone performance of 
semi-quantification and machine learning algorithms. It would also be used for algorithm 
training in later clinical studies. The justification for this was that algorithms trained to 
achieve the level of performance of an expert reporting team are still likely to be clinically 
useful. Furthermore, comparisons of cross validation metrics are unlikely to be significantly 
biased by a slightly increased level of uncertainty in the reference classification. The relative 
performance of each algorithm is key here, not the overall level of performance. 
 
A possible solution for reducing discrepancies between subsets A and B would be to exclude 
all data from subset B with a score of 2, 3 or 4, only keeping data that was either definitely 
normal or definitely abnormal. However, this would bias the trained algorithms and cross-
validation results towards a situation that did not reflect clinical reality, where images are 
sometimes difficult to classify. This approach was therefore rejected. 
 
SBR values were calculated for each patient in each subset following further image pre-
processing, which is summarised in later sections. 
2.2.2 Research data – PPMI database 
The PPMI dataset is a large online repository of diagnostic data from patients with PD and 
healthy controls, funded by the Michael J Fox foundation for Parkinson‘s Research. Different 
forms of Parkinsonism are explicitly excluded from the study, in contrast to the Sheffield 
data. As discussed previously, data were acquired prospectively from recruited patients. The 
full study protocol can be downloaded from the website (http://www.ppmi-info.org/). In 
summary, a battery of tests was applied to each recruit in order to assign them to a particular 
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diagnostic group. This methodology could dictate that the reference diagnosis is associated 
with reduced uncertainty as compared to the Sheffield data, particularly in comparison to the 
patients in subset B. For (I123)FP-CIT imaging specifically, the scanning protocol was 
largely similar to that used in Sheffield (see Table 2-7), other than imaging time which was 
set to a narrower window of 4 ± 0.5 hours post injection. In addition, Co57 markers were 
attached to each patient‘s head to enable correct orientation in subsequent processing. 
Specific scan parameters related to the collimators used and acquisition mode were set for 
each site and each scanner following initial assessment of phantom scans (75).  
 
Parameter PPMI database 
Administered activity 111-185 MBq 
Injection-to-scan delay 3.5-4.5 hours 
Acquisition time 30-45 minutes 
Acquisition pixel size Variable (scanner dependent) 
Number of projections 120 per head (over 360o) 
Energy window 159 keV ± 10% and 122 keV ± 10% 
Acquisition matrix size 128 x 128 
Table 2-7 Summary of PPMI data acquisition parameters 
 
Reconstruction was performed by a core lab, using Hermes HOSEM software (Hermes 
Medical), with 8 iterations, 8 subsets and a 6 mm Gaussian post-filter. This is quite different 
to the parameters used clinically for reconstruction at Sheffield. Furthermore, the 
reconstructed data available to download from the PPMI website is already non-linearly 
registered to a template (although the exact methodology is not clear). Images are also 
supplied with attenuation correction (through Chang‘s method (86)) applied.  
 
Following reconstruction, the PPMI core lab calculated SBR values for all the SPECT 
datasets. These were derived using PMOD software (PMOD Technologies LLC), by taking 
the 8 axial slices with greatest striatal uptake and summing together to create a compressed 
2D slice, to which regions of interest were applied (76). 
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Results 
 
All screening SPECT images from the PPMI repository were downloaded. This included 
images from 209 healthy controls and 448 PD patients i.e. 32% of the data was from 
patients with normal image appearances. These proportions were similar to that of subset A 
(40% normal appearances) and subset B (37% normal appearances). The mean age of the 
PPMI dataset was 61 years (SD of 10 years), which is similar but slightly lower than that 
seen in the Sheffield data. For comparison, the mean age of the healthy controls alone was 
also 61 years. Maximum and minimum ages for the combined PPMI dataset were 85 years 
and 31 years respectively. Thus, the age range covered is similarly wide to that of the 
Sheffield data. There were 232 females and 425 males in the PPMI database. In addition to 
the imaging data, SBR values calculated by the core lab were also downloaded from the 
PPMI website.  
 
Discussion 
 
There are a number of differences between the local and PPMI data that could impact on 
results. Firstly, the higher number of expectation maximisation equivalent iterations used for 
the PPMI data is likely to produce images with higher noise but greater contrast, which may 
improve contrast between striatum and background, particularly for borderline classification 
cases (47). This could possibly make the binary classification task simpler for machine 
learning / semi-quantification software.  
 
The use of non-linear registration for PPMI data may have caused some warping of striatal 
shape, which may impact upon semi-quantification and machine learning algorithms. The 
attenuation correction applied can help to reduce inter-patient differences in striatal 
appearances from variations in head geometry between subjects. This was not applied to 
the Sheffield data and so, again, this may cause the PPMI data to be incrementally easier to 
classify through a machine learning tool.  
 
There are other key differences between the PPMI dataset and the Sheffield dataset that 
should be kept in mind in the following investigations. Firstly, each site involved in the PPMI 
study was required to scan a phantom prior to each patient. This provided calibration data, 
which were applied to reconstructed patient images in order to remove systematic inter-site 
and inter-scanner differences. This procedure was not performed for the Sheffield data (and 
is not mandatory according to clinical guidelines), which suggests that the PPMI data may be 
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associated with reduced systematic error between acquisition equipment. Furthermore, as 
highlighted previously, patients were only included in the PD group if visual analysis of their 
SPECT data showed reduced nigrostriatal dopaminergic function. By explicitly excluding 
patients with PD symptoms but normal SPECT appearances, the dataset is likely to be 
biased towards more favourable classification accuracies when image analysis techniques 
are applied. 
 
Overall, the differences between local data and the PPMI database favour increased 
classification performance for the PPMI data. The different databases are therefore kept 
separate in the following investigations.  
 
The local image data and PPMI data required pre-processing, to different extents, before 
SVM algorithm training. SBR figures also needed to be extracted from local data. The 
developed methods for carrying out these steps are described briefly in the following three 
sub-sections. In each of these sections theoretical details are only discussed briefly. The 
reader is reminded that the focus of this work is on the implementation and evaluation of 
existing technology, not on development of fundamentally new classification concepts.  
2.2.3 Image pre-processing: spatial normalisation (local data only) 
Registration or spatial normalisation is crucial for maximising performance for the chosen 
machine learning approach. Each voxel in each image is effectively considered to be at the 
same geometric location in the patient‘s body, for all of the features considered. Significant 
variability in patient positioning can therefore cause a significant shift in where each 
particular input variable lies in the feature space, leading the SVM algorithm to define a 
separating hyperplane between classes in an inappropriate position.  
 
The PPMI images were downloaded having already been registered to a template by the trial 
core lab team and so required no further spatial normalisation. In contrast, the images 
extracted from the local hospital archives were orientated in the original patient positions on 
the scanner bed.  
 
Application of a fully non-rigid registration to local data would be likely to provide a mapping 
that gave the closest fit between each image and a template, thereby minimising geometric 
differences. Indeed, the PPMI data were all processed using a non-rigid translation step by 
the co-ordinating core lab. However, it was decided that registration of local data should be 
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restricted to an affine transformation (which only permits rotation, scaling, translation and 
shearing in all dimensions). Such rigid registration ensures that the shape of the striata 
cannot be significantly warped after registration. A non-rigid registration that was poorly 
constrained could cause an apparently abnormal image, with ‗full stop‘ striatal appearances, 
to be stretched into the shape of a comma if the template image was a normal dataset 
(which is often the case).  
 
Image registration is itself a wide and established scientific field with a variety of approaches 
described in the literature (87), many of which share the same basic concepts as machine 
learning (i.e. most methods are based on minimisation of an objective function). For this 
study a reliable, proven technology was required to perform image registration. Finding a 
technique that is likely to work consistently across a range of patient studies is of utmost 
importance for a tool designed for clinical use and so this was the major consideration. 
Searching out the best performing algorithm for the relatively limited datasets considered in 
this work was a secondary consideration. The Sheffield Image Registration Toolkit (ShIRT 
(88)) is an established technology that has previously shown good results in the registration 
of nuclear medicine data (89,90). It is based on minimisation of the squared differences 
between intensity values in pixels in corresponding positions on two images, which is a 
commonly used cost function in many registration algorithms.  Importantly, ShIRT has been 
used successfully in numerous clinical applications within Sheffield Teaching Hospitals for 
over 10 years. It was therefore an ideal candidate for the registration task in this study. 
 
ShIRT, as with many other registration tools, requires parameters to be set by the user. In 
addition, it is common to apply registration in stages, to iteratively bring images into 
alignment. In order to evaluate the success of different parameter choices and different 
combinations of processing stages, suitable metrics are required. In the following 
investigation a combination of qualitative and quantitative assessments were used, visual 
scoring and Dice Similarity Coefficients (DSCs) (91,92). These are two of the most 
commonly applied strategies for optimising registration procedures. Although each is 
associated with well-known limitations (subjectivity in the case of visual scoring and 
sensitivity to segmentation inaccuracies in the case of DSC), they are simple to implement 
and in combination should enable the development of a well optimised registration approach. 
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Method 
 
Spatial normalisation first required the creation of a suitable template image to provide a 
fixed target geometry. This was created from non-linear registration (again using ShIRT) of 
10 patient cases without dopaminergic deficit to a single dataset, followed by averaging of all 
voxels in all images. The combined template was then manually re-aligned, to ensure that 
the long axis of the head was along the middle of the image and that there was no right to 
left rotation. Finally, the left half of the template brain was reflected about the centreline to 
produce a template image with identical striatal structures on each side. This procedure is 
summarised by the flowchart in Figure 2-8. 
 
 
 
Figure 2-8 Flow diagram depicting the process for creating a registration template 
 
The goal of registration was to automatically bring the striata in each local patient image into 
alignment with that of the template. Registration accuracy in the caudate and putamen was 
therefore of most interest. Relative alignment of other brain tissues was considered to be 
relatively unimportant. This prioritisation is reflected in the evaluation procedure. After each 
iterative registration step, where a different combination of registration parameters and 
processing procedures were tried out, each registered image was overlaid on the 
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corresponding template, one at a time. Visual analysis focused on the discrepancy in striatal 
boundary between each database image and the template. DSC was calculated for images 
from the non-PDD class through a simple segmentation process, whereby volumes of 
interest for the test image and template were defined via the application of a threshold at 
20% of the maximum voxel intensity value in the image. The volumetric overlap of these 
segmentations was then calculated to give a DSC figure (see Figure 2-9 for a formal 
definition of DSC). DSC values for images from patients with PDD were not calculated as the 
striatal shapes in these images were expected to be very different to that of the template and 
thus DSC would be low whether an appropriate registration was achieved or not. For these 
images only qualitative analysis was used. 
 
 
Figure 2-9 Dice similarity coefficient definition 
 
Since the goal was to develop a tool that was robust to a range of image appearances, there 
was more of an emphasis on finding a technique that registered striata well in all images, 
rather than one that worked exceptionally well with just a few images. The optimal image 
registration procedure that was derived is summarised in Figure 2-10. In line with many other 
medical registration processes, the first stage involves a coarse registration of the test image 
to the template. This was followed by finer registration stages considering the left and right 
sides of the brain separately. In each registration step a loose registration mask was defined 
over the striatal region in the template image, such that registration focused on achieving 
spatial concordance in the striatal area. The DSC scores for the non-PDD images following 
this fully automated technique are shown in Table 2-8.  
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Figure 2-10 Flow diagram of the optimal registration procedure 
Results 
 
The similarity coefficients for datasets B and A were generally very similar and high (see 
Table 2-8), although the minimum reported value was lower for subset B than subset A 
 
Dice Similarity 
Coefficient 
Local data (subset 
A) 
Local data (subset 
B) 
Max 0.89 0.90 
Median 0.84 0.84 
Min 0.77 0.70 
Table 2-8 DSC results for data with a non-PDD classification, following registration 
optimisation 
Discussion 
 
The DSC results indicate that the registration method was similarly successful for both 
subset A and subset B, with a similar spread of values in each case. This implies that the 
method is likely to be successful for a wide variety of patient images. Given that registration 
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was constrained to an affine transformation, concordance between the striata of test images 
and the templates was unlikely to be complete. Furthermore, the simple thresholding method 
used for quantitative evaluation is likely to have been an imperfect method for striatal 
segmentation. Thus, the fact that DSC results fell as low as 0.70 was perhaps unsurprising. 
On visual inspection, after applying the optimum registration technique, there were no 
datasets where registration errors between test images and the template were felt to be 
significant. 
2.2.4 Image pre-processing: intensity normalisation (both PPMI and local data) 
Voxel intensities within a SPECT image can vary depending on a variety of patient and 
technical factors, including time between tracer administration and imaging, biological 
clearance rate, image acquisition time and camera sensitivity. Thus, some form of voxel 
intensity normalisation is usually required to reduce this confounding inter-subject variability 
before training a classifier, particularly when the voxels themselves are used as features. In 
this study, an approach was adopted that has previously been cited by many other 
researchers, namely normalisation of all image counts to the occipital lobe. In most patients 
this area of the brain is a region of relatively uniform, non-specific uptake. Dividing all voxel 
intensities in the image by the mean intensity within the occipital lobe is, in effect, a very 
similar calculation procedure to that required for calculating SBRs, where the mean counts in 
striatal regions are divided by a mean non-specific uptake value. This procedure causes 
voxel intensities to become a measure of contrast, which is independent of many of the 
patient and technical factors previously cited. 
 
The mean uptake in the occipital lobe was defined for each image in the PPMI and Sheffield 
datasets by applying a database-specific volume of interest. For the local data this volume 
was manually defined on the template image and transferred to each test image after the 
first coarse registration stage (see Figure 2-10). Normalisation was then applied. For the 
PPMI data the volume was manually defined on a single case and then propagated to all 
other (pre-registered) images in the dataset. 
 
There are a number of additional pre-processing options that could be considered before 
semi-quantification or machine learning is applied. For instance, additional image smoothing 
could be applied to reduce noise. The reconstruction parameters could be altered in order to 
change the contrast between the striata and background. However, in this study the default 
reconstruction parameters and image filtering steps of each database were left unaltered. No 
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optimisation of these factors was carried out as each set of data had already been optimised 
to some extent. For instance, the processing applied to the Sheffield data was designed to 
enable the best visual classification performance in the clinic. Given that more distinct image 
appearances for each classification group are also likely to give a greater contrast in 
extracted image features, it was likely that the existing image processing steps were already 
suitable for achieving good classification performance.  
 
If clinical performance of machine learning algorithms was found to be insufficient using the 
default reconstruction and filtering parameters then these would be re-evaluated as part of a 
whole processing pipeline re-assessment. 
2.2.5 Extracting SBRs from local data 
In order to compute the performance of the different semi-quantification approaches, and to 
provide SBR values for input to SVM algorithms, a method for extracting SBR figures from 
the local clinical images was required (PPMI data is downloaded with SBR figures already 
available). Having already registered the images to the same spatial location, a single series 
of regions needed to be defined on the registration template image, which could then be 
applied to all patients. 
 
The boundaries of the tissues of interest were defined by adapting the template from an 
established commercial semi-quantification tool (MIM Neuro analysis v6.6, MIM software). 
The regions of interest defined for the MIM Neuro analysis template were warped to the 
space of the registration template used in this study, using non-linear registration (again 
implemented with ShIRT). Using these transformed regions, SBRs were calculated for every 
local clinical image by finding the ratio of uptake within caudate and putamenal regions as 
compared to the occipital lobe according to Eq 1.1 in chapter 1. 
2.2.6 Conclusion 
This chapter has demonstrated production of training and test datasets and methods for 
extracting SBR figures. These are used in the following chapters, first for comparing the 
performance of semi-quantification and machine learning tools, and then for evaluating the 
impact of CADx on reporter performance. 
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3 Comparison of semi-quantification and machine 
learning 
Objectives addressed by this section (in black, bold): 
 
1) Select and implement machine learning classification tools 
2) Collect a database of (I123)FP-CIT images 
3) Compare the performance of machine learning algorithms with semi-
quantification 
4) Develop software for testing of human reporters 
5) Assess the impact of an automated classification tool, implemented as a CADx 
system, on reporting 
Table 3-1 Objectives addressed in section 3 
 
This chapter compares the standalone performance of established machine learning 
algorithms and a range of semi-quantification methods. A comprehensive, fair comparison 
between semi-quantification and machine learning, using the same data and validation 
methods for both approaches, has not yet been conducted in the literature. However, this is 
a vital step in understanding whether machine learning tools are effective classifiers for 
(I123)FP-CIT and whether they are likely to offer benefits above and beyond existing clinical 
tools. Furthermore, by conducting a wide comparison exercise, it will be possible to identify 
the most promising machine learning tool for use in the subsequent CADx reporting 
investigation.  
 
A summary of this chapter was written for publication in a peer reviewed journal (1). Many of 
the methods, results and discussion are reported in this document. 
3.1 Semi-quantification 
In order that the potential diagnostic performance of semi-quantification is fairly represented, 
a range of semi-quantification methods needed to be defined. One approach would have 
been to use all the available commercial software for (I123)FP-CIT imaging. However, 
obtaining access to all examples of such (expensive) software was impractical. Furthermore, 
by only relying on the tools that are currently commercially available, the range of calculation 
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methods is likely to be limited. In this work a number of methods were defined within a single 
software analysis platform (Matlab), covering the majority of approaches cited by both 
commercial tools and those discussed in the literature. These are described below 
3.1.1 Selected methods 
One of the main differences between semi-quantification approaches described in the 
literature is the number and type of SBRs and uptake ratios that are output by the software. 
As described previously, multiple quantities and associated normal ranges may be displayed 
to the clinician. If just one of these quantities falls outside its associated normal range a 
clinician may classify the whole image as abnormal. Furthermore, the greater the number of 
quantitative figures displayed, the greater the chances that one of these will fall outside its 
normal range by chance (i.e. the greater the chances of type I statistical error). Therefore, in 
this investigation, only SBRs from the putamen and caudate were extracted, to avoid overly 
pessimistic performance results. These were used for classification in two different ways, 
considering the putamen only and the caudate and putamen together. 
 
Semi-quantitative methods also differ in how they are compared to normal ranges and how 
they take account of the known correlation between age and SBR. One common approach is 
to establish the mean from healthy patients within a 10 year age window of the test sample, 
for each SBR result. The suggested cut-off may be established, for example, from a value 
that is a number of standard deviations from the healthy control mean (typically between 1 
and 2 standard deviations). A similar alternative would be to establish a cut-off from the 
minimum of age matched controls. A third approach would be to perform a linear regression 
(of SBR value against age) on available training data from normal patients. The predicted 
SBR for the test sample can then be derived from the fitted line and a cut-off set according a 
number of standard errors on the regression coefficients. All three of these methods are 
implemented in the following investigation. 
 
Another difference between semi-quantification approaches relates to the nature of the 
training data used to define the cut off in SBR values between the normal and abnormal 
class. So far it has been assumed that only data from healthy (or non-Parkinsonian) patients 
is used for learning the value of such cut-offs. However, this ‗one class‘ approach is 
fundamentally limited since, without knowledge of where the abnormal group lies in the 
classification space, it is less likely that an optimum cut-off will be found. Therefore, in this 
investigation a two class semi-quantification approach is also tested, whereby analysis of the 
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ROC curve derived from SBR values of normal and abnormal training data is used to find the 
cut-off which achieves the highest accuracy in binary separation of the two classes. This is 
then applied to the test sample. 
 
All of these different approaches to semi-quantification were implemented for direct 
comparison with the previously described machine learning algorithms. Table 3-2 
summarises the key characteristics of all the different semi-quantification methods utilised in 
this work.  
 
Semi-quantification 
method 
Comparison data SBRs considered SBR cut-offs 
defined by 
SQ 1 Age-matched 
normals 
Left and right 
putamen  
Mean – 2SD 
SQ 2 Age-matched 
normals 
Left and right 
putamen and 
caudate 
Mean – 2SD 
SQ 3 Age-matched 
normals 
Left and right 
putamen only 
Mean – 1.5SD 
SQ 4 Age-matched 
normals 
Left and right 
putamen and 
caudate 
Mean – 1.5SD 
SQ 5 Age-matched 
normals 
Left and right 
putamen  
Mean – 1SD 
SQ 6 Age-matched 
normals 
Left and right 
putamen and 
caudate 
Mean – 1SD 
SQ 7 Age-matched 
normals 
Left and right 
putamen  
Minimum 
SQ 8 Age-matched 
normals 
Left and right 
putamen and 
caudate 
Minimum 
SQ 9 All normals Left and right 
putamen  
Linear regression -
2SE 
SQ 10 All normals Left and right 
putamen and 
Linear regression -
2SE 
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caudate 
SQ 11 All normals Left and right 
putamen  
Linear regression -
1.5SE 
SQ 12 All normals Left and right 
putamen and 
caudate 
Linear regression -
1.5SE 
SQ 13 All normals Left and right 
putamen  
Linear regression -
1SE 
SQ 14 All normals Left and right 
putamen and 
caudate 
Linear regression -
1SE 
SQ 15 All normals and 
abnormals 
Lowest putamen Optimal point on 
ROC curve 
SQ 16 All normals and 
abnormals 
Lowest putamen and 
lowest caudate 
Optimal point on 
ROC curve 
SQ 17 Age matched 
normals and 
abnormals 
Lowest putamen Optimal point on 
ROC curve 
SQ 18 Age matched 
normals and 
abnormals 
Lowest putamen and 
lowest caudate 
Optimal point on 
ROC curve 
Table 3-2 Summary of the semi-quantification methods implemented for classification 
performance comparison (adapted from (1)) 
3.2 Cross-validation 
Fair comparison between the standalone performance of machine learning algorithms and 
semi-quantification methods is vital for assessing whether machine learning offers any 
potential benefit over existing clinical decision support technology. However, unfortunately, 
there are many examples in the literature of poor evaluation methodology being applied to 
image classification or regression algorithms, dictating that results are unreliable (93,94). 
This work is different in that clinical translation is seen as the ideal end goal, and evaluation 
techniques are deliberately adopted to ensure, as far as possible, that results reflect likely 
clinical performance.   
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In the following investigations it is assumed that the optimal form of an SVM algorithm 
(including optimal choice of hyperparameters such as the C value) is unknown a-priori, and 
needs to be derived as part of the training process. In these circumstances data used for 
training, choosing hyper-parameters and estimating performance should be fully 
independent to avoid over-optimistic bias.  
 
For the following investigation a repeated 10-fold cross-validation methodology was 
selected, with nesting and class stratification where appropriate. This approach has the 
advantage of providing estimates of uncertainty in performance results and should help to 
ensure a reasonable balance between bias and variance in the model (71–73,95,96). The 
model selection phase for each machine learning algorithm (within the nested loops) was 
performed using a grid search methodology, whereby each possible combination of 
parameters was exhaustively searched to find those which gave the highest mean F1 score 
in cross-validation. The F1 score is a commonly used metric for selecting classification 
algorithms and is defined as: 
 
 
    
   
         
 
Eq 3.1 
 
Where TP refers to the number of true positives, FN the number of false negatives and FP 
the number of false positives. This form of parameter searching is more computationally 
expensive than alternative approaches, such as a random parameter search (where 
parameter combinations are randomly selected) (97). However, grid search is 
straightforward to implement and guarantees that all parameter values deemed to be viable 
options are selected and tested.  
 
In addition, tests were also carried out to generate evidence of the relative bias-variance 
trade-off in the trained machine learning models through the creation of learning curves. 
Such evidence is usually not reported in the machine learning literature, but providing this 
information is considered as important for understanding whether an algorithm will 
generalise well to the clinic (92). Learning curves are produced by training the algorithms 
with increasing numbers of training data and classification performance is compared 
between that achieved with the training data and that measured from an independent test 
set. For an algorithm with optimal bias and variance characteristics it is expected that the 
performance figures for both training and test data would reach a similarly high value. For an 
algorithm with high bias (i.e. a model that under fits the data) performance figures for training 
  
67 
 
 
and test data are expected to be well matched but low. Finally, for an algorithm suffering 
from over-fitting (i.e. high variance) there will be a gap in performance figures, with training 
data performance being higher than that of the test data. 
3.2.1 Method 
All machine learning algorithms and semi-quantification methods were evaluated according 
to the same stratified, 10-fold cross-validation procedure, repeated 10 times. However, 
nesting and grid search were only necessary for the machine learning algorithms. The 
overall process for comparing semi-quantification and machine learning algorithms is 
summarised in Figure 3-1. For the semi-quantification tools it was necessary to use normal 
limits as a hard cut-off in that any SBR result that fell below the specified normal limit would 
be classified as a positive test.  
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Figure 3-1 Summary of the semi-quantification / machine-learning comparison methodology 
(adapted from (1)) 
The parameter values available in the grid search are shown in Table 3-3. This range of 
values was set after preliminary work, using a wider array of possible C and gamma values, 
examining which figures are typically chosen for each of the models considered.  
 
 Hyperparameters searched 
Algorithm C values Gamma values 
Voxel intensities 
input to linear SVM  
2^(-3,-2,-
1,0,1,2,3,4,5,6,7,8) 
 
PCs input to linear 
SVM 
2^(-3,-2,-
1,0,1,2,3,4,5,6,7,8) 
 
PCs input to SVM 
with RBF kernel 
2^(-3,-2,-
1,0,1,2,3,4,5,6,7,8) 
2^(-8,-7,-6,-5,-4,-
3,-2,-1,0,1,2,3) 
SBRs input to linear 
SVM 
2^(-3,-2,-
1,0,1,2,3,4,5,6,7,8) 
 
SBRs input to SVM 
with RBF kernel 
2^(-3,-2,-
1,0,1,2,3,4,5,6,7,8) 
2^(-8,-7,-6,-5,-4,-
3,-2,-1,0,1,2,3) 
Table 3-3 Parameters selected during exhaustive grid search 
 
Cross validation was completed for both the largest local database (subset B) and the full 
PPMI database, in both cases using Matlab scripts. Results were summarised using a 
number of different performance metrics including diagnostic accuracy, sensitivity and 
specificity, and their respective standard deviations. 
 
Learning curves were generated for three different machine learning algorithms, each 
making use of one of the three different types of image feature: one utilising principal 
components as features (ML 10), one using raw voxel intensities (ML 43) and one utilising 
SBRs (ML 46). In each case the algorithms were trained with incrementally larger 
proportions of the local training dataset (subset B), with 50 cases set aside for testing only 
(containing 18 non-PDD and 32 PDD patients). After selection of hyperparameters in a 
cross-validation procedure, classification accuracy was measured once for the training data, 
and once for the 50 independent test cases.  
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3.2.2 Results 
Table 3-4 and Table 3-5 show performance metrics for the machine learning algorithms 
using local data and PPMI data, respectively.  
Table 3-6 and Table 3-7 show equivalent metrics for all the semi-quantitative methods. 
These results show that varying the size of the image mask had little effect on results. 
Accuracy results for all semi-quantification methods and machine learning algorithms (using 
the smallest mask size) are summarised graphically in Figure 3-2 and Figure 3-3, illustrating 
slightly improved performance with machine learning compared to semi-quantification for 
both local and PPMI datasets. 
 
Algorithm Feature 
No. 
PCs 
Dilate 
(times) Kernel 
Mean 
accuracy SD 
Mean 
Sensitivity SD 
Mean 
Specificity SD 
ML 1 PCs 1 0 Linear 0.86 0.06 0.90 0.06 0.79 0.13 
ML 2 PCs 1 2 Linear 0.85 0.06 0.90 0.07 0.78 0.11 
ML 3 PCs 1 4 Linear 0.85 0.06 0.90 0.07 0.78 0.14 
ML 4 PCs 2 0 Linear 0.89 0.06 0.91 0.06 0.85 0.11 
ML 5 PCs 2 2 Linear 0.89 0.05 0.92 0.06 0.84 0.10 
ML 6 PCs 2 4 Linear 0.90 0.06 0.93 0.06 0.85 0.10 
ML 7 PCs 3 0 Linear 0.91 0.05 0.93 0.05 0.88 0.10 
ML 8 PCs 3 2 Linear 0.91 0.05 0.93 0.06 0.88 0.09 
ML 9 PCs 3 4 Linear 0.91 0.05 0.93 0.06 0.87 0.09 
ML 10 PCs 5 0 Linear 0.92 0.05 0.94 0.06 0.88 0.10 
ML 11 PCs 5 2 Linear 0.91 0.05 0.93 0.05 0.87 0.11 
ML 12 PCs 5 4 Linear 0.91 0.05 0.93 0.06 0.88 0.09 
ML 13 PCs 10 0 Linear 0.91 0.05 0.93 0.06 0.86 0.10 
ML 14 PCs 10 2 Linear 0.90 0.06 0.93 0.06 0.85 0.11 
ML 15 PCs 10 4 Linear 0.91 0.05 0.94 0.05 0.87 0.10 
ML 16 PCs 15 0 Linear 0.89 0.05 0.92 0.06 0.83 0.11 
ML 17 PCs 15 2 Linear 0.89 0.06 0.92 0.06 0.83 0.11 
ML 18 PCs 15 4 Linear 0.89 0.05 0.93 0.06 0.83 0.11 
ML 19 PCs 20 0 Linear 0.89 0.05 0.92 0.07 0.83 0.12 
ML 20 PCs 20 2 Linear 0.89 0.05 0.92 0.06 0.83 0.10 
ML 21 PCs 20 4 Linear 0.89 0.05 0.93 0.05 0.84 0.10 
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ML 22 PCs 1 0 RBF 0.86 0.06 0.91 0.07 0.78 0.12 
ML 23 PCs 1 2 RBF 0.85 0.07 0.90 0.07 0.76 0.13 
ML 24 PCs 1 4 RBF 0.85 0.07 0.90 0.07 0.76 0.12 
ML 25 PCs 2 0 RBF 0.91 0.05 0.91 0.06 0.90 0.10 
ML 26 PCs 2 2 RBF 0.89 0.05 0.91 0.06 0.86 0.11 
ML 27 PCs 2 4 RBF 0.90 0.05 0.92 0.06 0.88 0.09 
ML 28 PCs 3 0 RBF 0.91 0.05 0.91 0.07 0.89 0.09 
ML 29 PCs 3 2 RBF 0.91 0.05 0.92 0.06 0.90 0.08 
ML 30 PCs 3 4 RBF 0.91 0.05 0.92 0.06 0.89 0.09 
ML 31 PCs 5 0 RBF 0.91 0.06 0.92 0.06 0.89 0.10 
ML 32 PCs 5 2 RBF 0.91 0.05 0.92 0.06 0.89 0.09 
ML 33 PCs 5 4 RBF 0.91 0.04 0.92 0.05 0.89 0.10 
ML 34 PCs 10 0 RBF 0.90 0.05 0.91 0.07 0.88 0.09 
ML 35 PCs 10 2 RBF 0.91 0.05 0.92 0.06 0.89 0.10 
ML 36 PCs 10 4 RBF 0.91 0.05 0.92 0.06 0.89 0.09 
ML 37 PCs 15 0 RBF 0.89 0.05 0.91 0.07 0.87 0.10 
ML 38 PCs 15 2 RBF 0.90 0.05 0.91 0.06 0.87 0.10 
ML 39 PCs 15 4 RBF 0.90 0.05 0.92 0.07 0.88 0.10 
ML 40 PCs 20 0 RBF 0.90 0.05 0.90 0.07 0.89 0.10 
ML 41 PCs 20 2 RBF 0.90 0.06 0.91 0.07 0.89 0.10 
ML 42 PCs 20 4 RBF 0.90 0.05 0.91 0.07 0.90 0.09 
ML 43 Pixels 
 
0 Linear 0.88 0.05 0.91 0.06 0.84 0.11 
ML 44 Pixels 
 
2 Linear 0.89 0.05 0.92 0.05 0.84 0.12 
ML 45 Pixels 
 
4 Linear 0.89 0.06 0.92 0.07 0.84 0.12 
ML 46 SBR 
  
Linear 0.89 0.05 0.92 0.06 0.82 0.10 
ML 47 SBR 
  
RBF 0.89 0.06 0.91 0.07 0.85 0.10 
Table 3-4 Machine learning cross validation results for the local database (subset B, adapted 
from (1)) 
 
 
Algorithm Feature 
No. 
PCs 
Dilate 
(times) Kernel 
Mean 
accuracy SD 
Mean 
Sensitivity SD 
Mean 
Specificity SD 
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ML 1 PCs 1 0 Linear 0.87 0.03 0.92 0.04 0.75 0.08 
ML 2 PCs 1 2 Linear 0.86 0.04 0.92 0.04 0.75 0.10 
ML 3 PCs 1 4 Linear 0.86 0.04 0.92 0.04 0.74 0.10 
ML 4 PCs 2 0 Linear 0.96 0.02 0.97 0.03 0.93 0.05 
ML 5 PCs 2 2 Linear 0.94 0.03 0.95 0.03 0.90 0.07 
ML 6 PCs 2 4 Linear 0.93 0.03 0.95 0.03 0.89 0.07 
ML 7 PCs 3 0 Linear 0.97 0.02 0.98 0.02 0.96 0.04 
ML 8 PCs 3 2 Linear 0.97 0.02 0.98 0.02 0.96 0.04 
ML 9 PCs 3 4 Linear 0.96 0.03 0.97 0.03 0.93 0.06 
ML 10 PCs 5 0 Linear 0.97 0.02 0.98 0.02 0.96 0.05 
ML 11 PCs 5 2 Linear 0.97 0.02 0.98 0.02 0.96 0.05 
ML 12 PCs 5 4 Linear 0.97 0.02 0.98 0.02 0.96 0.04 
ML 13 PCs 10 0 Linear 0.97 0.02 0.98 0.02 0.96 0.04 
ML 14 PCs 10 2 Linear 0.97 0.02 0.98 0.02 0.96 0.04 
ML 15 PCs 10 4 Linear 0.97 0.02 0.98 0.02 0.96 0.04 
ML 16 PCs 15 0 Linear 0.97 0.02 0.97 0.02 0.95 0.04 
ML 17 PCs 15 2 Linear 0.97 0.02 0.98 0.02 0.95 0.04 
ML 18 PCs 15 4 Linear 0.97 0.02 0.98 0.02 0.96 0.04 
ML 19 PCs 20 0 Linear 0.97 0.02 0.98 0.02 0.96 0.05 
ML 20 PCs 20 2 Linear 0.97 0.02 0.98 0.02 0.95 0.05 
ML 21 PCs 20 4 Linear 0.97 0.02 0.97 0.02 0.96 0.04 
ML 22 PCs 1 0 RBF 0.87 0.04 0.91 0.04 0.79 0.09 
ML 23 PCs 1 2 RBF 0.86 0.04 0.91 0.04 0.76 0.08 
ML 24 PCs 1 4 RBF 0.86 0.04 0.91 0.04 0.75 0.10 
ML 25 PCs 2 0 RBF 0.95 0.02 0.96 0.03 0.94 0.06 
ML 26 PCs 2 2 RBF 0.94 0.03 0.94 0.04 0.93 0.06 
ML 27 PCs 2 4 RBF 0.93 0.03 0.94 0.03 0.91 0.06 
ML 28 PCs 3 0 RBF 0.97 0.02 0.98 0.02 0.97 0.04 
ML 29 PCs 3 2 RBF 0.97 0.02 0.97 0.02 0.97 0.04 
ML 30 PCs 3 4 RBF 0.96 0.03 0.97 0.03 0.95 0.04 
ML 31 PCs 5 0 RBF 0.97 0.02 0.97 0.02 0.97 0.03 
ML 32 PCs 5 2 RBF 0.97 0.02 0.97 0.03 0.97 0.03 
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ML 33 PCs 5 4 RBF 0.97 0.02 0.97 0.02 0.97 0.04 
ML 34 PCs 10 0 RBF 0.97 0.02 0.97 0.02 0.97 0.04 
ML 35 PCs 10 2 RBF 0.97 0.02 0.97 0.02 0.97 0.04 
ML 36 PCs 10 4 RBF 0.97 0.02 0.97 0.02 0.97 0.03 
ML 37 PCs 15 0 RBF 0.97 0.02 0.97 0.02 0.97 0.04 
ML 38 PCs 15 2 RBF 0.97 0.02 0.97 0.02 0.97 0.04 
ML 39 PCs 15 4 RBF 0.97 0.02 0.97 0.03 0.97 0.04 
ML 40 PCs 20 0 RBF 0.97 0.02 0.97 0.02 0.97 0.04 
ML 41 PCs 20 2 RBF 0.97 0.02 0.97 0.03 0.97 0.04 
ML 42 PCs 20 4 RBF 0.97 0.02 0.97 0.02 0.97 0.04 
ML 43 Pixels 
 
0 Linear 0.95 0.02 0.97 0.03 0.92 0.06 
ML 44 Pixels 
 
2 Linear 0.95 0.02 0.97 0.03 0.92 0.06 
ML 45 Pixels 
 
4 Linear 0.96 0.02 0.97 0.03 0.93 0.06 
ML 46 SBR 
  
Linear 0.95 0.03 0.97 0.03 0.91 0.06 
ML 47 SBR 
  
RBF 0.95 0.02 0.96 0.03 0.93 0.06 
Table 3-5 Machine learning cross-validation results for the PPMI database (adapted from 
(1))
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Summary of semi-quantification performance results for the local database 
Method 
number Cut-offs defined by SBRs Accuracy SD Sensitivity SD Specificity SD 
SQ 1 mean -2SD L+R putamen 0.79 0.08 0.68 0.12 0.97 0.05 
SQ 2 mean -2SD L+R putamen, L+R caudate 0.78 0.08 0.68 0.11 0.96 0.06 
SQ 3 mean -1.5SD L+R putamen 0.85 0.06 0.82 0.09 0.90 0.10 
SQ 4 mean -1.5SD L+R putamen, L+R caudate 0.85 0.06 0.83 0.08 0.88 0.11 
SQ 5 mean -1SD L+R putamen 0.86 0.06 0.91 0.06 0.77 0.12 
SQ 6 mean -1SD L+R putamen, L+R caudate 0.86 0.05 0.92 0.06 0.75 0.13 
SQ 7 min L+R putamen 0.83 0.06 0.78 0.08 0.92 0.08 
SQ 8 min L+R putamen, L+R caudate 0.84 0.07 0.81 0.09 0.89 0.10 
SQ 9 regress -2SE L+R putamen 0.82 0.07 0.72 0.11 0.99 0.03 
SQ 10 regress -2SE L+R putamen, L+R caudate 0.82 0.06 0.72 0.10 0.98 0.04 
SQ 11 regress -1.5SE L+R putamen 0.86 0.06 0.82 0.09 0.93 0.09 
SQ 12 regress -1.5SE L+R putamen, L+R caudate 0.86 0.06 0.83 0.08 0.91 0.10 
SQ 13 regress -1SE L+R putamen 0.87 0.06 0.92 0.06 0.78 0.12 
SQ 14 regress -1SE L+R putamen, L+R caudate 0.87 0.06 0.93 0.06 0.77 0.12 
SQ 15 ROC age matched lowest putamen 0.87 0.05 0.89 0.06 0.83 0.11 
SQ 16 ROC age matched lowest putamen, lowest caudate 0.83 0.07 0.92 0.07 0.67 0.16 
SQ 17 ROC lowest putamen 0.86 0.06 0.86 0.08 0.86 0.13 
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Table 3-6 Semi-quantification cross-validation results for the local database (adapted from (1)) 
 
Summary of semi-quantification performance results for the PPMI database 
Method 
number Method SBRs Accuracy SD Sensitivity SD Specificity SD 
SQ 1 mean -2SD L+R putamen 0.93 0.03 0.92 0.04 0.97 0.04 
SQ 2 mean -2SD L+R putamen, L+R caudate 0.93 0.03 0.92 0.04 0.96 0.04 
SQ 3 mean -1.5SD L+R putamen 0.94 0.03 0.95 0.03 0.92 0.06 
SQ 4 mean -1.5SD L+R putamen, L+R caudate 0.94 0.03 0.95 0.03 0.90 0.07 
SQ 5 mean -1SD L+R putamen 0.92 0.03 0.98 0.02 0.78 0.09 
SQ 6 mean -1SD L+R putamen, L+R caudate 0.89 0.04 0.98 0.02 0.71 0.11 
SQ 7 min L+R putamen 0.90 0.04 0.87 0.05 0.96 0.04 
SQ 8 min L+R putamen, L+R caudate 0.90 0.03 0.88 0.05 0.94 0.05 
SQ 9 regress -2SE L+R putamen 0.93 0.03 0.91 0.04 0.97 0.04 
SQ 10 regress -2SE L+R putamen, L+R caudate 0.93 0.03 0.91 0.04 0.97 0.04 
SQ 11 regress -1.5SE L+R putamen 0.94 0.03 0.95 0.03 0.92 0.05 
SQ 12 regress -1.5SE L+R putamen, L+R caudate 0.94 0.03 0.95 0.03 0.90 0.07 
SQ 13 regress -1SE L+R putamen 0.92 0.03 0.98 0.02 0.80 0.08 
SQ 14 regress -1SE L+R putamen, L+R caudate 0.89 0.04 0.98 0.02 0.71 0.11 
SQ 18 ROC lowest putamen, lowest caudate 0.84 0.06 0.90 0.07 0.74 0.14 
  
 
 
7
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SQ 15 ROC age matched lowest putamen 0.94 0.03 0.96 0.03 0.91 0.07 
SQ 16 ROC age matched lowest putamen, lowest caudate 0.89 0.03 0.97 0.03 0.73 0.09 
SQ 17 ROC lowest putamen 0.95 0.03 0.96 0.03 0.92 0.06 
SQ 18 ROC lowest putamen, lowest caudate 0.89 0.03 0.97 0.03 0.71 0.10 
Table 3-7 Semi-quantification cross-validation results for the PPMI database (adapted from (1)) 
 
Figure 3-2 Accuracy results for all semi-quantification and machine learning methods (with 0 additional dilation) applied to local data. Semi-
quantification results are grouped to the left of the graph (circular markers) and machine learning algorithms to the right (square markers). 
Whiskers represent one standard deviation. Taken from (1) 
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Figure 3-3 Accuracy results for all semi-quantification and machine learning methods (with 0 additional dilation) applied to PPMI data. Semi-
quantification results are grouped to the left of the graph (circular markers) and machine learning algorithms to the right (square markers). 
Whiskers represent one standard deviation. Taken from (1)
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Learning curve results from algorithms ML 10, ML 43 and ML 46 are shown in Figure 3-4, 
illustrating mismatched train-test performance figures for voxel intensity features, as 
compared to algorithms taking PCs and SBRs as input features, where train-test 
performance figures are more consistent with each other. 
 
Figure 3-4 Learning curves for linear SVM algorithms using 5 PCs (top left), voxel intensities 
(top right) and SBRs (bottom) as input features (and no additional mask dilation, ML 10, 43 
and 46) 
3.2.3 Discussion 
This investigation provided a detailed study of the differences in performance that might be 
expected when using machine learning algorithms for classification rather than semi-
quantitative methods. Two contrasting databases of images were used, of different sizes, 
demonstrating how performance can change depending on the characteristics of the 
available data 
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Semi-quantification 
 
For the semi-quantitative methods, performance was superior for the PPMI data as 
compared to local data, with higher mean values generated for the PPMI data and lower 
variance. This was as expected and highlights the differences in performing measurements 
on a research database, where screening procedures and imaging investigations are tightly 
controlled, in contrast to real clinical data where the reference diagnosis is less certain, the 
patient group more diverse and where inter-camera calibration is not routinely conducted. 
The measured performance of semi-quantitative methods for the local data was similar to 
that found by other researchers utilising a mixed clinical database, with established and 
commercial software tools (48). This provides added confidence that the methods developed 
in this study had similar discriminatory power to that of existing software that is used in clinic. 
 
Clinically, multiple SBRs and other derived ratios may be provided by semi-quantitative 
software to guide diagnosis. Typically, SBRs from the whole striatum as well as individual 
caudates and putamena on the left and right side are given. In addition, the caudate to 
putamen ratio and the right to left ratio may also be displayed. If all these individual SBRs 
and their associated normal limits are treated as individual tests, the final semi-quantification 
classification is likely to be overly sensitive (increasing the risk of type I error) and may give 
a pessimistic view on current standard of care approaches. Therefore, in this study only 
SBRs from individual putamena (with or without caudate results) were considered and so it 
is more likely that results reflect the best achievable from semi-quantification rather than 
typical performance.  
 
However, the way in which semi-quantification was evaluated is not completely reflective of 
its clinical function. The normal limits for each set of SBR results were used as hard cut-offs 
in that any value falling outside the boundary would lead to an overall abnormal image 
classification. In reality, semi-quantification is unlikely to be used in such a rigid manner. 
Semi-quantification results require some interpretation by clinicians and figures are usually 
treated as a whole, in light of other clinical information. It is therefore possible that a single 
SBR result which just falls outside the normal limits would be interpreted as an overall 
normal result, despite the classification being abnormal according to the rules of this study. 
Given this limitation, it should be kept in mind that measures of standalone performance do 
not reveal all of the advantages and disadvantages of a particular assistive reporting 
platform.  
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Semi-quantitative methods gave a relatively narrow range of accuracy scores across all the 
methods tested, with a wide range of sensitivities and specificities. It is interesting to note 
that two of the methods which treat classification as a two class problem, generating cut-offs 
from both normal and abnormal putamenal SBRs (i.e. methods SQ 15 and SQ 17), produced 
some of the highest accuracy figures, with lower variance and well balanced sensitivity and 
specificity values. This is perhaps unsurprising as all other semi-quantitative methods (which 
are more reflective of commercially available tools) define cut-offs from the normal 
population only, with no knowledge of the distribution or likely crossover of abnormal data.  
 
In general, the addition of caudate data to semi-quantitative calculations caused a slight 
increase in sensitivity and slight reduction in specificity with little effect on accuracy, other 
than for methods based on ROC curve calculations, which saw a drop in performance. This 
suggests that the vast majority of diagnostically useful information can be gleaned from 
consideration of putamen uptake only. Again, this is unsurprising as image appearances 
often show more marked reduction in putamen uptake than in the caudate (34). 
 
It should be noted that the Southampton semi-quantification method (39) was not 
investigated in this study. Recent research (48) suggests that the sensitivity of this approach 
is very low when calibration is not performed between different camera systems and is also 
significantly reduced when correction (including scatter correction) is not performed. 
Camera-specific calibration data was not available for the local database of images and 
scatter data were not accessible for the PPMI dataset and so the method was excluded.  
 
Furthermore, only one method of image registration and SBR calculation was used in this 
investigation. Commercial semi-quantification solutions use different registration algorithms. 
Some software also performs quantification in two dimensions, by summing consecutive 
slices, utilising different regions of interest. Other image corrections that are also sometimes 
implemented (such as partial volume correction) were not considered in this investigation. 
Thus, results presented here cannot be representative of all semi-quantification techniques. 
However, it is unlikely that investigation of a wider range of methods would have led to 
significantly different performance as the same fundamental limitations apply to all semi-
quantification techniques. 
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Machine Learning 
 
The machine learning algorithms produced performance metrics which generally exceeded 
that of the semi-quantitative methods on the same data. Other than algorithms based on just 
one principal component (ML1 - ML3), the machine learning algorithms all gave accuracies 
as high as or higher than any of the semi-quantitative methods. Accuracy, sensitivity and 
specificity were generally high and well balanced for each machine learning tool, with small 
standard deviation values, providing evidence that these approaches are accurate and have 
low variability. The smaller standard deviation results as compared to semi-quantification is 
particularly important from a clinical perspective as this suggests that machine learning tools 
will be more robust when used more widely on new datasets. 
 
Machine learning performance metrics for the PPMI data matched the best performing 
algorithms produced by other authors (see Table 1-3), with results that are comparable with 
current state-of-the-art. This provides some justification for the particular model selection 
(and grid search) processes used in this study. As with the semi-quantitative results, 
performance for the PPMI database was substantially higher than for the local data, 
reinforcing the assertion that classification of the PPMI dataset is an easier task than that 
seen in clinical reality. 
 
For both databases, algorithms using principal components as features gave the highest 
accuracies (as high as 0.97 for the PPMI database), though the addition of larger numbers of 
principal components and the use of a non-linear RBF kernel appeared to have little 
additional impact on results. Greater dilation of the image mask, incorporating a greater 
proportion of the brain, also appeared to have a minimal impact on results in most cases. 
The fact that high accuracies were achieved with just 2 principal components (only slightly 
lower than that measured for 20 components), shows that separation between groups can 
be achieved with very limited numbers of variables. The lack of significant improvement in 
classification accuracy using greater than 2 principal components was also reported by 
Towey (65). 2 PCs accounted for over 80% of the total variance in the training data when 
applied to the local database, demonstrating that (I123)FP-CIT images have few modes of 
variation, even for this relatively diverse set of patients. Results for one principal component 
were the lowest of all machine learning algorithms and the contrast in performance as 
compared to the other algorithms was particularly striking for the PPMI data. This 
demonstrates that the second principal component contains significant diagnostic 
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information and that there is a lower limit on the degree of algorithm simplification that can 
be applied without adversely impacting upon classification performance.  
 
Features based on raw voxel intensities gave slightly lower performance values in general, 
for example achieving an accuracy of 0.88 on the local database (algorithm ML43). 
Furthermore, there is evidence to suggest that such algorithms were associated with higher 
variance than the other types of algorithm investigated. The learning curve depicted in 
Figure 3-4 shows that for algorithm ML 43, accuracy on training data was consistently at 
100% across the available training data subgroups. This is a strong indicator that the 
algorithm is fitting a model to the available data, rather than the underlying trend. 
Comparison to performance on the independent test data shows a variable but consistent 
gap in results across all different numbers of training data, which again suggests that the 
extent to which the algorithm will generalise to other data samples is sub-optimal. This may 
be because the algorithm was performing classification largely based on individual voxel 
values that separate out test data well, but which may not be in a spatial location that 
correlates with the presence of disease. It is likely that the training and test performance 
curves would move closer together if many more training images were available. However, 
collecting much larger numbers of datasets is not feasible in this study. 
 
Conversely, learning curve results for the algorithms based on 5 principal components (ML 
10) and SBRs (ML 46) showed training and test performance figures that were more closely 
matched, at a relatively high level, even for the smallest number of training images. This 
suggests that both variance and bias were relatively low and that many fewer training 
samples than the 306 available could be used to create machine learning tools of high 
accuracy. Importantly, results indicate that algorithms based on principal components or 
SBRs are more likely to give more consistent performance when applied to new test data, 
than algorithms based on raw voxel intensities. 
 
Despite the favourable learning curve results, machine learning algorithms based on SBRs 
produced mean performance figures from the main cross-validation comparison that were 
slightly lower than that of PC-based algorithms. In this case reduced performance is likely to 
be a consequence of the limitations of using features based on ratios of mean intensity 
values inside regions of interest. In particular, SBRs do not contain information on the shape 
of striatal uptake patterns and they are reliant on accurate fitting of small regions of interest 
to the anatomical striatal outline. This reflects limitations that generally apply to semi-
quantification methods.  
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Although in general the machine learning algorithms appeared to perform better than the 
semi-quantification tools, the level of absolute performance improvement as compared to the 
best performing semi-quantification techniques was relatively small in this study. It is difficult 
to determine whether differences were statistically significant due to the non-independence 
of training and test data in each fold. However, examination of the standard deviation on 
performance results (see Figure 3-2 and Figure 3-3) suggests that there is some crossover 
in accuracy of the machine learning and semi-quantitative methods, particularly for the local 
data. Although utilising different techniques and a different evaluation methodology, Towey 
also reported accuracy results from machine learning algorithms that were similar or better 
than that of selected (commercial) semi-quantification tools (65). This small gain in 
performance from machine learning tools should be kept in mind in the following 
investigations of impact on reporting. 
 
Given that standalone semi-quantification accuracy is up to approximately 87% for clinical 
data (and 95% for research data), the margin available for performance gains from new 
machine learning algorithms is real but narrow. Even with the introduction of more advanced 
machine learning tools (such as convolutional neural networks) there cannot be a substantial 
gain in accuracy over the classical algorithms presented here, which suggests that 
developing more advanced software is of limited value. Therefore, the following sections will 
continue to use the machine learning algorithms defined in this chapter. 
 
Comparisons of standalone accuracy are not, by themselves, an adequate test of clinical 
utility. As previously suggested, clinical investigations demonstrating the impact of such 
assistive reporting tools on clinical decision making are required to fully understand any 
potential benefits. One particular aspect not covered by the current study is that machine 
learning algorithms simplify the information that is shown to the clinician. Rather than having 
to examine and interpret multiple SBR results and other ratio data, along with their normal 
ranges, clinicians are presented with a single number representing the overall likelihood of 
abnormality. This less ambiguous software output may be a better, more effective way of 
influencing clinicians‘ decisions. 
 
Overall, this investigation showed that there is a small gain in absolute standalone 
classification performance (and a corresponding reduction in variability) that can be gained 
from using effective machine learning algorithms rather than the best performing semi-
quantification methods. The superiority of machine learning algorithms is more substantial if 
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only ‗one class‘ semi-quantification methods are considered (which is the form of semi-
quantification that is frequently used in commercial, clinical tools). Furthermore, in this 
investigation only a subset of possible striatal uptake ratios were included in performance 
metric calculations. Typically, a greater range of semi-quantitative values is presented to 
reporting radiologists in clinic. If greater numbers of ratios were included in the analysis, 
classification performance for semi-quantitative methods would have been lower, providing 
more compelling evidence of the benefits of machine-learning algorithms.  
3.2.4 Conclusion 
This study has compared a range of semi-quantification approaches with different machine 
learning tools (based on SVMs) in order to evidence whether classical machine learning 
techniques are a superior means of classifying (I123)FP-CIT data into normal and abnormal 
groups. A research and local clinical database were used for repeated 10-fold cross-
validation. 
 
Results showed that classification performance was lower for the local database than the 
research database for both semi-quantitative and machine learning algorithms. 
However, for both databases, the majority of the machine learning methods generated high 
mean accuracies with low variability, and well balanced sensitivity and specificity. Results 
compared favourably with that of semi-quantification methods and are comparable with 
accuracies cited for clinician performance. 
 
Learning curve results indicate that algorithms taking raw voxel intensities as inputs were 
associated with high variance. In contrast, algorithms based on 5 principal components or 
SBRs were well balanced with low bias and variance.  
 
The increase in accuracy offered by machine learning algorithms as compared to the best 
performing semi-quantification methods was relatively small. However, the performance gap 
is likely to be an underestimate of that which might be seen in clinic with commercial, clinical 
semi-quantification packages. Furthermore, machine learning algorithms offer other benefits, 
such as the generation of just a single output, rather than multiple outputs, each of which 
must be interpreted by clinicians. Thus, the evidence suggests that machine learning 
algorithms may provide more effective and better assistance to reporters than established 
clinical reporting aids. 
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Further evidence is now required to establish whether machine learning can enhance 
reporter performance, since it is envisaged that the human reporter will continue to make the 
final diagnostic decision for (I123)FP-CIT tests.  
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4 Impact on reporting performance – pilot and main 
studies 
Objectives addressed by this section (in black, bold): 
 
1) Select and implement machine learning classification tools 
2) Collect a database of (I123)FP-CIT images 
3) Compare the performance of machine learning algorithms with semi-quantification 
4) Develop software for testing of human reporters 
5) Assess the impact of an automated classification tool, implemented as a CADx 
system, on reporting 
Table 4-1 Objectives addressed in section 4 
 
This chapter builds on the promising performance results of the previous chapter by 
measuring the impact of machine learning algorithms on reporter performance. Such tests 
are necessary for quantifying the effectiveness of CADx. However, performing clinical trials 
of medical devices is a costly and time consuming process. In order to minimise the risk that 
data are biased or uninformative a number of factors need to be considered, which in this 
case includes: the numbers of patient datasets to use, the number (and experience level) of 
radiologists to recruit, study design, the form of CADx output to adopt and the form of its 
display on the screen. In the absence of previous studies covering this specific topic, 
particular care should be taken when considering how the reporting investigation should be 
performed.  
 
In this work a pilot investigation was undertaken on a subset of the available data. Results 
from the pilot study were used to inform a subsequent larger reporting study and the 
following sections describe preparations for the pilot and main study, in particular the 
derivation of optimal machine learning algorithm parameters and development of reporting 
software. Following this, a summary of the testing methodologies is described, with results 
and a discussion.  
 
Of the available machine learning models that were trained and evaluated in previous 
sections, those based on principal components had been found to perform best in terms of 
mean classification metrics. These algorithms also appeared to have well balanced bias and 
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variance properties, in contrast to learning curve analysis of features based on raw voxel 
intensities, which showed signs of increased variance. Although there was much overlap 
between performance figures, the highest classification score was achieved by an algorithm 
based on 5 principal components, with a linear SVM model and no additional mask dilation 
(see section 2.1.3, algorithm ML10). Therefore, this was the algorithm chosen in the pilot 
and main study. 
 
Sections of the following method, results and discussion, particularly in relation to the main 
study, were published in a peer-reviewed journal article (2). 
4.1 Derivation of optimal SVM hyperparameter 
Although the previous chapter provided an estimate of machine learning algorithm 
performance on independent data, using different models, it is not yet known what the 
optimal hyperparameter is for the available training data, i.e. which C value should be 
chosen for the SVM classifier. Previously, optimal hyperparameters were estimated from 
within nested cross validation loops using approximately 81% of the data for training in each 
pass and 9% for validation. This information was then passed to the outer loop to estimate 
performance on the final 10% of the data. However, when the goal of cross-validation is 
simply to find optimal parameters, the outer cross validation loops are not required. Thus, 
optimal hyperparameters can be chosen using more of the available data, in a standard 10-
fold cross validation procedure i.e. using 90% of the data for training in each loop and 10% 
for testing. Utilising an incrementally greater proportion of the data to find the best 
hyperparameters may help to create an improved classification tool.  
 
For the pilot study, the optimal value of the C hyperparameter was selected by running a 10 
fold cross-validation procedure repeated 10 times. Within each set of cross validations the C 
parameter was changed according to a sparse grid search, as before (see section 3.2.1). 
The highest mean F1-score was used as the selection criteria. With this approach the 
optimal C value was found to be 2-2 or 0.25. The final classification algorithm was then 
derived by training on all the available training data from subset B, using this C value. This 
algorithm formed the basis for the CADx tool. 
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4.2 Software development 
Measuring reporting performance using realistic software (i.e. as foreseen for the clinical 
situation) is a key consideration. Significant deviations from the setup used clinically 
introduce additional uncertainty to results. Therefore, for these reporting studies the current 
standard clinical image viewer, Jview, was adapted to show CADx results to clinicians 
alongside image data in a standard format. Jview is a platform based on java software. 
Additional software was written to augment the functionality already available, rather than re-
writing the clinical software code. 
 
Data for the study were stored within a remote MySQL database, other than the image data 
itself which was held within a separate, remote filestore. An applet was written in Java to 
automatically manage the display of data to radiologists and to send results to the database. 
A schematic depicting each piece of software used and how they linked to each other is 
displayed in Figure 4-1. This particular model has the advantage that all data and the 
software classes are kept on a remote server, which can be accessed by several 
workstations at once. Any updates to the software code or data are therefore immediately 
passed on to local users. Each workstation only requires java to be installed. The remote 
servers and workstations depicted in Figure 4-1 are all within the Sheffield Teaching 
Hospitals IT network. No external hardware was used for this study. 
 
 
Figure 4-1 Schematic depicting the different elements of the data capture and display 
software used for the reporting study. Blue arrows represent data flows 
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It was hypothesised that the most helpful form of CADx output would be a probability value. 
This would give the radiologist an idea of the relative certainty of the machine learning tool, 
in addition to a decision on the binary classification. However, the output from a standard 
SVM function is a number which simply dictates on which side of the separating plane the 
test case lies. Values greater than zero are classified as a particular class and values less 
than zero classified as the alternative class. These are not probabilities. An SVM score 
needs to be viewed in the context of the typical values that would be expected for examples 
of either class in order to give the clinician an indication of relative confidence. Thus, a 
common step often applied to raw SVM scores is to convert them to probability values using 
techniques such as Platt scaling (98), whereby a logistic regression model is fitted to the 
available data. libSVM‘s inbuilt function for converting SVM scores to probabilities was 
adopted for this purpose [https://www.csie.ntu.edu.tw/~cjlin/papers/libsvm.pdf], which utilises 
cross-validation to fit the available data to the logistic function.  
 
The probability of belonging to the abnormal class was calculated for all the patient cases 
and added to the MySQL database. These values were displayed to the left of the user‘s 
computer screen at an appropriate point during the study. At all other times the CADx output 
was hidden. Given that the trained algorithms were binary, for cases where P >= 0.5, the 
corresponding probability of belonging to the normal class was 1-P (i.e. less than 0.5). For 
these patients the CADx output value was displayed in red font. For patients where P < 0.5, 
the corresponding probability of belonging to the normal class was greater than 0.5 and a 
blue font was used in the display. Thus, in this scheme red font is associated with an 
abnormal diagnosis. 
 
In the standard clinical protocol (I123)FP-CIT images are viewed following rigid registration 
to a template (to remove asymmetric appearances associated with head tilt). Four 
reconstructed slices are typically displayed to the reporter, from within the centre of the 
brain. A summed image, derived from axial slices throughout the central brain is also 
available. The java applet written for the study enforced this display format for every case. 
Additionally, a series of buttons were located in the left-hand pane to allow the user to move 
between cases and provide a classification decision. These were provided below the box 
which was used for display of the CADx output. Figure 4-2 provides an example of the 
software display that the reporters saw, in this case with the CADx result being visible. 
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Figure 4-2 Example of the Jview software display provided to reporters (The CADx 
probability output is visible in the top left corner this case. The number below refers to the 
patient age on the day of the scan)  
4.3 Pilot study 
The pilot study had three main aims: 
 
 Quantify the influence of CADx on reporting accuracy and reliability 
 Obtain qualitative feedback on the current CADx design 
 Document the effects of CADx on reporting behaviours 
 
In order to gain an estimate of inter-reporter reliability multiple reporters were required.  
Due to limitations in the number of available staff with necessary expertise, the pilot study 
focused on 7 junior radiologists (specialist registrars) who had significant experience of 
reporting images, but not of reporting (I123)FP-CIT scans specifically. 
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4.3.1 Method 
The methodology adopted for the pilot study and the full clinical study are largely dictated, 
where possible, by the recommendations set out by Eadie and colleagues (99) following a 
review and critique of existing literature on the impact of assistive reporting software (100). 
This aims to make the results as relevant to clinical practice as possible, within the particular 
constraints of the study, and that the metrics measured are of clinical relevance.  
 
The overall approach involved reporters examining images three times and giving a 
diagnostic confidence score in each case on a scale from 1 to 5. A score of 1 was equivalent 
to having high confidence that the image showed abnormal dopaminergic function and a 
score of 5 was equivalent to having high confidence that the image was normal. Scores of 2 
and 4 were assigned to images where reporters were less confident in their overall 
assessment, but still favoured one of the binary choices and a score of 3 was used for any 
equivocal cases.  
 
An overview of the pilot study methodology is shown in Figure 4-3. A chronological 
description of the main steps involved is summarised below: 
 
1) Training. An introductory lecture was delivered on tracer uptake processes, image 
acquisition and indications to provide context to the reporting exercise. A series of 10 
images (separate to those of subset A) were shown to the group to demonstrate 
typical normal and abnormal appearances. Following this a further 10 datasets were 
displayed and the group was encouraged to give their opinions on classification, in 
order that training could be reinforced and checked. Finally, the radiologists were 
given an overview of the functionality of Jview along with a clear, concise summary of 
the information that would subsequently be displayed to them. A brief introduction to 
the concept of CADx was given, which included an explanation of the probabilistic 
output of the machine learning tool used in the study. It was explained to the 
radiologists that the algorithm had been trained to accurately distinguish between 
normal and abnormal (I123)FP-CIT scans and that initial tests on other data had 
suggested a binary accuracy of approximately 90%. The worksheets used as a guide 
to the pilot study are shown in the appendix (see Appendix 1). 
2) Read 1. Reporters scored all 30 images, shown in a random order, through visual 
assessment. 
3) 1 hour break (to reduce recall bias) 
  
91 
 
 
4) Read 2 and 3. Reporters examined the images again, shown in a different random 
order (read 2). However, immediately after giving a diagnostic score from visual 
analysis the same image was presented alongside a probability value from the 
machine learning tool. The reporters then gave a score for a third time (read 3). 
Thus, comparison between the first and second visual reads provided an insight into 
intra-reporter reliability. Comparison of the second and third reads gave an indication 
of the impact of CADx (i.e. whether the reporter chooses to change his / her decision 
when supported by CADx software). 
5) Questionnaire. Each reporter was given a questionnaire to fill in. Questions were 
designed to assess the influence of CADx software on clinician decision making. In 
addition, the questions solicited information on possible differences in the way that 
the CADx system could be designed or used. The questionnaire included a mix of 
open and closed questions with both restricted response categories (to allow for 
more straightforward analysis) and the opportunity for general comment. Where 
possible, questions were posed in a neutral manner in order not to overly influence 
the response. 
 
 
Figure 4-3 Overview of pilot study methodology 
 
All radiologists were in the same room during the study and all used separate workstations, 
although these computers were not optimised for clinical reporting. An advisor was available 
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throughout the study to provide technical support if required. In this pilot investigation patient 
age was not revealed to the radiologists and the patients‘ clinical history was not available. 
 
The standalone performance of the machine learning algorithm was also measured for the 
30 cases. This was done to confirm that the assisted reporting tool, trained on cases where 
only the radiology report was available for ground truth classification, was sufficiently 
accurate when exposed to independent data with a clinical gold standard diagnosis. 
 
The performance metrics selected for the pilot study were in line with those normally used in 
clinical investigations, namely sensitivity, specificity and diagnostic accuracy. These metrics 
were calculated by compressing the submitted confidence scores into 3 classification 
categories: with disease, without disease and equivocal.  
 
In addition, intra-class correlation coefficient (ICC) was used for evaluating intra and inter-
reporter reliability. Values of ICC can range from 0 to 1 where 1 represents perfect reliability 
with no measurement variability and zero is representative of no reliability. ICC is calculated 
from the ratio of variance between subjects (patients) as compared to the total variance 
(which includes between-subjects variance and error variance). In this study, the two-way 
random model was implemented for measuring inter-reporter reliability, with single measures 
(i.e. ICC(2,1)), and the one-way random model with single measures (i.e. ICC(1,1)) 
implemented for assessing intra-reporter reliability. These particular forms of ICC were 
selected based on the guides by Rankin (101) and Koo (102). 
4.3.2 Results 
Quantitative 
 
The results presented below summarise the data transferred to the MySQL database during 
the pilot study. Unfortunately, a technical fault invalidated results from two of the radiologists 
on their final read. Therefore, the tables and figures below are not quite complete. Table 4-2 
presents an overview of the quantitative results captured in the database whilst Table 4-3 
provides a comparison between mean performance figures for read 2 and read 3 (for those 
radiologists with a complete set of results). Figure 4-4, Figure 4-5 and Figure 4-6 display the 
summary data in graphical form.  
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  Radiologist 
Metric 1 2 3 4 5 6 7 
Sensitivity read 1 0.75 1.00 0.94 1.00 1.00 1.00 0.94 
Sensitivity read 2 1.00 1.00 1.00 1.00 1.00 0.94 0.81 
Sensitivity read 3 1.00   0.88 1.00 1.00   0.88 
Specificity read 1 0.71 0.71 0.86 0.86 0.86 0.64 0.93 
Specificity read 2 0.79 0.79 0.93 0.86 0.86 0.79 0.93 
Specificity read 3 0.93   0.93 0.86 0.93   0.93 
Accuracy read 1 0.73 0.87 0.90 0.93 0.93 0.83 0.93 
Accuracy read 2 0.90 0.90 0.97 0.93 0.93 0.87 0.87 
Accuracy read 3 0.97   0.90 0.93 0.97   0.90 
Table 4-2 Summary of quantitative results for the pilot study 
 
 
Mean 
95% CI 
(lower) 
95% CI 
(upper) 
Sensitivity read 2 0.96 0.80 1.13 
Sensitivity read 3 0.95 0.82 1.08 
Specificity read 2 0.87 0.75 0.99 
Specificity read 3 0.91 0.85 0.98 
Accuracy read 2 0.92 0.85 0.99 
Accuracy read 3 0.93 0.87 1.00 
Table 4-3 Mean performance figures for read 2 as compared to read 3 (for radiologists 
1,3,4,5 and 7) 
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Figure 4-4 Diagnostic accuracy figures for the 3 image reads, as compared to standalone 
CADx performance 
 
 
 
Figure 4-5 Sensitivity figures for the 3 image reads, as compared to standalone CADx 
performance 
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Figure 4-6 Specificity figures for the 3 image reads, as compared to standalone CADx 
performance 
 
Examining the impact of CADx on a scan by scan basis, comparing read 2 and 3, there was 
a change in classification score in approximately 15% of cases taken across all radiologists 
where data was complete. Table 4-4 and Figure 4-7 summarise the intra- and inter-reporter 
reliability results, respectively 
 
 Intra-reporter reliability 
Radiologist ICC 
95% CI 
(lower) 
95% CI 
(upper) 
1 0.65 0.39 0.82 
2 0.82 0.71 0.93 
3 0.93 0.87 0.97 
4 0.91 0.83 0.96 
5 1.00 0.99 1.00 
6 0.72 0.49 0.86 
7 0.84 0.70 0.92 
Table 4-4 Intra-reporter reliability (ICC) results for all radiologists 
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Figure 4-7 Inter-reporter reliability (ICC) results for each of 3 image reads (for radiologists 
1,3,4,5 and 7). Whiskers represent 95% confidence intervals 
 
Qualitative 
 
The questionnaire revealed that 3 of the radiologists had used quantitative diagnostic tools 
before and so the idea of assisted reporting was not an entirely new concept to all the 
participants. However, as expected, none of the radiologists stated that they had previously 
reported (I123)FP-CIT images. 
 
The following results summarise the responses given on the distributed questionnaire in 
relation to the CADx software tool. Each question is first stated and the proportion of the 
radiologists giving different answers is then shown. Any additional written comments which 
are of interest are also stated 
 
Question 1: In general, how would you rate the impact of the CAD algorithm on your 
reporting decisions? 
Responses: 0/7, - no impact, 3/7 – small impact, 3/7 – moderate impact, 1/7 - substantial 
impact 
Comments: 
―Gave more confidence if computer agreed with what I thought, disappointing when I wasn't 
sure and computer wasn't either‖ 
―Would help identify borderline cases that need more scrutiny‖ 
―Helped to re-look and decide‖ 
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―Good impact when CAD agreed with my opinion. Prompted me to view the image again‖ 
―Made up my mind when I thought abnormal but unsure‖ 
 
Question 2: To what extent did you trust the CAD algorithm results? 
Responses: 0/7 – not at all, 0/7 – a little, 4/7 – moderately, 3/7 – a lot 
Comments: 
―I was more trusting when it agreed with me when I was confident‖ 
―Still new to CAD therefore would need to 'trust' and prove it is accurate‖ 
―If the CAD algorithm was in line with my thought then more likely to trust it‖ 
 
Question 3: Would you prefer a binary CAD output as opposed to a probability value? 
Responses: 0/7 – yes, 5/7 – no, 2/7 – not sure 
 
Question 4: Would it benefit you if the CAD system also provided information on the location 
of image abnormalities? 
Responses: 0/7 – no, 0/7 – yes (small benefit), 0/7 – yes (moderate benefit), 6/7 – yes 
(substantial benefit), 1/7 – not sure 
Comments: 
―Depends on accuracy and would it be able to identify several areas or 'globally' abnormal?‖ 
―This will help to concentrate on that abnormal area and decide‖ 
―It would help to highlight areas to review‖ 
 
Question 5: To what extent would the CAD system be a useful training tool to improve 
DaTSCAN reporting performance for inexperienced clinicians?  
Responses: 0/7 – no benefit, 0/7 – small benefit, 1/7 – moderate benefit, 5/7 – substantial 
benefit, 1/7 – not sure 
4.3.3 Discussion 
This pilot study represents the first test of machine learning classification tools for assisted 
(I123)FP-CIT reporting. There are no directly comparable studies in the literature and so 
findings must be largely considered on their own merit. Results are discussed below with 
respect to quantitative findings first, followed by qualitative analysis. 
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Quantitative  
 
The quantitative data produced by the study indicates the potential value of the designed 
CADx system. One of the main findings from the data was that the performance of individual 
radiologists was variable both in terms of consistency in decision making and metrics of 
overall performance. For example, radiologist 1 had highly variable sensitivity and accuracy 
scores between read 1 and 2 (see Figure 4-4 and Figure 4-5) despite there being no change 
in reading conditions (with only a one hour break between reads). Their intra-reporter 
reliability score (ICC) was also low. Conversely, radiologist 5 had very consistent 
performance scores across the 3 image reads and had a perfect ICC score.  
 
However, examination of Table 4-2 shows that for 6 of the 7 radiologists individual accuracy 
results were in the range 0.83-0.97 when reading images without CADx assistance (i.e. 
reads 1 and 2). This is in line with visual accuracy results previously reported by other 
authors, with more experienced radiologists (see section 1.1.5). This suggests that relatively 
accurate reporting of (I123)FP-CIT images, at least in terms of binary classification, can be 
achieved with little training. It also suggests that for the majority of radiologists recruited in 
this study there is no compelling evidence that performance is different to that of the more 
experienced radiologist population.   
 
Despite the variability seen at the individual radiologist level, taken together the results show 
that there was a small change in overall accuracy between reads 2 and 3 (see Table 4-3), 
indicating that the overall impact of CADx in terms of a change in binary diagnosis was low. 
Interestingly, however, the combined data showed a larger increase in mean specificity (with 
a slight decrease in sensitivity). This is consistent with the CADx tool causing radiologists to 
change their overall image classification on a few occasions (i.e. moving between scores of 
1-2, 3 and 4-5) but that the overall error rate only improved slightly as a result. Thus, the 
main influence of the machine learning algorithm output on binary decision making appears 
to be that it encouraged the radiologists to be slightly more cautious in reporting images as 
abnormal. 
 
The most significant influence of CADx can be seen from the inter-reporter reliability results 
(see Figure 4-7). Taken across 5 radiologists there is a substantial difference in the ICC 
value from reads 1 and 2 as compared to read 3 (0.84 and 0.86 vs 0.95). Taking into 
account the 95% confidence intervals on the ICC scores, there is no overlap between the 
two different reporting scenarios, suggesting that this difference is significant. This implies 
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that although CADx did not cause a significant shift in overall binary classification accuracy, 
it may have had a greater effect in ‗pushing‘ radiologists towards a common image score.  
 
The standalone performance results of the machine learning algorithm were reassuringly 
high (higher than many of the reporters) and demonstrate that the tool was suitable for use 
as an assistant to radiologists. The results also show, in a relatively limited sample, that an 
algorithm trained with data that has an inferior ground truth diagnosis (visual analysis only) 
can achieve high diagnostic accuracy. This identifies that the selected machine learning 
model has the potential to be a clinically useful CADx tool. 
 
In this study the delay between reads 1 and 2 was short and it is likely that recall bias would 
not have been completely eliminated. Furthermore, reading multiple images of the same 
type in a short space of time is not necessarily reflective of clinical workloads. In Sheffield, 
for example, there are typically only 2 new (I123)FP-CIT cases per week to report. These 
factors are likely to increase uncertainty in pilot study results. 
 
The stark differences in performance between individual radiologists are difficult to account 
for. It may have been that some of the radiologists didn‘t fully understand the reporting task, 
hadn‘t fully appreciated the differences between normal and abnormal appearances or were 
unsure how to use the software (at first). As suggested by Eadie, training processes used to 
familiarise reporters with CADx software (100) can be vitally important. It is possible that the 
training provided was inadequate, and so results may have included learning curve effects, 
where the radiologist becomes more confident in using the software over time. A longer 
training period may have helped to reduce these issues.  
 
Qualitative 
 
The radiologist-CAD relationship is complex and cannot be fully reported in terms of 
diagnostic performance figures alone. Qualitative evaluation of the psychological aspects of 
computer assisted reporting can provide a much richer dataset, giving insights into software 
design steps that may improve overall performance. However, such investigations are rarely 
carried out (99). Thus, although relatively basic, the questionnaires provided to participating 
radiologists in the pilot study offer a useful, complimentary and novel insight into how CADx 
affects decision making for (I123)FP-CIT. 
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The responses to question 1 show that CADx mostly had a small or moderate impact on 
decision making processes. This is reflected in classification scores that were changed for 
15% of patient cases. It should be emphasised however, that the junior radiologists tested in 
this study may be more open to influence by CADx software than more experienced 
radiologists. 
 
An important consideration was the extent to which the accuracy of the machine learning 
algorithm was revealed. By disclosing that the standalone accuracy of the system was 
approximately 90%, i.e. at the level of a human expert, it is possible that participants may 
have been more trusting of the algorithm than if no performance data had been provided.  
 
The comments received in relation to question 1 indicate that the tool was of most use and 
had the biggest impact when its output reflected the original opinion of the radiologist. 
Generally, if the radiologist and CADx classified the image in the same way, the radiologist 
was more confident in his/her diagnosis. In addition, comments also suggested that the 
algorithm output caused some of the radiologists to look again at the image, to scrutinise 
appearances in light of objective findings from the CADx. This is reassuring as it reflects the 
intended purpose of the CADx system.  
 
However, one of the comments suggested that the machine learning algorithm was of less 
help in difficult cases, where the probability was also on the borderline between the two 
classes. Here, the CADx system appears to have a similar ability to that of the radiologists, 
providing more equivocal results when image appearances were difficult to classify. 
Although this may limit the usefulness of CADx (a high-probability, independent check may 
be more helpful in equivocal cases), it is perhaps unsurprising. If a human struggles to 
visually classify an image then it is likely that extracted features, based on the same data, 
will also not provide a clear classification in all cases.  
 
The responses to question two reveal that in general the CADx software was trusted by the 
radiologists, which is vital if such a system is to achieve clinical acceptance. Interestingly, 
the submitted comments reveal that trust was intrinsically linked to the radiologists‘ 
experiences. If the tool agreed with their initial image read then trust increased. This might 
indicate that an assisted reporting tool should largely agree with reporters in order for it to be 
accepted in clinic. However, this potentially creates a problem. If a CAD tool always agrees 
with a radiologists‘ first impressions then its usefulness as a means of increasing 
performance is decreased. There needs to be some discrepancy in a minority of cases in 
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order to influence reporters to move away from an incorrect diagnosis. Conversely, if the 
disagreements between a radiologist and the CADx tool are too frequent, even if the 
radiologist is wrong, then trust in the tool may be decreased and the reporter may simply 
ignore it. 
 
The responses to question 3 justify the choice of a probability value as an output from the 
classifier, as opposed to a binary discrimination. However, question 4 reveals that the 
current system design is less than perfect. The current classification approach takes the 
whole image as an input and so is unable to provide local information on the possible sites of 
any abnormalities. This is a potential disadvantage as compared to semi-quantification, 
which localises uptake quantities to striatal sub-regions (in some cases). The desire for a 
localisation mechanism also implies that reporters may benefit from gaining a better 
understanding as to which aspects of an image‘s appearance caused the CADx system to 
classify a patient in one way or another. However, it should again be emphasised that the 
radiologists recruited for the study were relatively inexperienced. For consultant radiologists, 
localisation information (and further details on why a classification decision was made) may 
be less of an asset. 
 
Responses to the final question suggest that radiologists found the CADx tool to be a 
potentially useful training aid. Given that the standalone accuracy of the classification tool 
was high this is perhaps unsurprising. Allowing a reporter to analyse an image, form their 
own opinion, then compare to an independent ‗expert‘, the overall experience is similar to 
that of being trained by a more experienced colleague. The major advantage of this form of 
training is that once setup, the costs of the software would be negligible. Utilising the 
machine learning tool in this way deviates from the original intended purpose for which it was 
developed, but this added application could offer another route for demonstrating 
effectiveness in the clinic. 
4.3.4 Conclusion 
The pilot study provided a useful insight into the effects of a machine learning algorithm on 
radiologist performance, when utilised as a CADx system. Although the radiologists recruited 
had no previous experience of reporting (I123)FP-CIT images their unaided reporting 
accuracy (following training) was in most cases at a similar level to that typically reported for 
more experienced reporters. For the limited set of 30 images used in the study there was a 
small change in overall performance, in terms of accuracy, after the introduction of the 
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machine learning algorithm to the reporting process. However, there was a substantial 
improvement in inter-reporter reliability. The standalone accuracy of the algorithm was found 
to be high, justifying its use as a CADx tool.  
 
The results of the questionnaire demonstrate that the tool was well trusted and had a 
small/moderate impact on reporting decisions. The questionnaire also revealed that a 
probabilistic CADx output was preferred to a binary one but that localisation information 
would have made the assistive reporting tool more useful. The received opinions suggest 
that the machine learning tool may have an important role to play in future training of 
inexperienced radiologists, which could offer a new route to clinical acceptance. 
4.3.5 Implications 
Although limited, the pilot study was a useful precursor to a larger scale clinical evaluation. 
Results justify inclusion of a much larger number of clinical cases to measure a significant 
change in reporting accuracy after introduction of CADx, assuming that such a difference 
exists. Biasing the test patients in the main study towards more difficult cases may help to 
further expose the performance benefits available from CADx, particularly for more 
experienced radiologists, for whom reporting opinions are unlikely to change if visual 
analysis shows classical normal or abnormal appearances. 
 
The effect on inter-reporter reliability and reporting confidence of the CADx system were 
encouraging, but results for more experienced radiologists may be less dramatic (i.e. they 
may trust their own judgement more and be less swayed by algorithm output). This again 
dictates that a larger number of cases should be included in a clinical trial to measure what 
may be a relatively small effect. It is difficult to predict the minimum number of cases 
required and so utilising as much of the available data as possible is likely to be the best way 
of ensuring that clinical impact is measured adequately.  
 
The pilot study results also suggest that a localisation mechanism would be a useful 
addition. However, this would require a complete algorithm redesign. It was not the intended 
focus of this work to design a completely new tool and so this option was rejected for the 
larger trial. In general, the results from the questionnaire were insightful and added useful 
contextual information on the influence of CADx. The larger, main study described below will 
include an expanded list of questions for discussion, to explore these issues more deeply. 
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4.4 Main study – assessment of experienced reporters 
The aim of the main clinical evaluation study was to generate in-depth, reliable evidence of 
the impact of a CADx tool in a clinical reporting scenario with experienced reporters, from a 
qualitative and quantitative perspective. This data adds to the evidence gathered so far on 
the effectiveness of CADx for (I123)FP-CIT reporting. 
4.4.1 Introduction 
The data from the local hospital that was available for clinical studies was limited. All of 
subset B had already been used for training the machine learning algorithm, and so could 
not be used for clinical testing. Subset A contains only 55 cases in total, which is unlikely to 
be sufficient for measuring the impact on reporting decisions with high confidence. 
Therefore, for the main clinical study the PPMI data was used in addition to the local data. 
As previously discussed the PPMI data is not necessarily a good representation of the 
images seen in clinic in the UK. However, this added data does enable a more 
comprehensive assessment of the possible benefits of CADx for (I123)FP-CIT reporting. In 
addition, the inclusion of PPMI data enables assessment of reporter performance with 
unfamiliar images (reflective of the situation when radiologists move to a new hospital, for 
example). 
 
Given the very different acquisition conditions and processing parameters associated with 
the PPMI data, a separate classification algorithm was trained. Utilising the algorithm trained 
on local data, for classification of PPMI data, is likely to have led to reduced performance, 
giving a false impression of the potential for CADx.  
 
The pilot study showed high performance figures for many of the junior radiologists when 
reporting local data unaided and there were relatively few cases where the CADx caused a 
change of opinion. Given that the PPMI data is associated with strict inclusion and exclusion 
criteria (for example PD patients without abnormal SPECT appearances are excluded) it is 
likely that unaided visual reporting performance and confidence may be even higher for this 
cohort, and the potential for CADx to influence reporters‘ decisions even lower. Thus, test 
data were skewed towards more difficult cases in order that the number of cases where 
reporters‘ visual impression was uncertain was maximised, increasing the potential for CADx 
system to influence diagnostic performance 
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To achieve this, the PPMI set was split in half, maintaining the same proportion of normal 
and abnormals in each sub-group. The first half, containing 328 images, was used for 
algorithm training. For the second half of the data SBR figures were examined to find the 40 
healthy controls with the lowest putaminal uptake ratios and the 60 PD cases with the 
highest uptake ratios. This collection of 100 images, skewed towards more equivocal data 
(according to semi-quantification results), was used in the clinical evaluation. The remaining 
data, which was neither used for algorithm training nor for testing with radiologists, was 
excluded. 
 
Method 
 
Two radiologists and one clinical scientist were recruited for the study. All three had at least 
5 years of experience of reporting on (I123)FP-CIT image appearances as part of a routine 
clinical service. By including reporters from two different specialisms it was possible to gain a 
wider perspective on potential differences in opinion as to the value of CADx in a clinical 
scenario. The study procedure was similar to that adopted for the pilot study, with three 
separate reads conducted for each image, two without CADx support and one with. 
Measurements of standalone performance on the test data were also conducted. However, 
there was no reporter training phase other than a brief demonstration of the software. 
Furthermore, the time gap between the first and second read was much longer in order to 
reduce uncertainties associated with recall bias (a minimum of 4 months). In contrast to the 
pilot study, each reporter worked through the test cases at their convenience, on their own 
(using standard clinical reporting hardware). The main differences between pilot and main 
studies are summarised in Table 4-5. 
 
Calculation of performance metrics and inter/intra reporter variability was the same as for the 
pilot study, considering the PPMI and local data separately. The qualitative aspects of the 
study were expanded, with additional questions added to the questionnaire. In contrast to 
the pilot study where time was very limited, the volunteers were individually guided through 
the questionnaire after the 3 image reads had been completed. This enabled a greater 
exploration of any salient points that were raised. Due to the reporters‘ previous experience 
of standard reporting using semi-quantification, there was also scope to explore the 
perceived benefits (or disadvantages) of using CADx instead through specific questions.  
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 Pilot study Main study 
Time delay between reads 
1 and 2 
1 hour 4 months+ 
Total images reported 30 155 
Number of reporters 7 3 
Experience level of 
reporters 
None 5 years+ 
Reporting environment Single room, shared 
with all reporters, 
standard PCs 
Separate, standard 
clinical workstation for 
each reporter 
Reporting conditions Time pressured, all 
cases for all 3 reads 
completed within one 
joint lab session 
Reporters worked 
through cases at their 
convenience 
Table 4-5 Summary of the differences in methodology between pilot and main CADx studies 
4.4.2 Results  
Quantitative 
 
A different naming system is used in the following results to distinguish between each 
reporter (referred to as Rad1, Rad2 and CS1). This was done partly to emphasise the 
differences as compared to data measured from junior radiologists in the pilot study, and 
partly because the reporters now represented a mixed group, containing two radiologists and 
one clinical scientist. The delay between reads 1 and 2 ranged from 137 days to 356 days 
across the two datasets and 3 reporters, well in excess of 4 months. 
 
Figure 4-8, Figure 4-9 and Figure 4-10 summarise performance metrics for each reporter for 
each for the 3 reads, with local data and PPMI data. These graphs also display the 
standalone performance of the CADx system, where appropriate. 
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 Figure 4-8 Diagnostic accuracy figures for the 3 image reads, for PPMI data (left) and local 
data (right). Standalone CADx performance is also shown, for comparison. Adapted from (2) 
 
Figure 4-9 Sensitivity figures for the 3 image reads, for PPMI data (left) and local data (right). 
Standalone CADx performance is also shown, for comparison. Adapted from (2) 
  
Figure 4-10 Specificity figures for the 3 image reads, for PPMI data (left) and local data 
(right). Standalone CADx performance is also shown, for comparison, Adapted from (2) 
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As a result of being exposed to the CAD software output the reporting score was changed in 
approximately 13% of cases for the local data, and in approximately 17% of cases for the 
PPMI data (similar to the 15% change rate seen in the pilot study). Intra and inter reporter 
reliability results are shown in Table 4-6 and Figure 4-11. Due to apparent differences in the 
ways that the radiologists and the clinical scientist responded to the CADx, separate inter-
reporter reliability figures are displayed from all three reporters together and considering just 
the radiologists alone. 
 
 Intra-reporter reliability 
 PPMI Local 
Reporter ICC 
95% CI 
(lower) 
95% CI 
(upper) ICC 
95% CI 
(lower) 
95% CI 
(upper) 
Rad1 0.87 0.82 0.91 0.89 0.82 0.93 
Rad2 0.95 0.92 0.96 0.93 0.88 0.96 
CS1 0.91 0.87 0.94 0.88 0.80 0.93 
Table 4-6 Intra-reporter reliability (ICC) results for all reporters, for PPMI data and local data. 
Adapted from (2) 
 
 
Figure 4-11 Inter-reporter reliability (ICC) results for each of the 3 image reads for PPMI data 
and local data. The graph on the left is derived from radiologist data only (Rad1 and Rad2), 
the graph on the right is from all reporters. Whiskers represent 95% confidence intervals. 
Adapted from (2) 
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Qualitative 
 
As previously, the following results summarise responses received to specific questions. In 
addition, any salient comments that reporters made are highlighted. Given the differences 
shown in reporting trends between the radiologists and clinical scientist, the responses and 
comments are assigned to the particular reporter. 
 
Question 1: In general, how well did your reporting decisions correlate with the CAD output? 
 
 Responses 
Reporter 
Not at 
all 
A little Moderately A lot Comment 
Rad1    ✓  
Rad2    ✓ 
―Only one or two cases 
where I disagreed‖ 
CS1    ✓  
Total 0 0 0 3  
Table 4-7 Reporter responses to question 1 
 
Question 2: In general, how would you rate the impact of the CAD algorithm on your 
reporting decisions? 
 
 Responses 
Reporter 
No 
impact 
Small 
impact 
Moderate 
impact 
Substantial 
impact 
Comment 
Rad1  ✓   
―Depends on the case. I liked the 
fact that in most cases it 
confirmed my opinion as we only 
single read these scans. It 
generally added confidence‖ 
Rad2   ✓  
―On the few occasions where my 
opinion differed significantly from 
the CAD, it had a substantial 
impact‖ 
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CS1  ✓    
Total 0 2 1 0  
Table 4-8 Report responses to question 2 
 
Question 3: To what extent did you trust the CAD algorithm results? 
 
 Responses 
Reporter 
Not 
at all 
A little Moderately A lot Comment 
Rad1    ✓ 
―My performance changed depended on 
the preceding cases [if several CAD 
scores agreed with my opinion in a row I 
grew more confident and trusting in the 
algorithm then gave CAD more weight]‖ 
Rad2    ✓ 
―Trust increased as I gained more 
experience‖ 
CS1   ✓  
―After my experiences so far I‘d give it 7 
out of 10 in terms of how much I trust it‖ 
Total 0 0 1 2  
Table 4-9 Reporter responses to question 3 
 
Question 4: Would you prefer a binary CAD output as opposed to a probability value? 
 
 Responses 
Reporter Yes No Other 
Not 
sure 
Comment 
Rad1   ✓  
―I would like to see both. I was swayed 
by the colour of the probability value as 
well as the actual number‖ 
Rad2  ✓   ―Very much liked the scale‖ 
CS1  ✓    
Total 0 2 1 0  
Table 4-10 Reporter responses to question 4 
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Question 5: As compared to semi-quantification, how does CAD compare in terms of what it 
offers you as a reporting assistant? 
 
 Responses 
Reporter Comment 
Rad1 
―I prefer CAD to semi-quantification. Semi-quantification presents too many 
numbers and can be confusing‖ 
Rad2 “Bit of extra information. Difficult to know exactly how they differ‖ 
CS1 
―It would be nice to know why an image was classified as abnormal (which semi-
quantification gives you)‖ 
Table 4-11 Reporter responses to question 5 
 
Question 6: Would you prefer to have CAD for assistive DaTSCAN reporting or semi-
quantification? Or Both? 
 
 Responses 
Reporter CAD 
Semi- 
quantification 
Both 
Not 
sure 
Comment 
Rad1   ✓  
―CAD as a first line then semi-
quantification if I needed it‖ 
Rad2   ✓   
CS1   ✓  
―I wouldn‘t want anything too 
complex though‖ 
Total 0 0 3 0  
Table 4-12 Reporter responses to question 6 
 
Question 7: Would it benefit you if the CAD system also provided information on how it 
came to its decision (e.g. reduced putamen uptake, high background uptake etc.) 
 
 Responses 
Reporter No 
Yes 
(small 
Yes 
(moderate 
Yes 
(substantial 
Comment 
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benefit) benefit) benefit) 
Rad1  ✓   
―I had a good idea why the 
algorithm decided what it did‖ 
Rad2  ✓   
―I could usually see why it 
thought what it did‖ 
CS1   ✓  
―It needs to give some 
understanding of how it 
reached its decision (if 
possible)‖ 
Total 0 2 1 0  
Table 4-13 Reporter responses to question 7 
 
Question 8: To what extent would the CAD system be a useful training tool to improve 
DaTSCAN reporting performance for inexperienced clinicians?  
 
 Responses 
Reporter 
No 
benefit 
Small 
benefit 
Moderate 
benefit 
Substantial 
benefit 
Not 
sure 
Comment 
Rad1  ✓     
Rad2  ✓     
CS1   ✓  
 ―Already have training 
sets for people to work 
through‖ 
Total 0 2 1 0   
Table 4-14 Reporter responses to question 8 
4.4.3 Discussion 
As for the pilot study, the discussion is presented in separate sections, considering the 
quantitative data first, followed by the collected qualitative data.   
 
Quantitative  
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In common with the pilot study, standalone diagnostic accuracy for both machine learning 
classification algorithms was in excess of 90%, which again shows that the chosen 
classification model performs at least as well as humans using visual analysis alone.  
 
Analysis of Figure 4-8, Figure 4-9 and Figure 4-10 indicates that there was relatively high 
variation in per-reporter performance metrics between the first and second reads in some 
cases, for both sets of data. This identifies the degree of intra-reporter variability when 
analysing images visually, even for experienced reporters. This is backed to some degree by 
intra-reporter reliability (ICC) figures, which although generally higher than those seen for 
junior radiologists, were less than 0.9 for Rad1 and CS1 for the local data. Rad2 appeared 
more consistent. These findings were unexpected and may be exacerbated by the relatively 
long time gap between image reads, such that reporters‘ impressions of what constitutes a 
normal or abnormal image may have drifted. The variability seen may be an exaggeration of 
what is normally expected in the local clinical service, where a group reporting scenario is 
used routinely, with semi-quantitative results and patient notes available. This may help to 
ameliorate the effects of individuals‘ changing visual impression. Nonetheless, results do 
provide a reminder that human perception and understanding of medical images is not a 
constant. This again adds weight to arguments on the need for assistive software (or 
algorithms which take diagnostic decisions independently). 
 
Comparing reads 2 and 3 (i.e. directly before and after the CADx was shown to the reporter) 
it does appear that there was some uplift in performance for the PPMI data, where every 
performance metric either stayed the same or increased for all reporters. Conversely, for the 
local data there was no clear change in performance as a result of the introduction of CADx. 
For the PPMI data it is interesting to note the contrasting results between the clinical 
scientist (CS1) and the two radiologists (Rad1 and Rad2). For both radiologists there was a 
substantial increase in accuracy after viewing the CADx results, with similar increases in 
specificity and sensitivity. However, for the clinical scientist there was no change in any of 
these figures. Indeed, analysis of the individual scan results indicates that CS1 only changed 
his / her diagnostic confidence score in 7% of cases for the PPMI data, as compared to 21% 
and 22% for Rad1 and Rad2 respectively. A similar but less marked trend was seen in the 
local data, where CS1 changed his score in 6% of cases as compared to 9% and 23% for 
Rad1 and Rad2. It appears that the radiologists relied more heavily on the CADx decision 
than the clinical scientist, particularly for the unfamiliar PPMI data.  
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The fact that the PPMI test data was skewed towards more borderline cases may have 
increased reliance on the CADx for the radiologists, which may have emphasised its benefits 
to a greater extent (as was intended). The performance gains seen for the radiologists in this 
half of the study are also likely to be related to the fact that the standalone performance of 
the CADx tool was generally higher than that of the volunteers during reads 1 and 2, i.e. by 
aligning their opinions more with the CADx tool, the radiologists‘ performance was pulled 
closer to that of the trained algorithm. This contrasts to trends seen with the local data where 
baseline reporter performance was generally higher, and standalone accuracy of the CADx 
tool was essentially the same as that of the reporters.  
 
The inter-reporter reliability results echo previous findings in that responses from different 
reporters became more consistent after exposure to the machine learning output. Figure 
4-11 demonstrates that for the radiologists at least, there was a noticeable increase in the 
intraclass correlation coefficient between reads 2 and 3. For the PPMI data the 95% 
confidence interval bounds suggest that this increase in reliability (and hence reduction in 
variability) was statistically significant. These trends are reinforced by percentage agreement 
figures: for the PPMI data the radiologists had complete agreement in confidence scores in 
77 and 74% of cases for reads 1 and 2, rising to 87% agreement after introduction of CADx. 
However, as for the performance figures related to accuracy, sensitivity and specificity, these 
trends are less clear when the clinical scientist was included in the analysis. The apparent 
differences in performance between the two staff groups are explored further in the following 
qualitative analysis section. 
 
Given the increased consistency between reporters during read 3 it is likely that the 
introduction of a CADx system would also have benefits in terms of reduced intra-reporter 
variability. However, estimation of such an effect would benefit from the reporting exercise 
with CADx assistance being repeated. 
 
The increase in accuracy for the radiologists, as a result of exposure to CADx output, when 
scoring unfamiliar (PPMI) data, is perhaps clearer than the mixed performance trends seen 
in the pilot study. This may be due to increased noise in the pilot study data due to variable 
understanding of the task presented, and the much increased time pressure of the pilot 
study setup. However, both the pilot study and main study showed an overall increase in 
inter-reporter reliability after introduction of the CADx (though there were differences in the 
magnitude of change). The proportion of cases where reporters / radiologists changed their 
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scores was also similar between the studies. Apparently the assistive reporting tool can be 
as influential on very experienced reporters as those who are beginners. 
 
It is difficult to directly compare these findings to those of wider studies evaluating the effects 
of semi-quantification on radiologists‘ performance, mainly due to differences in data used 
and methodology. However, the broad findings of this work – that CADx can improve 
accuracy if adopted by reporters with limited experience of the data, and that inter-reporter 
reliability may also improve as a result – are consistent with much of the previous work 
related to semi-quantification, where increased confidence and consistency were found to be 
the main benefits (see section 1.2.1).  
 
This study was conducted under more realistic conditions than the pilot investigation. As well 
as the much longer time gap between reads (to reduce recall bias), the reporters used the 
same workstations as they would normally view clinical images on. This focus on more 
realistic testing conditions contrasts with much of the machine learning literature, where 
clinical validation is often not performed or is insufficient (100,103–106). Thus, findings 
provide a useful addition to current knowledge on the clinical potential for CADx. 
 
However, there remains some limitations in the testing scenario, as listed below: 
 
 Patients‘ clinical history was not available to reporters as it would have been in clinic. 
If such information were available the impact size of CADx may have been reduced. 
 Although it was intended that patient age would be visible to reporters for all reads, it 
was only displayed to reporters on read 2 and 3. This may have caused additional 
intra-reporter variability.  
 The reference diagnoses of all the images studied was binary (i.e. either with or 
without disease). However, the 5 point confidence scale used by reporters 
associated a score of 3 with an equivocal classification, giving users a choice of 3 
different classifications. This mismatch dictated that accuracy, sensitivity and 
specificity were all negatively affected whenever a reporter submitted an equivocal 
confidence score. Although a score of 3 was selected in less than 3% of cases for 
the main study, diagnostic performance figures may have provided a more 
pessimistic outcome than might have been the case if only two classifications were 
available for users to select.  
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 Participating reporters understood that they were taking part in a research study and 
their decisions would not affect patient care. This may have caused them to be less 
cautious than would normally be the case (107).  
 Re-reporting of the same images with and without the assistance of an automated 
classification system is an artificial process necessary for clinical evaluation, but 
which can lead to changes in reporter performance (108).  
 
Although it is important to be aware of such uncertainties, these factors do not detract from 
the main, positive findings of the quantitative analysis, namely: standalone performance of 
the CADx tool was at least as high as that of experienced reporters, CADx improved 
performance of the reporters for the PPMI data and that CADx increased consistency 
between reporters across both datasets. 
 
Qualitative 
 
The qualitative findings indicate that the CADx tool generally agreed well with the reporters‘ 
classification decisions, with only a very limited number of disagreements. This reflects the 
quantitative findings which showed similar standalone performance between the CADx tool 
and reporters using visual analysis. Many of the responses to the questions are very similar 
to those recorded in the pilot study. For example, the CADx tool was generally felt to have a 
small impact on reporting decisions and was found to increase the confidence of reporters 
when both the reporter and the classification tool came to the same conclusion. 
Furthermore, as with the pilot study, the tool was generally well trusted (although the level of 
trust changed across the duration of the study) and in most cases the reporters preferred the 
probability output to a purely binary image score.  
 
These observations provide evidence that the more experienced, established reporters 
viewed CADx similarly to the junior radiologists. However, there were some notable 
differences. For example, Rad1 and Rad2 felt that having an idea of why the CADx tool 
came to a particular decision was relatively unimportant. This contrasts with the junior 
radiologists who felt that having a localisation mechanism to identify where in an image the 
likely abnormality was, would be useful. These findings are perhaps unsurprising given that 
more experienced reporters will more easily recognise patterns of normal and abnormal 
uptake, requiring less prompting from the computer. 
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The questions asked of the more experienced reporters also offered additional insight. Of 
particular interest was the contrast between semi-quantification and CADx. Interestingly, all 
three reporters felt that having access to both CADx and semi-quantification was preferable 
to having access to one or other. This implies that the functionality of each was felt to be 
different but complementary. Perhaps a greater impact on reporting performance would be 
measured by performing a clinical study using a combined software algorithm giving SBRs 
and overall probabilities. 
 
The qualitative results provide additional evidence that the approach and opinions of the two 
radiologists were close to each other, but differed with that of the clinical scientist. In general, 
the clinical scientist was less positive about the CADx tool, and more cautious about relying 
upon it. For example, CS1 gave a lower relative score for his / her level of trust in the CADx 
tool than the two radiologists. This is also reflected in the fact that CS1 selected the 
equivocal image score more times than Rad1 and Rad2 when using CADx. CS1 also felt it 
important that the CADx tool gave a reason for its classification decision, which contrasts 
with the radiologists who felt that they did not need this extra information. Indeed, Rad1 saw 
the very simple colour-coded CADx output as an advantage. Furthermore, the radiologists 
were generally positive about using the CADx tool as a training resource for inexperienced 
radiologists, whereas CS1 felt that existing data and methods were sufficient.  
 
These differences in how the CADx tool was appreciated could, at least in part, be attributed 
to differences in the professional background of the two staff groups. Clinical scientists are 
taught to understand the technology that is associated with their area of expertise. Indeed 
the local semi-quantification tool used clinically in Sheffield was originally developed and 
tested by clinical scientists. Without providing the volunteers with information on how the 
CADx tool worked, it was effectively presented as a ‗black box‘ with little scope for gaining 
intuition as to why certain classification decisions were reached. For radiologists there is 
much less focus on understanding imaging technology in their training and a greater 
emphasis on interpreting images using provided software. Thus, they may have been more 
at ease accepting the output from the CADx than the clinical scientist, who normally 
interprets images using technology which they understand in detail. Arguably, for centres 
where clinical scientists carry out reporting, more information on the technology behind the 
CADx tool may need to be provided in order to persuade them of its merits. Furthermore, it 
may help the case for adoption if the CADx tool could be adapted to provide some indication 
as to why a decision has been made.  
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The fact that radiologists were generally trusting of the CADx algorithm, and that their level 
of trust increased with experience of using the tool (in both this study and the pilot study), 
does perhaps present an added risk. There is a danger that individuals could come to rely 
more and more on the CADx to make the diagnostic decision for them, relying less on their 
own judgement. This is particularly relevant in the current healthcare environment where 
radiologists‘ workloads are becoming ever larger. It is feasible that in cases where the CADx 
tool made an incorrect classification, perhaps due to unusual image appearances not seen 
in training data, this could have undue influence on the final report, that might otherwise 
have given a different conclusion if the radiologist was working alone. Therefore, it is 
important that reporters are trained to understand that the technology is not always right. 
Striking a balance in reporters between scepticism (as displayed by the clinical scientist) and 
being open to influence is likely to be a challenge for this CADx application and for others. 
 
Although the questions asked during the main study expanded upon those presented during 
the pilot study, there are perhaps still additional questions that could have been posed to 
gain additional insight. For example, given the similar (or higher) performance of the CADx 
tool as compared to the reporters there is potentially a role for such automated classification 
systems in auditing the reports produced in the clinical department. This is likely to become 
increasingly important as imaging centres (and healthcare professionals) seek ongoing 
accreditation. Exploring opinions on this aspect of the CADx software may have yielded 
useful insights. 
4.4.4 Conclusion 
Overall there were many similarities between the pilot study and main study. Standalone 
accuracy of the automated classification tool was at a similarly high level in both cases, and 
exposure to its output caused a similar proportion of changes in reporting decisions. Both 
sets of reporters also had a similarly high level of trust in the algorithm. The unaided, visual 
diagnostic performance of all the experienced reporters was more variable over time than 
was expected, which suggests that CADx could potentially have a role to play in reducing 
intra-reporter variability as well as inter-reporter variability. 
 
Quantitative results demonstrated positive benefits of CADx in terms of increased accuracy 
for the two experienced radiologists, when viewing (unfamiliar) PPMI data. In addition, the 
introduction of CADx appeared to increase consistency between the two radiologists, for 
both the PPMI and local data. However, the clinical scientist was less affected by the CADx 
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tool, with less change in reporting performance between reads 2 and 3, for both sets of 
patient images. The more cautious approach of the clinical scientist is apparent in answers 
to the questionnaire, which suggested a lower level of trust than for the radiologists and a 
greater need to understand the mechanism behind the machine learning algorithm‘s output 
probability. Questionnaire results also indicated that clinical reporters would prefer to have 
access to both CADx and semi-quantification in clinic.  
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5 Dilemmas of clinical application 
The clinical studies described in the previous chapter provide valuable insight into (I123)FP-
CIT reporting and how a particular CADx tool may impact upon performance. These results, 
combined with previous tests, have addressed the original aims of this thesis.  
 
The original research question for this work was: How effective is a CADx tool, based on 
established machine learning algorithms, for assisted (I123)FP-CIT image reporting? 
Effectiveness was defined in terms of independent classification accuracy and in terms of 
the impact upon human reporter accuracy, sensitivity, specificity and inter-reporter reliability. 
Overall, CADx was found to be highly effective in that it increased consistency between 
reporters and increased their diagnostic performance (particularly when viewing unfamiliar 
data). Furthermore, the standalone accuracy of machine learning tools was found to be in 
excess of semi-quantification tools, which are the current standard for clinical assistive 
software in (I123)FP-CIT imaging.  
 
The work conducted so far represents a step change in comparison to previous research on 
machine learning for (I123)FP-CIT in that algorithms here have been considered in the 
clinical context. The direct comparison with competing clinical technologies (semi-
quantification) and testing with reporters as part of a CADx workflow are novel aspects not 
yet investigated by other researchers. Indeed, given the high standalone performance of the 
developed algorithms, a case could be made for using the classification tools independently 
in clinic, as part of a different reporting paradigm. For example, the classification tool could 
perhaps be used to screen out images with high chance of being normal from the reporting 
list. Alternatively, the tool could be used as a training device, allowing junior radiologists to 
compare or audit their reporting decisions against software which performs at a similar level 
to that of an experienced reporter. Such an approach could reduce the supervisory burden 
on consultant radiologists (who may be difficult to access for junior staff, particularly in small 
hospitals).    
 
However, although the results presented are undoubtedly persuasive, and add weight to the 
case for the routine adoption of machine learning tools for (I123)FP-CIT, the approach 
adopted so far has arguably been naïve. Firstly, clinical reporting has been considered as a 
single, isolated classification task involving binary classification of an image. In reality, 
reporting is a more complicated mental process, which takes into account multiple other 
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factors such as results from other tests and the patient‘s clinical history. Extrapolating 
findings to the clinic is therefore associated with a degree of uncertainty. Furthermore, there 
are many additional barriers that remain in the quest for widespread clinical adoption, both in 
relation to this application and for other machine learning classification software. Most 
starkly, these are: regulations, economics, heterogeneity of the clinical environment, data 
ownership and change management 
 
These are considered in the list below, (extracts of which are also presented in peer 
reviewed journal articles (4,5)): 
 
1) Regulations. In Europe, when software which is designed to have an impact on 
patient diagnosis or treatment is released, it is considered to be a medical device and 
the manufacturer must adhere to the Medical Device Directive (Medical Device 
Regulations from May 2020). Whatever the classification under the regulations, there 
are a minimum series of requirements that need to be met. Under the updated 
regulations, requirements related to risk management and quality management 
systems are prominent. Products need to be designed in such a way that patient or 
user safety is not compromised and that testing is carried out to ensure that the 
product performs as intended. This could require a substantial re-writing or 
repackaging of the original software code, as well as clinical trials. Importantly, 
ongoing surveillance is required in order to identify and fix any bugs associated with 
the software. Meeting the regulations requires significant financial resources and 
specialist knowledge not normally found in an academic environment. Costs are 
particularly big if the risk classification is high, which may be the case for (I123)FP-
CIT classification software developed in this work.  
2) Health economics. When deciding on whether to invest in particular medical 
products many healthcare systems around the world utilise economic analysis to 
inform their decision. In the UK for example, the National Institute for Health and 
Care Excellence (NICE, www.nice.org.uk) places strong emphasis on such data 
when generating guidance on medical technologies. Therefore, ensuring that 
developed products have a strong health economic case is important for promoting 
adoption. However, even for the most simplistic economic analysis methods, such as 
cost-consequence analysis, evidence is required to quantify resource implications of 
the technology, in addition to data on the likely clinical benefits. For CADx in 
particular, gathering convincing data on the implications for patient care, as 
compared to standard reporting, is likely to be complex and difficult. 
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3) Heterogeneity of the clinical environment. Machine learning tools cannot be 
implemented in isolation. Software needs to be integrated within hospital 
infrastructure such that it is easy to access and use. However, the available 
information technology resources and associated restrictions may vary considerably 
between hospitals. Furthermore, software outputs need to be adapted to the 
particular scanning equipment and imaging protocols used locally, such that 
associated differences in image appearance do not cause algorithm performance to 
be degraded (it is well known, for example, that SBRs can vary according to the 
gamma camera used (50)). Understanding and adapting to this heterogeneity is vital 
when considering software design. However, gathering such data is again resource 
intensive. Creating automated classification or CADx tools that are applicable to 
many different settings is difficult and, ultimately, it may not be possible to 
accommodate all the requirements of different hospital environments. 
4) Data ownership. Using retrospective patient data for machine learning research, as 
in the case of this thesis, requires appropriate governance approvals to be in place, 
particularly with regards to ethics. These requirements are well established, with 
systems such as the Integrated Research Application System (IRAS) providing 
guidance. However, if the developed algorithms presented in this work were 
ultimately used in a clinical software package that was sold for profit, issues around 
data ownership and ethics can arise (109). This is another hurdle to development 
and may dissuade commercial partners from assisting with the push towards clinical 
adoption.  
5) Change management. As highlighted by a recent Kings Fund report on adoption of 
innovation in the NHS, significant investment is usually needed to promote and 
support implementation of new technology. Simply generating evidence of impact, as 
in this thesis, is not enough to guarantee uptake (110). This conclusion is reflected in 
much of the literature on change management, which often highlights people‘s 
natural aversion to changing practice. For example, one of the most frequently cited 
models of change is that created by Kotter (111). This 8 stage model places 
emphasis on a guiding coalition leading and managing the change process (which in 
this case would be moving to reporting with CADx assistance, or automated 
computer screening of images). Without such a leadership team in place it is argued 
that (successful) changes do not happen. Therefore, if machine learning is to 
become a truly game-changing technology for (I123)FP-CIT imaging, and for the rest 
of radiology, support and leadership is likely to be needed from key professionals 
such as IT specialists, managers, radiographers as well as radiologists to ensure it is 
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properly integrated in clinic. Not only does this require protected time (and therefore 
increased financial support) but these individuals have to be persuaded of 
classification software‘s merits. Significant investment is therefore also required to 
promote the technology, to ensure that clinicians actively push the implementation. 
However, the perceived threat to radiologists‘ role from machine learning, which is 
often inflated by articles in the popular press, is likely to make it harder to persuade 
the clinical community of the need for change. 
 
Issues 1, 2, 3 and 5 would be relevant to any new diagnostic technology being introduced 
into the health service on a wide scale. However, given the additional reliance on large 
databases of realistic clinical data, acquired according to appropriate governance 
procedures (issue 4), translation barriers are perhaps even greater for machine learning 
technology.  
 
Although other authors have begun to recognise the enormity of the translation challenge, 
and have identified the inadequacy of validation and verification often performed in machine 
learning research (99,112,113), the translation issues described above are perhaps more 
wide ranging than has yet been identified in the literature. Barriers to translation are multi-
factorial, going beyond technical and clinical considerations, covering psychology, 
economics, law and management. This dictates that a multi-disciplinary approach is needed. 
Clearly, the resources required to push machine learning into the clinic are considerable. 
 
The scale of this translation challenge is demonstrated by the recently reported failure of 
IBM Watson for Oncology to achieve widespread clinical adoption (114), despite the use of 
advanced cutting-edge algorithms, and with backing from a major multi-national company. 
 
The machine learning literature for medical imaging is substantial and results appear to be 
impressive. For instance, machines have already been shown to outperform radiologists in 
specific disease recognition tasks, such as diagnosis of pneumonia from chest x-rays (115).  
Even for the relatively niche application of classification in (I123)FP-CIT imaging there are a 
large number of articles reporting high accuracy results (see section 1.3.2), and this thesis 
has shown that even basic machine learning tools are highly capable. Thus, algorithm 
technology appears to be ready for clinical usage. However, current clinical uptake for any 
radiological application remains vanishingly small. Plainly, therefore, the prevailing approach 
to machine learning research and development in radiology requires a radical overhaul if the 
technology is to fulfil its potential in the clinic.  
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Without tackling any of the listed issues for (I123)FP-CIT imaging, the work presented so far 
is unlikely to be sufficient for ensuring that developed classification tools are used clinically 
on a wide scale. As for the vast majority of previous machine learning research in radiology, 
algorithms would most likely remain in the research arena, or at best, be used only locally (in 
Sheffield). This would be an unsatisfactory and wasteful outcome, perpetuating the 
limitations and lack of foresight that are common in machine learning research. A much 
greater focus on addressing the barriers to translation is required, and it is on this basis that 
the remainder of the thesis proceeds. 
 
Given the enormity of the translation burden, and the limited remaining resources available 
in this research work, identifying a strategy for making meaningful progress is challenging. 
My approach is to consider which of the previously described translation issues needs to be 
addressed first in the pathway towards routine clinical usage, focusing solely on this area in 
the following chapters. Targeting one specific area in this way is likely to be more fruitful than 
dedicating small amounts of effort to each of the different translational hurdles. 
 
Arguably, heterogeneity of the clinical environment is the most pressing consideration for 
(I123)FP-CIT classification tools. In particular, if the classification tools cannot demonstrate 
adequate performance outside of the specific equipment and scanning protocols used at 
Sheffield Teaching Hospitals, it is unlikely that a convincing case can be made for further 
investment to develop clinical software, and to overcome regulatory, economic and 
management barriers. 
 
To address this issue, ideally multiple patients would be scanned according to a variety of 
different scanning conditions, using a variety of different camera equipment. Any changes in 
classifier performance associated with each combination of parameters in these sensitivity 
tests could then be measured and assessed. However, such an approach would be 
prohibitively expensive, logistically difficult and would require ethical approval. Repeatedly 
scanning realistic patient phantoms is a much more viable option, which is also being 
actively pursued in other CADx fields such as mammography (116). 
 
With this in mind, the following chapters have three main objectives, to appreciate the 
influence of heterogeneity in the clinical environment: 
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 Objective A:  Examine and develop phantom technology to provide a toolset that can 
be adapted to simulate a range of realistic (I123)FP-CIT image appearances.  
 Objective B: Use the toolset to demonstrate the influence of heterogeneity by: 
1) Analysing and prioritising the individual imaging parameters that may affect 
classification software performance.  
2) Performing sensitivity tests to measure the impact of different imaging 
parameters on developed classification tools 
 
In this way, the following work demonstrates how aspects of the translation gap, in relation to 
heterogeneity of the clinical environment, could be addressed for (I123)FP-CIT classification 
software. Unlike the investigations conducted in chapters 3 and 4, which were mostly 
specific to certain classification algorithms, and certain datasets, much of the following work 
is dedicated to creating generally applicable methodologies and phantom technology that 
may also be useful for other researchers. This is important because translation issues are 
universal to all classification / CADx systems and, given the resources required, meeting 
these challenges is much more achievable as part of a group endeavour.   
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6 Beyond reporter performance – new tools for a new 
diagnostic paradigm 
New objectives addressed by this section (in black, bold): 
 
A) Examine and develop phantom technology to provide a toolset that can be 
adapted to simulate a range of realistic (I123)FP-CIT image appearances.  
B-1) Use the toolset to demonstrate the influence of heterogeneity by: Analysing and 
prioritising the individual imaging parameters that may affect classification software 
performance 
B-2) Use the toolset to demonstrate the influence of heterogeneity by: Performing 
sensitivity tests to measure the impact of different imaging parameters on developed 
classification tools 
Table 6-1 New objectives addressed in section 6 
 
Having measured the performance of machine learning classification tools and CADx 
software for (I123)FP-CIT imaging, the results of which were found to be largely positive, the 
remaining barriers to translation are now considered in order that the developed tools remain 
on a pathway towards widespread clinical use. This chapter is dedicated to phantom 
technology, which is a key ingredient required for assessing the impact of different 
acquisition factors (i.e. for measuring the influence of heterogeneity of the clinical 
environment).  
 
The following sections first consider the available, commercial phantom technology for 
(I123)FP-CIT imaging in the context of sensitivity testing for machine learning classification 
algorithms, the key requirement being that simulated images must be sufficiently similar to 
that of real patients under the same scanning conditions. Furthermore, the candidate 
technology must also be adaptable to different patient appearances. Due to a lack of ―off-
the-shelf‖ solutions, new phantom technology is proposed and developed. 
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6.1 Conventional technology – the need for a new type of phantom 
Imaging phantoms are typically divided into two categories: physical phantoms and digital 
phantoms. The advantage of physical phantoms is that real acquisition equipment can be 
used, incorporating the imaging characteristics seen in clinic. Conversely, for digital 
phantoms the imaging physics must be approximated in software, adding uncertainty to 
results. The major advantage of digital phantoms is that multiple tests can be simulated and 
run very quickly on a computer, dramatically increasing the number of variables that can be 
investigated.  
 
If phantoms are to be used to generate compelling evidence of the significance of different 
acquisition factors on classifier or CADx performance, uncertainties in the imaging process 
need to be minimised, particularly if results are to be used to justify clinical adoption. 
Therefore, physical phantoms are likely to the most appropriate choice. 
 
For (I123)FP-CIT imaging there is one commercially available phantom that can be 
purchased. This is the Alderson striatal phantom 
(http://www.rsdphantoms.com/nm_striatal.htm). In the context of this work it has a number of 
significant disadvantages. Firstly, it is constructed from fixed plastic cavities. Therefore, there 
is no possibility of altering the anatomy to reflect a range of patient appearances. This is 
unlikely to be sufficient for comprehensively assessing the performance of classification 
tools. 
 
Secondly, the design represents an oversimplification of tracer uptake patterns that are seen 
in patients. The putamen and caudate on both sides, and the remaining brain, are 
manufactured as single, separate cavities that must be filled with a single liquid. This 
dictates that more complex variation in uptake patterns, such as the reduced tracer levels 
often seen in the brain ventricles, cannot be replicated. The shape of the striatum is also not 
reflective of most patients. It extends further in the medial-lateral direction than is typically 
seen. Figure 6-1 demonstrates these contrasting image appearances using example data 
acquired at Sheffield Teaching Hospitals.  
 
These features severely limit the usefulness of the phantom in evaluating machine learning 
classification tools, particularly those algorithms which take whole images as inputs, such as 
the PCA-based algorithms presented in previous chapters. In these cases phantoms are 
required which are able to reproduce the voxel intensity distribution of real patients.  
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Figure 6-1 Reconstructed, central trans-axial slice from a typical normal patient (right) and 
from the Alderson phantom (left), demonstrating clear differences in striatal geometry (a/b < 
c/d). In this case the phantom was filled with an 8 to 1 striatum to reference brain activity 
concentration ratio. Each slice is scaled to its maximum pixel value. Adapted from (3) 
 
For these reasons a different approach is needed. The next section considers the creation of 
a new type of (I123)FP-CIT phantom, based on sub-resolution sandwich phantom 
technology. 
6.2 Development of a sub-resolution sandwich phantom for (I123)FP-
CIT imaging 
A promising physical phantom technique that could be adapted for creating a range of 
realistic image appearances is sub-resolution sandwich phantoms (SSPs). SSPs are created 
from inter-leaved layers of attenuating material and paper sheets with radioactive ink 
patterns on the surface. The ink patterns, reflective of patient uptake appearances, are 
typically created from an inkjet printer using cartridges containing both standard printer ink 
and aqueous radioactive solution. The greater the amount of ink printed per unit area, the 
higher the subsequent radioactive concentration.  
 
SSP technology is highly flexible and has been successfully adapted for a number of 
applications, including simulation of SPECT brain perfusion scans (117–119) and Positron 
Emission Tomography (PET) scans (120). With this impressive history in closely related 
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fields, SSP technology represents a low risk choice in the search for cost-effective 
technology that can facilitate sensitivity tests of classification algorithms. 
 
Although SSP technology appears capable of fulfilling the main requirements of objective A, 
the developed solution must also be practical, controllable and repeatable. Therefore, after 
setting out the phantom design concept, the following sub-sections examine each aspect of 
the phantom printing process and derive relevant metrics of performance. This data is used 
as a platform for creating a full head phantom, representative of a patient and useful for 
evaluating the impact of variations in acquisition on classifier / CADx performance.  
 
The following investigations were conducted in collaboration with colleagues at University 
Hospitals Bristol. Specifically, the 3D printed head was loaned from Bristol, and the method 
for generating and warping the anatomical template was adapted from that previously used 
in brain perfusion studies (119). Extracts of the following investigations contributed to a peer-
reviewed publication (3). 
6.2.1 Sub-resolution sandwich phantom: design concept 
SSPs consist of two separate parts that must be brought together when the final phantom is 
assembled – thin slabs of attenuating material and radioactive ink printed sheets. However, 
each of these constituent parts can be produced in several different ways. For the creation of 
(I123)FP-CIT phantoms, which is a previously unexplored application for SSP, the goal was 
to devise a production method that would lead to suitably realistic images for assessing 
classification / CADx systems. This is the motivating factor behind the following design 
choices. 
 
In relation to the attenuating material, the conventional approach is to use stacked plastic 
layers cut to a simple shape (119,120). However, with the advent of inexpensive additive 
manufacturing devices, 3D printing has also started to be used (121). The major advantage 
of 3D printing using Fused Deposition Modelling (FDM) is that infill density can be adjusted 
and filament materials changed in order to better reflect the radiation attenuation properties 
of tissue. Furthermore, the shape of the print can be finely tuned to achieve a geometry that 
is reflective of a real patient. For these reasons a 3D printing approach was adopted in this 
case. 
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In this work a 3D printed head was loaned from Bristol Teaching Hospitals to use as a basis 
for creating SSPs (see Figure 6-2). The head was constructed from 1.9mm thick slabs, the 
geometry of which was defined from a patient‘s segmented, high-resolution CT scan. The 
slab thickness was several times smaller than SPECT resolution and therefore each non-
radioactive slab, which was placed between radiation emitting paper, was indistinguishable 
on SPECT imaging. Each slab was printed with two different filament materials, conventional 
Polyactic Acid (PLA), at 85% infill density, and bronze-doped PLA at 100% density. The 
materials were designed to reflect the radiation attenuation properties of soft tissue and bone 
respectively. At a photon energy of 159 keV the linear attenuation coefficient of the PLA 
structure was approximately 0.16 cm-1, for the bronze-doped material it was approximately 
0.21 cm-1. 
 
 
Figure 6-2 Pictures of the 3D printed head loaned from Bristol, fully assembled (left) and with 
individual slices laid out separately (right) 
 
The paper sheets that define the radiopharmaceutical uptake are printed from an inkjet 
printer, where the cartridge contains both conventional ink and radioactive solution. The 
particular printer model selected for all the following investigations was an HP 8100 Officejet 
pro. This particular printer was selected due to its low cost and most importantly, the ease 
with which liquids can be injected into its cartridges. The input to the printer is a set of 
images, representing the patient‘s uptake profile in separate 2D slices (the anatomical 
template). These can be created manually or may be derived from real patient scans. The 
latter option was chosen in this study, in order to maintain clinical realism as far as possible. 
Each pixel in the anatomical template is converted from a greyscale value to an ink and 
radioactivity density by the printer. The printer‘s ink profile curve defines the mapping 
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between the two. Once printed, each sheet is drilled and then interleaved between the 
attenuation slabs, using the guide rods to locate the paper in the right position. The 
proposed overall workflow for creating (I123)FP-CIT phantoms is depicted in Figure 6-3 
 
 
Figure 6-3 Workflow depicting the proposed manufacturing process for creating physical 
(I123)FP-CIT phantoms. Adapted from (3) 
 
Further details on the anatomical template are set out in following sections in relation to the 
specific tests performed. 
6.2.2 Ink profile curve derivation 
The ink profile curve of the particular inkjet printer selected needs to be characterised in 
order to ensure correct activity distribution for the phantoms. The profile is defined in the 
printer software and the exact profile shape, which relates screen intensity to printed 
‗blackness‘ could theoretically be accessed by sending a request to the manufacturer. 
However, empirical testing was used in this case in order to derive a curve that was 
particular to the device in use. The ink (and radioactivity) density deposited by the printer 
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should be highly repeatable if several phantoms are to be created, with fixed design 
parameters. With this in mind the following investigation examined several repeated 
measurements of count density at different greyscales in order to characterise printer 
performance 
 
Method 
 
12 different greyscale levels were selected on a linear scale from 0.1. to 1.0, where 0.0 
represents the colour white and 1.0 black. Intermediate values are different shades of grey. 
The selected values were: 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.85, 0.9, 0.95 and 1.0. The 
increments in greyscale are smaller towards the top of the range to account for the likely 
exponential nature of the profile curve (i.e. small changes between darker shades of grey 
are likely to give bigger changes in ink density than the same magnitude changes at lower 
greyscale levels). 
 
For this test a black ink cartridge was filled with black ink and 99Tcm Pertechnetate in a 1:1 
volume ratio. The overall radioactive concentration of the ink-radionuclide mixture was 
approximately 50MBq / ml. Although the radionuclide used in this case was different to that 
of (I123)FP-CIT, mainly due to the much reduced cost of 99Tcm Pertechnetate, it is not 
anticipated that this will have any bearing on repeatability results. 
 
Each grey level was printed on to paper in the shape of a small rectangle (2cm x 5cm), using 
standard office paper (density 80g/m2). Each was then cut out, rolled up and placed within a 
tube on a rack before counting on a PerkinElmer 2480 sample counter (PerkinElmer). To 
ensure consistent geometric efficiency each piece of printed paper was placed at the bottom 
of each tube. Counting proceeded for 6 minutes per tube using an energy window centred at 
140 keV (±15%), with decay correction turned on. Total counts recorded in each case was 
greater than 400 kcts. The experiment was repeated 5 times (i.e. 60 measurements were 
made in total). This data was then used to create a continuous profile, mapping greyscale 
level to output printed radioactivity concentration. 
 
Results  
 
Figure 6-4 summarises the results of the sample counting experiments  
  
132 
 
 
 
Figure 6-4 Graph of total measured counts (measured over 6 minutes) against input 
greyscale level. Error bars depict maximum and minimum values across the 5 experiments. 
Adapted from (3) 
  
133 
 
 
Discussion 
 
The results demonstrated that the relationship between greyscale of the input and count 
density of the output print was non-linear, as expected. However, it also appeared that the 
repeatability was substantially degraded at higher greyscale levels as compared to lower 
greyscale levels. For example, the coefficient of variation for a greyscale of 0.95 and 1.0 was 
7% and 9% but 3% or lower for greyscales of 0.9 or less. This random error was in most 
cases greater than that which would be expected from the random nature of radioactive 
decay (i.e. greater than the standard deviation expected from Poisson statistics). It is likely 
that the ink printing mechanism introduced additional uncertainties, which were more acute 
for higher levels of ink deposition. This could perhaps be due to reduced precision 
associated with printer jets at the highest output rates or saturation effects on the paper. 
Given these results, it is prudent to restrict all future investigations to a maximum greyscale 
of 0.9 where repeatability errors are acceptably small for creating highly controlled prints. 
6.2.3 Printer uniformity 
In addition to tests of ink deposition repeatability it is also important to assess the uniformity 
of the printed output. If the printer is unable to achieve consistent radioactive ink deposition 
across a page then fully assembled phantoms may contain artificially raised or lowered 
areas of radionuclide density as compared to the anatomical design template. 
 
Method 
 
The most convenient method for assessing the uniformity of radioactivity across a page is 
gamma camera imaging. Although a gamma camera‘s response is unlikely to be perfectly 
uniform across the detector face, if resultant uniformity metrics are similar to that which 
would be expected from a uniform flood source then it can be assumed that any non-
uniformities present are insignificant in terms of SPECT imaging. 
 
For this test a constant level of greyscale was printed across a whole A4 page, excluding 
margins, at greyscale values of 0.5 and 0.9. This size of print is likely to be bigger than the 
cross-sectional area of most brain slices and so results will represent the likely worst case 
scenario. 
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Following printing using the same printer and cartridge setup as for section 6.2.2, each sheet 
was placed within a thin plastic wallet and then placed flat on the face of a GE Infinia gamma 
camera (GE Healthcare), with LEHR collimators in place. The camera in question had 
already passed relevant quality control checks on that day, including a test of uniformity. 
Imaging was conducted over a long acquisition period (10 hours) due to the low activity level 
present in each single printed sheet, using an acquisition matrix size of size 256 x 256 
(giving a smaller pixel size than that used during clinical SPECT acquisition). A standard 140 
keV ± 10% energy window was used. Images were assessed both visually and by 
measuring summary statistics across the printed area (after reducing the matrix size to 64 x 
64 to increase the counts per pixel). 
 
Results 
 
Figure 6-5 shows the raw acquired images from the uniform printed sheets at greyscale 
levels of 0.5 and 0.9. Table 6-2 shows summary descriptive statistics for the quantitative 
uniformity results. Here, parametric measures are used as it was assumed that variation in 
pixel values was largely due to random radioactive decay. 
 
 
 
Figure 6-5 Screen captures depicting the raw images acquired from A4 sheets printed with 
greyscale values of 0.9 (left) and 0.5 (right). Images are colour scaled individually.  
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Figure 6-5 demonstrates that although images were relatively noisy there were no significant 
non-uniformities present in either of the printed sheets 
 
 Pixel counts (kcts) 
Greyscale 
level 
Maximum Minimum Mean Standard 
deviation 
Coefficient 
of variation 
0.9 30.98 25.86 27.99 1.08 0.039 
0.5 2.97 2.34 2.71 0.10 0.036 
Table 6-2 Summary descriptive statistics for counts detected from A4 sheets printed with 
uniform greyscale levels 
Discussion 
 
The results of the uniformity test showed that the printer utilised in this study provided a 
relatively consistent ink output across a large area, with no areas of significant non-
uniformity seen from visual analysis. Even though quantitative results included the effects of 
extrinsic camera uniformity errors, the coefficient of variation of pixel values across each 
sheet was less than 4%. This compares to an expected counting error (from Poisson 
statistics) of approximately 0.6% per pixel for the image of printed ink at a greyscale value of 
0.9, and 2.0% for the image acquired from a sheet printed at a greyscale value of 0.5.  
 
Previous tests of camera uniformity conducted during routine quality assurance 
investigations, utilising a uniformly filled flood phantom, with a similar count per pixel to that 
of the 0.5 greyscale image, also produced a coefficient of variation of 4%. This indicates that 
the printing process does not introduce significant additional uncertainties in uniformity on 
top of the uncertainty already present due to the imperfect detection system.  
6.2.4 Printer input-output comparison  
Having demonstrated that the printer produces consistent and controllable ink output across 
a wide area, one further set of validation tests comparing the input design template and 
output print was undertaken to confirm close correlation between the two. This validation 
step mainly investigates the printer‘s resolution and geometric accuracy, and the reliability of 
the printer head motors. It is the first test conducted so far that scrutinises the whole printing 
process. 
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Method 
 
An anatomical template typical of a (I123)FP-CIT subject was generated such that results 
were relevant to the intended application. For this, a segmented brain scan was required 
which depicted the putamen and caudate as well as the remaining brain ―background‖. An 
assumed level of radiopharmaceutical uptake also had to be set in each of these different 
areas. In this case the well-established Montreal Neurological Institute (MNI)152 template 
was adopted (122). This is an MRI-based anatomical reference, created through the 
combination of scans from 152 healthy subjects, after non-linear registration to a common 
co-ordinate system. The automated anatomical atlas (AAL) is a freely available and 
frequently cited parcellation of the MNI template (123), providing regions of interest which 
encircle the different brain structures. This was used to denote the boundaries of the left and 
right striata of the MNI reference as well as the remaining brain (derived by combining all 
remaining brain regions).  
 
As previously suggested, apparent increased uptake within the putamen on SPECT imaging 
is in reality a combination of tracer uptake in the putamen and globus pallidus, which cannot 
be resolved separately due to limitations in camera resolution. In this study the globus 
pallidus was kept as part of the larger, non-specific background region and thus was 
assumed to not have a strong affinity for the tracer.  
 
Voxels within the striatal and brain background regions were set to intensity values that 
reflected uptake ratios from a healthy patient such that the striatum shape would appear 
prominently on subsequent imaging. Thus, all voxels within the left and right putamen and 
caudate were set to a greyscale level of 0.9, the maximum achievable for consistent printing 
using standard paper. Voxel intensities in the remaining background brain area were set to a 
greyscale value of 0.33, which through linear interpolation of the graph in Figure 6-4 
represents a count density ratio of 8 to 1, which is reflective of normal striatal binding ratios 
typically seen for healthy individuals (40). 
 
5 central slices from the created anatomical template were printed with radioactive ink, again 
using the same printer setup as for sections 6.2.2 and 6.2.3. Each was then inserted into 
separate plastic wallets and placed, one by one, on to the surface of a LEHR collimator of a 
GE Infinia gamma camera (GE Healthcare). Each was imaged for one hour using a 512 x 
512 matrix. By imaging with a large matrix size, at the surface of the detector, the extrinsic 
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resolution of the system was maximised, enabling a more detailed inspection of radioactive 
ink patterns. 
 
For analysis, the input anatomical template and imaged printed sheets were compared in 
terms of their relative overlap. This was achieved through rigid registration of each pair of 
images on a slice by slice basis, followed by a degree of smoothing (using a 5mm Gaussian 
filter). Segmentation of each gamma camera image was conducted by applying a whole 
image threshold, set at two different levels, in order to isolate the boundary of the striata and 
whole brain separately. Threshold levels were determined through measuring the mean 
count level at the centre of each structure and then dividing by 2. Each of these steps was 
performed using MIM software v6.6. 
 
The segmented gamma camera images and the original anatomical templates (with regional 
boundaries defined by the AAL) were compared visually and through the measurement of 
Dice Similarity Coefficients (DSCs, see Figure 2-9 for a formal definition). 
 
Results 
 
Visual comparison demonstrated that the whole brain region of each gamma camera image 
closely fitted the whole brain region of the input anatomical template. However, the 
segmented striatal shape extracted from the gamma camera images deviated from the 
anatomical template to a greater degree than the whole brain region. This was particularly 
noticeable in the small area in between the putamen and caudate on both sides, and at the 
inferior pole of the putamen (see Figure 6-6 for an example).  
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Figure 6-6 Example acquired image (left) alongside corresponding template image (right). 
Regions of interest generated from segmentation of the acquired data are shown, overlaid 
on the anatomical template  
 
Table 6-3 shows overlap results from comparison between segmented output images and 
the regions of interest derived from the AAL, averaged over 5 images. Standard deviation of 
the results is shown in brackets. 
 
Structure Dice Similarity Coefficient 
Whole brain 0.99 (0.00) 
Striatum 0.90 (0.01) 
Table 6-3 DSC scores of the relative overlap between imaged, segmented brain structures 
and regions in the anatomical template. Adapted from (3)  
Discussion 
 
The gamma camera images of the individual slices were largely as expected, showing 
consistent count levels through the striatum and the brain background. Despite the relatively 
high noise level in the images, the outline shape of the striata could be clearly seen. 
Overlaying of the gamma camera images on to the registered, corresponding anatomical 
template slices demonstrated that the two sets of data had a very similar shape. This is 
confirmed by Dice scores, which were high (with small standard deviation figures), 
particularly for the whole brain region. As might be expected from partial volume effects, the 
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scores were slightly lower for the striata, where the divide between putamen and caudate 
could not clearly be visualised on gamma camera acquisitions and where the thin ‗tail‘ of the 
putamen was cut-off following segmentation procedures. 
 
The analysis method chosen to quantify the relative overlap between input and output data 
was simplistic. The accuracy of this approach was limited to some extent by the high levels 
of noise. This explains the relatively jagged appearance of the brain region boundaries that 
were generated (see Figure 6-6). However, despite the limitations in the chosen 
methodology, results demonstrated that the printer output was a good representation of the 
input anatomical template in terms of the position of the boundaries of representative brain 
regions. 
6.2.5 Assembly and validation of a full phantom 
Having established that the technology is suitable for consistently producing radioactive ink 
patterns that accurately reflect a design template, and that ink output is predictable, tests of 
a fully assembled phantom may now be conducted. Resultant images will enable 
assessment of the complete SSP production and assembly process. In addition, usability 
aspects of phantom assembly and performance can also be assessed, in particular the time 
taken to fully build the phantom, the amount of ink required and resultant count rate from a 
full printed head.  
 
Validation of the fully assembled phantom is based on measurements of striatal binding 
ratios and linear dimensions of the striata. These values are compared with those of real 
patients (from subset A). SBRs provide an insight into whether mean uptake within the 
striatum was set at a realistic level for the patient group being replicated, whilst 
measurements of its dimensions give an indication as to the suitability of the chosen striatal 
geometry and shape (the Alderson phantom being deficient in this respect, see section 7.1).  
 
Method  
 
The anatomical template from section 6.2.4, which was largely derived from the automated 
anatomical labelling atlas, was registered to the geometrical space of the 3D printed head 
such that the ink patterns would fit within the assembled phantom structure. This process 
first involved segmentation of the CT scan originally used for manufacture of the 3D printed 
head. This was carried out in SPM12 software 
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(http://www.fil.ion.ucl.ac.uk/spm/software/spm12/). The procedure included segmentation 
and spatial normalisation of the CT images to MNI space, enabling the creation of forward 
and inverse deformation fields (124). The inverse deformation field was applied to warp the 
anatomical template from MNI geometric space on to that of the CT scan (see flowchart in 
Figure 6-7). Following registration, the template was resampled to a 2mm slice thickness 
such that each printed sheet would be positioned correctly between the 1.9mm thickness 
attenuation slabs (3).  
 
 
Figure 6-7 Workflow depicting the steps taken to create an anatomical (123)I-FP-CIT 
template fitted to the same geometry as the 3D printed head (adapted from (3)) 
 
In contrast to previous tests of the SSP technology, this investigation required that 123I be 
used as the printed radionuclide rather than 99mTc in order that gamma photons detected 
were representative of those emitted by (I123)FP-CIT. The most inexpensive (and 
accessible) form of this radionuclide is I123 Iodide, provided to most UK hospitals at a 
concentration of 37MBq/ml, which is lower than the radioactivity concentration used 
previously in this work and in published data from other authors. In order to maximise the 
phantom count rate the ratio of black ink to radioactive solution injected into the ink cartridge 
should be minimised. However, if too little ink is used then the printer deposition method is 
likely to be adversely affected due to the associated change in viscosity. Thus, a volume 
ratio of 1:1 was maintained for this investigation. 
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Greyscale values in the modified anatomical template were set to give a count density ratio 
of 8 to 1 in the striatum as compared to the surrounding brain tissue, using the measured ink 
profile curve. Again, this is reflective of the uptake ratios expected in healthy controls. Each 
slice was sent to a HP8100 printer and printed using a black ink cartridge containing 
approximately 16ml of combined ink-radionuclide solution. The full stack of paper from a 
single template print was placed within a jig, drilled in 3 places and then the paper sheets 
were interleaved, one-by-one, within the 3D printed head as shown in Figure 6-3. Excess 
paper was cut from around the border of the head as necessary. Once the whole phantom 
had been tightened using nylon screws it was placed on the camera bed, in the head 
support routinely used for patient acquisitions.  
 
The phantom was scanned on a GE Infinia camera with LEHR collimators in place. 
Acquisition parameters were the same as those used clinically (see section 2.2.1). 
Acquisition time was adjusted such that the total counts in the scan were approximately 
1.5Mcts, which is the minimum level considered acceptable by SNM guidelines and similar 
to the mean count level recorded for clinical patients over a 35 minute scan. 
 
Following acquisition, projections were reconstructed using the same, standard 
reconstruction protocol on Xeleris and the same method for calculating SBRs as applied in 
previous investigations (see section 2.2.1 and 2.2.5 for details). In addition, the medial-
lateral extent and the anterior-posterior extent of the striata in the new SSP design were 
measured on a 2D slab that was created through summation of 10 central brain slices. 
Ratios of these two values gave an aspect ratio that was a simple measure of striatal shape.  
 
This analysis was conducted in MIM software after manually aligning reconstructed data 
such that the trans-axial plane was parallel to the line connecting the anterior and posterior 
commissure, and then further adjusting alignment such that there was approximate 
symmetry between left and right hemispheres in both coronal and trans-axial views (see 
Figure 6-8 for a diagrammatic representation of these pre-processing steps). Linear 
measurements of left and right striata were carried out manually with the caliper tool. 
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Figure 6-8 Diagrammatic representation of the image rotation steps carried out before 
summation of axial slices and measurement of striatal lengths 
 
For comparison, analysis methods were also applied to 22 patient images from subset A 
where the probability of not having PDD was high (i.e. where uptake in the striatum was 
normal).  
 
Results 
 
Phantom printing and assembly took approximately 75 minutes to complete. Approximately 
4ml of I123 Iodide-ink solution was required to print 56 slices of the (I123)FP-CIT template, 
covering the entire brain. In order to acquire 1.5Mcts over the course of the acquisition an 
imaging time of 30s per projection was required. Four central, transaxial slices taken from 
the reconstructed images of the new SSP design are displayed in Figure 6-9 (reconstructed 
slice thickness was 7.2mm). 
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Figure 6-9 Four reconstructed slices from the centre of the new SSP design 
 
Figure 6-10 shows striatal binding ratio results for the SSP and for 22 clinical patients 
without evidence of PDD (whiskers represent maximum and minimum values).  
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Figure 6-10 Striatal binding ratio results for the new SSP design and for 22 clinical patients 
from subset A without pre-synaptic dopaminergic degeneration. Whiskers represent 
maximum and minimum SBRs 
 
Figure 6-11 and Figure 6-12 show linear measurements of striatal geometry and derived 
anterior-posterior / medial-lateral aspect ratio measurements for the new SSP design 
phantom and for the group of 22 patients. 
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Figure 6-11 Linear measurements of the striatum in images acquired from the new SSP 
design and from a group of 22 patients without evidence of dopaminergic deficit. Whiskers 
represent maximum and minimum lengths. Taken from (3) 
 
Figure 6-12 Anterior-posterior / medial-lateral aspect ratio measurements from the phantom 
and a group of 22 patients without evidence of dopaminergic deficit. Whiskers represent 
maximum and minimum aspect ratios. Taken from (3) 
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Discussion 
 
This investigation presents a new application of SSP technology, printing phantoms with an 
ink mixture based on 123I Iodide. The volume of ink solution required to print one full 
phantom suggests that approximately 5 different radioactive ink patterns could be printed 
from a single standard-sized cartridge (if filled to a maximum capacity of 23ml). The total 
printing and assembly time was longer than the preparation time required for the Alderson 
phantom (approximately 1-1.5 hours for the SSP as compared to 30-45 minutes for the 
Alderson phantom). However, the SSP assembly process has not yet been optimised. There 
is potential for time savings by, for example, rounding off the ends of the nylon guides rods 
to enable quicker stacking of paper and plastic layers. 
 
The imaging time required to reach typical clinical count levels was similar to that of patients, 
which suggests that even when using 123I Iodide at a relatively low radioactivity 
concentration (37 MBq/ml), SSP is a practical alternative technology to traditional fixed 
cavity phantoms. This is an important finding as 123I Iodide is widely (and cheaply) available 
to UK nuclear medicine departments. 
 
Visual analysis of the reconstructed phantom images (see Figure 6-9) demonstrates uniform, 
high uptake throughout the striata on both sides with a wide area of relatively low, uniform 
uptake in remainder of the brain. This closely reflects the characteristics of the simplified 
anatomical template and provides some reassurance that there were no significant problems 
in phantom assembly. Visually, the reconstructed SSP images had similar appearances to 
that of real patients, although there was a noticeable lack of skin uptake (this could however 
be corrected in the design template). In addition, linear measurements of the shape and size 
of the striata were also within the range measured from real patients. This is reassuring in 
light of previous criticisms of the Alderson phantom. 
 
Striatal binding ratio results (in the left and right putamen and caudate) for the SSP were 
above the mean but still within the range of results generated for a group of 22 non-
Parkinsonian patients. This suggests that the SSP design was reflective of non-PDD patients 
with higher uptake ratios, and provided a degree of reassurance that the developed SSP 
method was capable of producing images reflective of a particular patient cohort. 
 
However, it is also worth acknowledging methodological limitations:  
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 Patient age is a known co-variate for striatal binding ratio (40) and was ignored in the 
comparison exercise. 
 SBR and striatal dimension measurements do not define every important feature of a 
(I123)FP-CIT dataset, and are therefore not a comprehensive assessment of the 
SSP‘s suitability for replicating particular scan appearances.  
 The anatomical template used in this investigation is idealised. There are several 
areas where the template differs from real patient data. For example, patient SPECT 
images often show reduced uptake in the ventricles and increased uptake in extra-
striatal tissues such as the pons and thalamus (125). Furthermore, the template only 
included increased uptake in the putamen and caudate, and not the smaller globus 
pallidus. 
 
Although these limitations dictate that the developed phantom cannot yet be considered as 
providing an exact replica of real patient appearances, nonetheless the findings indicate 
suitability of the technique for creating 3 dimensional uptake patterns closely resembling 
certain (I123)FP-CIT scan features. Using the current anatomical template, image 
appearances are already more realistic than the available commercial phantom technology 
(i.e. the Alderson phantom).   
 
Less idealized, more patient specific ink patterns could be created through suitable alteration 
of the anatomical template pattern. This could be achieved, for example, through 
comparison of reconstructed phantom and patient scans, followed by iterative adjustment 
and reprinting of the anatomical template, then repeated scan comparisons, as per Holmes 
et al. (119). 
 
Thus, the results presented in this section show that SSP technology can be successfully 
adapted to (I123)FP-CIT imaging. The developed techniques lay the groundwork for the 
creation of realistic, patient specific phantoms.  
6.3 Summary 
Performing sensitivity analysis to examine the impact of different acquisition factors on 
machine learning algorithm performance in (I123)FP-CIT imaging requires repeated imaging 
of the same patient uptake pattern. Phantoms can enable this type of investigation without 
having to scan real patients. However, the only commercially available physical phantom, 
the Alderson phantom, is inadequate for replicating patient appearances to the level 
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demanded for investigations of classification software performance. Thus a new type of 
physical phantom was investigated and developed, based on sub-resolution sandwich 
phantom technology. 
 
Tests were conducted to probe the practicality, controllability and repeatability of the chosen 
SSP production method for simulating (I123)FP-CIT appearances. Firstly, the radioactive ink 
printing process, which is central to SSP technology, was shown to be highly controllable 
and consistent. Ink deposition was predictable for a range of greyscale values (up to 0.9) 
and the printer produced sufficiently uniform printed sheets. Individual slices from an input 
anatomical template (based on the MNI dataset) closely matched the resultant output. All of 
these findings justify the use of the particular printer setup for creating phantoms for 
investigations of classification algorithm performance. 
 
The final section of this chapter demonstrated successful application of SSP technology to 
creating a full (I123)FP-CIT phantom. Although the radionuclide used had a relatively low 
radioactivity concentration (approx. 18 MBq/ml when mixed with ink), resultant count rate 
was acceptable. Total assembly and printing time was slightly longer than the assembly time 
of the conventional Alderson phantom. However, unlike for the Alderson phantom, measures 
of SBR and linear striatal dimensions showed that the simple MNI-based anatomical 
template produced quantitative measures in line with clinical data.  
 
Overall, this chapter demonstrated that the highly flexible SSP process is a practical, 
inexpensive and repeatable solution for creating controllable, 3D (I123)FP-CIT phantoms. 
This is a crucial first step for enabling comprehensive evaluation of automated classification 
tools, which isn‘t possible with existing Alderson phantoms. Through careful selection of the 
anatomical input template, the developed SSP technology can now be used to mimic a 
range of patient appearances and to evaluate any classification tool.  
 
Having selected an appropriate physical phantom technology, the next chapter considers 
sensitivity analysis for (I123)FP-CIT classification algorithms. 
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7 Measuring the impact of clinical heterogeneity: 
sensitivity analysis 
New objectives addressed by this section (in black, bold): 
 
A) Examine and develop phantom technology to provide a toolset that can be adapted to 
simulate a range of realistic (I123)FP-CIT image appearances.  
B-1) Use the toolset to demonstrate the influence of heterogeneity by: Analysing 
and prioritising the individual imaging parameters that may affect classification 
software performance 
B-2) Use the toolset to demonstrate the influence of heterogeneity by: Performing 
sensitivity tests to measure the impact of different imaging parameters on 
developed classification tools 
Table 7-1 New objectives addressed in section 7 
 
Image acquisition procedures and protocols vary between hospitals, giving rise to different 
image appearances for the same tracer distribution. To minimise the effects from such 
confounding variables, clinical data in this work was taken from only a single institution 
where the acquisition procedures were consistent and the range of gamma cameras used 
was limited. If a mixed database of patients from multiple hospitals was used to train a 
classifier, with no algorithm adaptations to take account of the increased variability in the 
data, it is likely that accuracy would be reduced. Used in a CADx context, this could increase 
the likelihood of a clinician making an incorrect diagnosis, which could lead to inappropriate 
treatment.  
 
However, even if the training database is restricted to data from a single institution, if the 
algorithm is applied on a wide scale throughout the NHS it is likely that at least some of the 
clinical cases would have been acquired in a different way to the training data, which would 
again reduce classification accuracy and increase the risk of incorrect patient care.  
 
Consequently, the sensitivity of classification algorithms to different acquisition factors needs 
to be examined, and this is particularly pertinent if a fixed diagnostic threshold is involved. 
Once this important issue has been addressed, further effort can be expended in addressing 
other regulatory, economic and management aspects of the clinical translation challenge. 
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This chapter first seeks to develop a strategy for identifying and prioritising imaging 
parameters in terms of their potential impact on CADx / classification software. Following 
this, the developed SSP technology is used as an example, illustrating a sensitivity analysis 
of classification tools, according to the strategy. 
7.1 Strategy for prioritising image acquisition factors 
A strategy for sensitivity analysis relies on an understanding of the expected variability in 
image acquisition factors currently found in the clinic. In order to understand such variability, 
an audit should ideally be performed. However, although a national audit of Nuclear 
Medicine departments has recently been performed in the UK, revealing useful information 
with regards to the make/model of gamma cameras currently in use, and the type of 
collimator adopted (37), the data available is limited. A more comprehensive audit is required 
for this study but is not feasible within the time frame of this work. 
 
Therefore, relevant clinical guidelines (from EANM, SNM and the leaflet supplied with vials 
of (I123)FP-CIT) are used instead. The range of values cited within these documents for 
different acquisition parameters is assumed to be representative of the breadth of acquisition 
conditions seen in different hospitals. This information is used as a basis for creating a 
focused strategy, dictating which types of tests should be carried out in order to understand 
the likely performance variability of classification software in clinic. Information from 
guidelines is supplemented by data from protocols used locally at Sheffield Teaching 
Hospitals, as well as relevant research, which may also inform practice. 
 
Some of the differences in acquisition parameters that are implied by relevant guidelines are 
likely to be relatively unimportant in terms of impact on classification algorithm performance, 
or may be controlled to such an extent they are no longer of concern. Acknowledging that 
resources available for testing classification algorithms are likely to be limited, each 
acquisition factor is considered in turn to find those which are of highest priority (see Table 
7-2). In each case the potential impact on classification algorithm performance is scored 
qualitatively considering the likely variability between centres. The potential for controlling 
variability is also scored. By combining these two outputs a priority rating is given. The 
highest scores are associated with acquisition factors judged to have a high potential impact 
on classification algorithm performance, and low potential for control. 
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In addition to image acquisition recommendations, clinical guidelines also provide guidance 
on patient factors, such as the influence of vascular lesions on image appearances and the 
effects of different types of drugs on tracer uptake levels. Although these are important, such 
patient selection and patient preparation considerations are excluded from the table below in 
order to provide a strategy that is focused purely on the mechanics of acquiring and 
processing data.
  
 
 
1
5
2
 
 
Image acquisition factors, ordered according to relative priority for investigation in sensitivity tests 
Image 
acquisition 
factor 
Explanation and potential variability Potential impact 
on classification 
algorithm 
performance 
Potential for control Priority for 
investigation 
Camera-
collimator 
design 
Collimator geometry dictates image resolution, sensitivity and also 
image noise (through relative contribution from septal 
penetration).  
 
There are differences in guideline recommendations: the leaflet 
supplied with (I123)FP-CIT recommends ―high resolution‖ 
collimators, SNM recommends LEHR or LEUHR collimators (32), 
EANM suggests that LEHR / LEUHR collimators are the most 
frequently used but specifically recommends fan-beam design 
over parallel hole design (6). 
 
This potential variability in selected collimator is exacerbated by 
the known large differences between the resolution and sensitivity 
of GE cameras with LEHR collimators and Siemens cameras with 
LEHR collimators (the two most commonly used systems (37)).  
HIGH. Different 
camera systems 
(with different 
collimators) are 
known to give rise 
to different semi-
quantitative values 
(50), and therefore 
different 
appearances 
 
LOW. Many 
departments only have 
camera(s) from one 
manufacturer with 
limited collimator 
options 
HIGH 
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Non-standard 
detector 
positioning 
For patients that are not able to tolerate a standard acquisition 
due to, for example, claustrophobia or a physical deformity 
preventing scanning close to the head, gamma camera detectors 
can be positioned differently during acquisition to reduce chances 
of a failed scan.  
 
Although not specifically recommended by any guidelines, in 
Sheffield a single planar vertex view (acquired superiorly to the 
skull) is currently acquired for those that cannot tolerate a detector 
passing close to the face. Detectors are also set at an increased 
radius, incorporating shoulders, for patients with kyphosis. 
 
Recent studies suggest that diagnostically useful information 
could be collected from claustrophobic patients by acquiring data 
with detectors moving behind the patient only (126). Therefore, 
there are potentially many different non-standard acquisition 
procedures used in hospitals 
HIGH. Planar 
vertex views 
cannot be 
processed by the 
developed 
algorithms. 
Acquiring data at a 
greater radius, or 
using an 
incomplete 
acquisition arc is 
known to cause 
significant changes 
in appearances as 
compared to a 
standard 
acquisition 
(126,127) 
LOW. Claustrophobia is 
likely to be very difficult 
to control and physical 
deformities, such as 
kyphotic spine, cannot 
be scanned under a 
normal protocol using 
conventional gamma 
camera equipment 
HIGH 
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Total 
acquisition 
counts 
Radioactive decay is a random process and so the more counts 
detected from the patient, the greater the signal to noise ratio in 
the final image. 
 
The leaflet supplied with (I123)FP-CIT recommends total counts 
of > 0.5Mcts. SNM guidelines recommend > 1.5Mcts (32) and 
EANM guidelines recommend > 3Mcts (6). Thus, there is 
potentially wide variation between centres. 
HIGH. Wide 
ranging image 
counts is likely to 
be associated with 
wide ranges in 
image noise and 
appearances 
HIGH. Total counts 
could be much more 
strictly controlled if 
required (for example 
by estimating count rate 
from an initial static 
image and setting 
acquisition time 
accordingly).  
MEDIUM 
Radius of 
rotation 
The radius of rotation dictates distance from the patient and 
therefore image resolution, which is an important consideration 
given that striatal tissues are small and relatively deep within the 
brain. 
 
The (I123)FP-CIT leaflet recommends a radius of 11-15cm (SNM 
guidelines suggest these values are ―typical‖ (32)), EANM 
recommends the ―smallest possible‖ radius (6). 
 
MEDIUM. Imaging 
at 11cm or 15cm, 
as permitted by 
guidelines, has 
been shown to be 
associated with 
small changes in 
SBRs (127) (and 
therefore 
appearance) 
MEDIUM. Departments 
could set stricter radius 
settings if tolerable by 
patients (if not, see 
non-standard 
acquisition protocols for 
alternatives) 
MEDIUM 
Reconstructio
n software 
and 
Reconstruction method (whether analytical or iterative) and 
associated parameters have a substantial impact on contrast, 
noise and resolution. 
HIGH. 
Reconstruction 
methods / 
HIGH. Most 
departments have 
access to adjustable 
MEDIUM 
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parameters  
EANM and SNM both recommend either filtered back projection 
or iterative reconstruction with low pass filtering (6,32). 
Attenuation correction is also recommended by both. However, no 
guidance is given on number of iterations, subsets or other 
specific parameters and so clinical departments may have a wide 
range of different reconstruction settings. 
 
 
parameters can 
have a substantial 
effect on measured 
SBRs (47,48) (and 
therefore 
appearances) 
reconstruction software. 
It is possible to obtain 
similar reconstruction 
results between 
software from different 
vendors for example by 
measuring and 
matching the frequency 
response curves after 
applying different 
reconstruction 
parameters, as 
performed by Lawson 
et al. (128) 
Rotation step 
size 
The rotation step size is one of the factors which determines 
SPECT image resolution 
 
EANM and SNM guidelines both recommend 3 degrees per step 
(6,32). The (I123)FP-CIT leaflet suggests this should be a 
minimum target. Thus, there is little difference in 
recommendations. 
LOW.  HIGH. All modern 
gamma cameras allow 
fine control of step size 
LOW 
Energy The energy window selected dictates the relative proportion of LOW.  HIGH. All modern LOW 
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window primary and scattered photons detected by the system and is 
therefore linked to the signal to noise ratio and appearances of 
the image 
 
SNM guidelines and the (I123)FP-CIT leaflet both recommend a 
single window of 159 keV ± 10% (32). EANM gives no specific 
recommendations (6). Therefore, there is little difference in 
recommended values. 
gamma cameras allow 
fine control of energy 
windows 
Pixel size 
(image zoom) 
Image zoom (and pixel size) have an impact on image resolution 
and noise 
 
Both SNM guidelines and the (I23)FP-CIT leaflet recommend a 
pixel size of 3.5-4.5mm (32). EANM recommendations are very 
similar: a pixel size that is one third to one half of the system 
resolution (6). Therefore, there is little difference in recommended 
values. 
LOW. HIGH. Pixel size can be 
controlled to a high 
degree on modern 
camera systems 
LOW 
 
Table 7-2 Summary of acquisition factors with qualitative assessment of their potential impact on classification algorithm performance, and 
potential for control in clinic. Factors are ordered according to decreasing priority for investigation. 
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Table 7-2 provides a guide to machine learning researchers as to which acquisition 
parameters should be considered first when performing sensitivity analysis of classification 
algorithms for (I123)FP-CIT. It shows that there are two image acquisition factors which are 
judged to be of highest priority: camera-collimator design and non-standard detector 
positioning. Both of these factors are related to issues that cannot be controlled in clinic and 
which could potentially limit the scope of application of classification algorithms. Camera-
collimator design is perhaps of most concern as the vast majority of (UK) patients are 
currently scanned with either a GE or Siemens system, equipped with LEHR collimators 
(37). If significant differences are found in terms of how a classification algorithm responds to 
these systems, a significant proportion of (I123)FP-CIT patients could immediately be 
excluded from the benefits of CADx. Should alternative detector positioning be 
contraindicated when applying CADx, the number of patients potentially benefitting is likely 
to be smaller.  
 
The following section will consider these two highest priority acquisition factors in a set of 
practical investigations, putting into practice the developed phantom technology to assess 
changes in classification output as a result of varying acquisition conditions. 
7.2 Method 
Ideally, sensitivity tests would be conducted with a number of different, realistic SSP 
designs, to reflect the expected range of patient appearances, in order to comprehensively 
assess all the developed classification algorithms. However, the radionuclide and gamma 
camera resources available within this study for further developing anatomical template 
designs are limited. Therefore, the following sensitivity tests continue to use the simplified 
SSP anatomical template that is already established, in a limited number of imaging 
acquisitions.  
 
The continued use of an idealised anatomical template dictates that acquired images are 
most useful for testing classification algorithms based on simple, derived image features 
such as SBRs, rather than those based on raw voxel intensities or principal components 
(which would require phantoms that were clinically realistic at the voxel level). Therefore, 
only the simplest of the algorithms developed in chapter 2 is analysed: the ML46 algorithm 
(see chapter 2.1.3), where 4 SBR values and patient age are input to a linear SVM. 
Algorithms based on principal components, such as that adopted for reporting tests in 
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chapter 4, could be tested in the same way in future once more realistic anatomical 
templates have been created and optimised. 
7.2.1 Metrics 
To assess the impact on classification algorithm performance of different acquisition 
settings, appropriate metrics are required. However, given that clinical heterogeneity is rarely 
considered in the machine learning literature, there is little guidance or consensus on which 
metrics may be most appropriate. For the following studies the raw SVM scores output from 
the algorithm are examined, in line with previous work by Abdulkadir et al. (129). To provide 
context, Figure 7-1 characterises the distribution of SVM scores measured for patients in 
subset A for the ML46 algorithm. This shows that the SVM output was more variable for the 
non-PDD, normal patients than for the diseased group. The gap in scores between the pre-
synaptic dopaminergic degeneration group and the non-dopaminergic degeneration group 
(approximately 4 on average) provides a baseline against which changes in SVM score, as a 
result of patient and equipment factors, can be compared. 
 
Figure 7-1 SVM score distribution for patients in subset A, using features based on SBRs. 
Median and inter-quartile ranges are shown in grey 
7.2.2 Acquisition  
The methodology for each investigation is summarised in Table 7-4. For each set of tests, 
unless otherwise stated, most camera acquisition parameters were consistent (see Table 
7-3). These parameters were largely dictated by the available guidance on (I123)FP-CIT 
imaging (6,32) and the settings used in the local clinical service. 
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Acquisition parameter Value 
Total counts 1.5 Mcts 
Matrix size 128 x 128 
Radius of rotation 14cm 
Zoom 1.2 
Projections 60 per head over 180 degrees 
Energy window 159keV ± 10% 
Collimator LEHR 
Table 7-3 Camera acquisition parameters 
Following acquisition, each scan was reconstructed using the standard reconstruction 
protocol on Xeleris. Data were then processed through the selected machine learning 
algorithm as previously described (see chapter 2). Patient age was assumed to be 60 years 
in all cases. All investigations in this chapter are based on algorithms trained with local 
clinical data (from subset B) only, as such algorithms are more likely to be of use in the clinic 
than algorithms trained with PPMI research data.  
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Sensitivity analysis: summary of investigation methods 
Factor Investigation method 
Camera-
collimator 
design 
Tests considered two different acquisition cameras: a GE Infinia and a Siemens Symbia. These are the most commonly used 
acquisition systems, according to a recent UK audit (37). 
 
Using the same template shape described in the previous chapter, two different phantom prints were designed with two different 
greyscale ratios. The first phantom had printed count densities of 8 to 1 in both striata as compared to the remainder of the brain 
(‗normal‘ phantom) whilst the second phantom had a count density ratio of 5 to 1 (‗borderline‘ phantom). 8 to 1 is representative 
of the true underlying tracer concentration ratio present in normal controls (130). 5 to 1 represents a more borderline case. 
Additional uptake ratios were not tested due to limitations on time and scanning resources 
 
After assembly, each phantom was scanned twice on each camera (enabling evaluation of repeatability). Scanning parameters 
were either the same or as close as possible for each camera (the only difference was in applied zoom, 1.2 for the Infinia and 
1.23 for the Symbia).  
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Non-
standard 
scanning 
conditions 
Tests evaluated three alternative scanning protocols that may be applied for complex patients, including those that are 
claustrophobic and those with anatomical abnormalities (such as kyphosis), which dictate that detectors cannot be brought close 
to the patient‘s head. In the local clinical department, these are the main reasons for protocol deviations or abandoned 
acquisitions. 
 
Two acquisition methods were considered for claustrophobic patients: acquiring from behind the head only using either a single 
detector (with the other at maximum radial distance), or both detectors set at 90° to each other in ‗L-mode‘ (126). For patients 
where anatomical abnormalities prevent a small radius of rotation, a standard acquisition at an increased radius was the only 
alternative considered. 
 
The same anatomical template was adopted as in the previous investigation (i.e. striatal uptake was defined from adaptation of 
the MNI template). The fully assembled head was scanned four times on a GE Infinia camera, as follows: 
 
1) Standard acquisition procedure 
2) ‗L-mode‘ acquisition, acquired over 180°, posterior to the patient. 
3) Standard acquisition with one active detector acquiring data close to the posterior of the head and the other inactive 
detector at the maximum radius away from the patient‘s face 
4) Standard acquisition with both detectors at an increased radius of rotation (21.4cm, such that a patient‘s shoulders could 
reasonably be expected to be included within the field of view) 
 
A schematic of these different acquisition conditions is shown in Figure 7-2 (numbered according to the list above). The 
anatomical template was printed twice, with different striatum to background ratios, to reflect two different patient appearances. 
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As before, print 1 had a striatum to background greyscale ratio of 8 to 1 on both sides of the brain (‗normal‘ phantom). Print 2 had 
a striatum to background ratio of 6.5 to 1 on the right and 5 to 1 on the left side (‗borderline‘ phantom).  
 
 
 
Figure 7-2 Schematic of the different acquisition protocols. 
 Table 7-4 Summary of investigation methods for assessing classification algorithm sensitivity to different acquisition factors 
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7.3 Results 
7.3.1 Camera-collimator design 
Figure 7-3 shows the SVM score results for the two phantoms scanned on the different 
camera systems (for an assumed patient age of 60 years). Note that SVM scores for the 
borderline phantom are so close to zero that they are barely visible. Table 7-5 summarises 
repeatability errors. Table 7-6 provides an estimate of between camera differences, taken 
from differences in the means of the repeated scans on each camera.  
 
 
Figure 7-3 Summary of the mean SVM score results for different camera systems (assumed 
patient age of 60 years) 
 
Camera 
system  Phantom 
SVM score differences 
between repeat scans 
GE Borderline 0.05 
GE Normal -0.44 
Siemens Borderline -0.04 
Siemens Normal 0.17 
Table 7-5 Summary of repeatability results 
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Phantom 
Mean SVM score differences 
between cameras 
Borderline 0.10 
Normal 1.18 
Table 7-6 Summary of camera comparison results (mean GE Infinia result minus mean 
Siemens Symbia result) 
7.3.2 Non-standard scanning conditions 
Figure 7-4 shows reconstructed slices following acquisition under standard conditions, and 
with both detectors set in L-mode. Figure 7-5 summarises the figures output from the SVM 
algorithm after inputting data acquired under different conditions. Table 7-7 shows 
differences in SVM scores as compared to standard scanning conditions.  
 
 
Figure 7-4 Reconstructed slices from the normal phantom acquired in H-mode (left) and L-
mode (right) 
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Figure 7-5 Summary of the SVM score results for different acquisition protocols for both 
phantoms (patient age of 60 years) 
 
 
SVM score differences vs standard 
acquisition 
Phantom L-mode 
One 
detector 
increased 
radius 
Borderline 0.18 -0.35 0.25 
Normal 0.33 0.36 0.23 
Table 7-7 Summary of acquisition conditions comparison (SVM score from standard 
acquisition minus SVM score from alternative scenario). 
7.4 Discussion 
This chapter first sought to develop a strategy for prioritising the different acquisition 
conditions that could affect classification algorithms performance, and to conduct a 
sensitivity analysis using developed phantom technology. These endeavours are a response 
to the research objectives identified in chapter 5. 
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The sensitivity analysis strategy was largely based on examination of relevant clinical 
guidelines with respect to equipment factors. Although this is likely to be less reflective of the 
range of acquisition conditions seen in clinic, findings provide a suitable starting point for 
evaluation of classification tools. The strategy could perhaps be updated and improved in 
future through consultation with relevant stakeholders in the (I123)FP-CIT clinical 
community. 
 
It was intended that sensitivity analysis would be conducted using a number of different 
phantoms, after further optimising the SSP anatomical template to more closely reflect real 
patient appearances. Although, due to resource constraints, this was not achievable, results 
from the application of a simplified phantom to one of the developed classification tools do 
provide useful insights, as described below. The processes and analysis employed here 
could be applied to any classification tool, including that used for clinical reporting tests in 
chapter 4, when more realistic anatomical template designs have been created and 
optimised. 
7.4.1 Camera-collimator design 
Many clinical departments in the UK do not have the luxury of being able to choose between 
cameras when scanning patients. Often there may be only one camera available or there 
may be multiple cameras locally, but all from the same manufacturer. Furthermore, after a 
gamma camera has been in use for longer than its expected lifetime, a hospital may choose 
to buy a completely different model as a replacement. Across the country there will be 
multiple different types of systems in use at any one time, with varying acquisition 
procedures between centres. Before a CADx or automated classification tool can even be 
considered for development into widely available software, performance for the most 
commonly available camera-collimator equipment needs to be understood. This is a key 
consideration that is often neglected by the machine learning research community. 
 
Camera comparison results demonstrated that differences between GE and Siemens 
systems can be relatively large for a machine learning algorithm built on SBR features. The 
maximum recorded difference in SVM score was 1.18, which is approximately one third the 
size of the mean difference between normal and abnormal patients (see Figure 7-1). This 
score differential was consistent across all assumed patient ages (due to the linear nature of 
the adopted classification algorithm). In every case the GE camera produced a higher 
classification algorithm output than the Siemens camera, thus for every patient there was an 
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increased probability of belonging to the non-PDD group if they were scanned with GE 
equipment. These findings are perhaps unsurprising given that the classification algorithm 
was created with data that were only acquired from GE systems, and so the Siemens data 
represented a shift in input signal that was not accounted for in the training process. 
Previous research has shown that GE and Siemens scanners give systematic differences in 
SBR measurements (50), due to differences in resolution and septal penetration 
characteristics. In this case it appears that such differences in SBR translated into an overall 
change in classification algorithm score. 
 
It is interesting to note that the magnitude of the change in SVM score was far larger for the 
phantom with a count density ratio of 8 to 1 (normal phantom) than for the phantom based 
on a count density ratio of 5 to 1 (borderline phantom). This can perhaps be attributed to the 
underlying SBR figures, which changed by a greater magnitude for the normal phantom 
when scanning on the different systems. There was also a substantial difference in the 
repeatability error: differences in SVM score were 0.05 and 0.44 for the borderline and 
normal phantom respectively. Without taking further measurements it is difficult to ascertain 
whether repeated scanning (and processing) of the more borderline simulated patient is 
associated with less variability, or whether variability differences between the phantoms are 
due to chance. However, whatever the underlying pattern in repeatability error, it is clear that 
differences in acquisition equipment can have a substantial impact on the algorithm under 
consideration, and would potentially stop it from being developed further into a widely 
available clinical tool. 
 
The apparent differences in results for the two phantoms emphasises the importance of 
testing a range of different patient appearances (ideally more than was investigated in this 
case), in order to fully assess the sensitivity of a classification algorithm. This again 
emphasises the inadequacy of the fixed Alderson phantom for evaluating machine learning 
tools. Ideally, further experiments would also be carried out on other commonly used camera 
systems to evaluate whether patterns seen here are reflected more widely.  
 
In this study a single GE and Siemens camera were tested. However, it is likely that there 
would be some variability between the performance of individual cameras of the same model 
type. Tests on multiple identical cameras would be needed to quantify this variability.  
 
The magnitude of the measured change in classification algorithm output needs to be 
understood in the clinical context. Figure 7-3 shows that although the changes in SVM score 
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were much smaller for the borderline phantom (and may not be significant beyond 
repeatability error), scanning on the different systems did cause the SVM output to change 
between a positive and negative value. Thus, overall binary classification for the phantom 
changed depending on the camera used (classification was normal when scanned on the 
GE system, and abnormal group when scanned on the Siemens system). Conversely, the 
larger changes in SVM score seen for the normal phantom still resulted in a large, overall 
positive classification algorithm score (and therefore high probability of belonging to the 
normal class), no matter which camera system was used. Hence, it could be argued that the 
small changes seen for the more borderline simulated patient are perhaps more critical in 
the clinical context, particularly if the classification tool was to be used as an automated 
system for screening out normal scans from the reporting list.  
7.4.2 Non-standard scanning conditions 
(I123)FP-CIT scanning using a standard protocol requires patients to remain still for 
approximately 35 minutes, with gamma camera detectors passing close to the face. In 
addition, the patient‘s head is firmly strapped into a support. However, some patients cannot 
tolerate these conditions due to different physical or mental health difficulties. For 
claustrophobic patients seen at Sheffield Teaching Hospitals this would have previously 
dictated that the scan was either abandoned or a planar vertex view taken. For those with a 
physical deformity, preventing scanning close to the head, acquisition would have continued 
but with detectors at an increased radius (such that the shoulders could be included in the 
field of view for example). All such patients were excluded from the local databases used in 
this thesis. 
 
Although not recommended specifically by any clinical guidelines, the local Nuclear Medicine 
department is currently considering alternative scanning procedures for claustrophobic 
patients in order to reduce the number of failed acquisitions, namely: scanning from behind 
the head with either a single detector or with both detectors set at 90° to each other. Other 
Nuclear Medicine departments are currently using such protocols routinely. It is essential to 
understand how a classification algorithm performs under these conditions, or when the 
detector radius is set at a larger value, such that decisions can be made as to whether CADx 
is contraindicated for these patients or not. Without such evidence or guidance machine 
learning tools could cause inappropriate diagnosis or patient care when used in the clinic 
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Figure 7-4 demonstrates one of the problems caused when data is collected asymmetrically, 
from only one side of the patient, namely that the striata can appear warped. This geometric 
distortion was as expected given that gamma camera imaging characteristics, including 
attenuation, scatter and particularly resolution, are depth dependent. In a standard H-mode 
acquisition, acquired for one full rotation, the effects of improved resolution near the camera 
face, and degraded resolution far from the detector, are averaged out over the whole scan. 
However, for a 180° L-mode acquisition where detector heads never pass close to the 
patient‘s face, the anterior brain is never sampled at a higher resolution. The distortion 
effects from an incomplete acquisition rotation are worse the further away the object from the 
centre of rotation (131,132). Unfortunately, in this case it was not possible to place the 
detectors close enough to the bed to always keep the striatum within the central field of view. 
Thus, the geometric distortion appears worse than might otherwise be expected. 
 
However, despite the obvious differences in appearances caused by the alternative 
scanning conditions for claustrophobic patients, the measured differences in SVM score 
were not as large as might be expected. For the normal phantom, for example, the SVM 
score differential as compared to standard scanning conditions was 0.33 and 0.36 for the L-
mode and one-detector acquisitions respectively, which are far lower than differences 
caused by scanning on a different camera system (see 7.3.1). These differences are also 
lower than the maximum repeatability error seen in the previous section. SVM score 
differentials for the phantom representing a more borderline patient (5 / 6.5 to 1) were of 
similar magnitude and are perhaps of more concern in the clinical context given that the 
machine learning algorithm output is closer to zero (the boundary between normal and 
abnormal groups). 
 
The fact that there was much less contrast between phantom results in this investigation, as 
compared to the previous, again shows that reproducing a range of simulated patient 
appearances is important for fully appreciating the impact of different acquisition settings. 
 
Due to the geometric distortion induced by both forms of 180° acquisition, the image 
registration step is likely to have played a significant part in either causing or reducing 
discrepancies in SVM or SBR score. Visual analysis suggested that the affine registration 
had placed each striatum in approximately the right position as compared to the template. 
However, given the thin, elongated shape of the striatum in the L-mode 180° acquisition (see 
Figure 7-4), there is no single ‗correct‘ registration. A number of different scan 
transformations may have placed the organs in approximately the correct position, each of 
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which may have led to different scores. Therefore, results presented here are as much a 
function of image pre-processing as the analysis algorithms themselves, probably more so 
than for investigations of other factors. 
 
Results for the acquisition carried out at an increased radius of rotation, simulating the 
effects of including a patient‘s shoulders within the field of view, showed a consistent but 
relatively small effect on SVM scores across the two phantoms. This suggests that the loss 
in resolution caused by this scanning setup may be less important in terms of algorithm 
performance than acquiring data on different camera systems. 
 
It is interesting to note that in all but one case, the 3 alternative scanning scenarios gave 
SVM scores that were slightly higher than for the standard acquisition (therefore having a 
greater probability of belonging to the normal patient group). This was unexpected given that 
each of the alternative acquisitions was associated with appearances that would normally be 
considered to be more abnormal. These findings emphasise the fact that a machine learning 
algorithm built on derived SBR features may not necessarily behave in the same way as a 
human observer. Classification algorithms which analyse raw pixel values, or principal 
components of raw pixel values, may give very different results. 
 
This investigation considered only a limited number of patient conditions that would require 
alternative scanning procedures. There are many more that could be considered, particularly 
those causing patient movement during acquisition. For example, a patient suffering from 
DLB may be very forgetful and may try to get up during an acquisition. Furthermore, for the 
patient group referred for clinical (I123)FP-CIT scanning, Dyskinesia is a common symptom, 
which may cause constant movement of the striatum during a scan. Any such significant 
movement is likely to lead to reduced resolution and perhaps reduced contrast, which could 
result in significantly altered striatal appearances and reduced classification algorithm 
reliability. Investigations are required to examine the extent of movement that can be 
tolerated by classification algorithms before their use becomes contraindicated. However, 
given that there is likely to be wide variability between patients in terms of the magnitude, 
timing and duration of their movements, investigation of effects on classification algorithm 
performance would require a large number of acquisitions to be performed to cover these 
variations. These could be considered in future. 
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7.5 Summary 
This chapter first provided a strategy for prioritising investigations into the sensitivity of 
classification systems to different acquisition conditions, as part of an overall aim to address 
heterogeneity of the clinical environment, a vital consideration in the drive towards clinical 
translation. The two acquisition conditions found to be of highest priority in terms of their 
potential impact were camera-collimator design and non-standard patient positioning. 
 
Following this, a set of sensitivity analyses were conducted using developed SSP 
technology. A single machine learning algorithm was considered for all tests, based on 
binding ratios and patient age input to a linear SVM classifier. Of all the developed 
classification algorithms, this was most suited to testing with the idealised SSP patient 
uptake pattern that was developed in previous investigations. However, the testing 
methodology applied in this chapter is likely to be relevant to any form of classification tool 
(assuming that sufficiently realistic phantoms can be produced) and so provides a guide to 
other researchers also grappling with the challenges of clinical translation. 
 
Initial investigations characterised the baseline level of difference in SVM score between 
PDD and non-PDD patient groups (acquired under a single set of acquisition conditions), to 
give perspective to the findings. The examinations that followed utilised a limited number of 
phantom acquisitions, based on an idealised uptake pattern.  
 
Overall, the collected evidence suggested that utilising a different gamma camera system to 
that which the algorithm was trained on can give a systematic change in SVM score, which 
can be substantial and may be larger than repeatability error.  
 
Selection of an alternative acquisition protocol, as might be used for claustrophobic patients 
or those with physical deformities, was generally associated with smaller changes in SVM 
output, less than the maximum repeatability error. Such protocols are clearly less of an issue 
for the classification algorithm, even though they were not addressed in the algorithm‘s 
training process. The raw SVM scores from each alternative scenario were generally 
increased as compared to standard scanning conditions. This was despite the more 
abnormal striatal appearances. These findings emphasised the fact that a classification 
algorithm built upon derived binding ratios may not always behave in a similar fashion to a 
human observer.   
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The SVM score provided a useful metric for analysing the sensitivity of SVM algorithms to 
different scenarios. However, in the clinical CADx context the impact of the reporter also 
needs to be considered in order to understand how changing algorithm outputs translates 
into changing diagnostic decisions. This is a more complex problem, which may vary 
depending on the experience, skill and confidence of the reporter. In order to make any 
insights further reporting tests are required, using changing algorithm outputs.  
 
It is clear from the analysis above that different acquisition factors can have a substantial 
impact on classification algorithm performance. Results imply that, for the algorithm under 
consideration, use of a Siemens camera may be contraindicated due to the potential 
substantial shift in SVM score. Thus, theoretically, a large proportion of UK centres would 
not be able to benefit from the software, if it were released for clinical use in its current form. 
Even at a local level, results suggest that if a new camera were purchased (with different 
characteristics), the CADx / classification system may not achieve adequate performance. 
Such major limitations would be likely to discourage further investment. This again shows 
the importance of considering heterogeneity of the clinical environment in the journey 
towards clinical translation. 
 
However, algorithms such as this can be redesigned to some extent in order to ameliorate 
the impact from different acquisition conditions, in order that the potential for positive clinical 
impact is maximised. Possible methods for overcoming issues highlighted in sensitivity 
analyses, for this algorithm and more widely, are discussed in the following section. 
7.6 Algorithm adaptations for the clinic 
The problem of differing data acquisition conditions is a major concern in other machine 
learning applications in other imaging modalities (133). Often in the radiological machine 
learning literature, algorithms are developed using established ‗legacy‘ data, acquired using 
certain equipment and protocols. Frequently this is data from research studies, such as the 
Alzheimer‘s Disease Neuroimaging Initiative (ADNI), http://adni.loni.usc.edu/. However, once 
trained, the goal is usually to apply machine learning algorithms to images acquired under 
different (clinical) conditions, using different and often more modern scanning equipment. 
Under these conditions the performance of even state-of-the-art algorithms, such as 
Convolutional Neural Networks (CNNs), is often poor (134).  
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Techniques for adaptation of machine learning algorithms to different acquisition conditions 
are often referred to as ‗transfer learning‘ or ‗domain adaptation‘. There are many methods 
that fall under these headings. The most obvious solution to enable domain adaptation is to 
collect large databases of images covering all possible data acquisition conditions, where 
patient classification is known. This data can then be directly implemented within the 
algorithm learning process such that the relationship between extracted features and 
different acquisition parameters can be modelled. However, this is usually impractical.  
 
One possible approach to transfer learning, utilising only limited data, involves different 
weighting of samples in the training process according to their origin. For example, in the 
adaptation of classification algorithms to patient data acquired from a Siemens camera, 
images acquired from a GE camera could be given a lower weighting in algorithm training 
than samples from a Siemens camera. Here the GE data would help to regularise the 
classification model but not at the expense of reduced performance on Siemens data. This 
form of sample weighting can help to create reliable classification algorithms even with just a 
few training examples acquired under the target scanning conditions (133). However, 
improved performance using such techniques is not necessarily guaranteed. Furthermore, 
research into the specific use of transfer learning for SPECT data is so far very limited and 
thus there is little indication of the likely success of this form of algorithm training. 
 
Alternatively, different acquisition factors could be normalised for in image pre-processing. 
This could be achieved, for example, by incorporating physics models into the processing 
pipeline or deriving empirical correction factors between camera systems based on limited 
phantom data, such that semi-quantification figures are transferrable between different 
equipment. This is the approach used for the PPMI data and in the ENCDAT project 
(http://earl.eanm.org/cms/website.php?id=/en/projects/enc-dat.htm). Although such 
corrections ignore differences due to striatal anatomy variations, this technique has been 
shown to reduce differences in SBR figures between camera systems (49) and would be 
likely to dramatically reduce the inter-camera variance seen in the sensitivity analysis of 
section 7.3.1.  
 
Overall, it is acknowledged that classification algorithms could be further adapted, if 
required, to enable better generalisability to different clinical environments. However, even if 
machine learning tools are trained to cope with varying acquisition conditions from the 
outset, methods for validating the impact of clinical heterogeneity are still required. The 
previous two chapters provide guidance on methods that could be used to assess (I123)FP-
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CIT classification algorithms in relation to this important translational issue, and represent an 
important step forward in clinical machine learning research. 
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8 Concluding remarks 
8.1 Summary 
This thesis was composed of two separate but complementary parts. In the first part the 
main research question was: How effective is a CADx tool, based on established machine 
learning algorithms, for assisted (I123)FP-CIT image reporting? Defining effectiveness in 
terms of independent algorithm classification accuracy, and in terms of the impact on 
reporter performance, the question was addressed through setting and pursuing 5 main 
objectives: 
 
1) Select and implement machine learning classification tools.  
2) Collect a database of (I123)FP-CIT images.  
3) Compare the performance of machine learning algorithms with semi-quantification.  
4) Develop software for testing of human reporters.  
5) Assess the impact of an automated classification tool, implemented as a CADx 
system, on reporting. 
 
These objectives were met in the following ways: 
 
A selection of binary automated classification algorithms were designed and implemented 
based on promising techniques identified in the literature. Data for training and testing was 
collected from Sheffield Teaching Hospitals NHS Foundation Trust, with a minority of the 
patient cases having diagnosis established through clinical follow-up. This data was 
supplemented by images from the PPMI database. In the cross validation exercise the 
developed classification algorithms demonstrated similar or superior standalone 
performance in classifying both the local and PPMI data, as compared to a wide range of 
different semi-quantification methods. This is the first comprehensive comparison exercise 
conducted between these assistive technologies, and provides justification for the pursuit of 
clinical machine learning tools. 
 
Software for capturing reporting decisions of human observers was manufactured through 
adaptation of an existing clinical program. A CADx tool based on 5 principal components and 
a support vector machine classifier was selected for testing. A pilot study and main clinical 
study quantified the effects on reporting decisions from using this tool, again with both local 
and PPMI data. CADx output was in the form of a single probability value. It was shown that 
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reporters gave more consistent image scores (with increased inter-reporter reliability) after 
being exposed to these figures and that reporting accuracy was higher as a result, 
particularly when reporters were shown images with unfamiliar appearances. It was also 
found that intra-reporter variability, using visual analysis alone, was high. This was the case 
for both junior radiologists and more experienced reporters, which exposes the disadvantage 
of relying on human visual perception alone in image reporting. Indeed, reduced reporting 
variance may be one of the most important benefits of CADx, particularly given that 
(I123)FP-CIT imaging is a relatively rare test which, in smaller nuclear medicine 
departments, may only be seen by a reporter a few times a year. 
 
These novel, encouraging results for CADx were complemented by analysis of questionnaire 
results, which provided rich insights into the reporter-CADx relationship (which has not 
previously been studied in the field of (I-123)FP-CIT imaging). In particular, it was found that 
reporters were generally highly trusting of the classification system and that reporters from 
different clinical backgrounds appeared to have differing opinions on the usefulness of a 
CADx system.  
 
The standalone binary classification performance of the CADx tool was consistently shown 
to be at a similar level to that of experienced reporters. Results therefore suggested that the 
machine learning tool could perhaps instead be used independently, possibly as an initial 
screening tool to remove normal cases from the list of images viewed by reporters. The main 
advantage of this approach over the CADx paradigm is that the potential efficiency savings 
are higher. 
 
Despite the large number of published journal articles related to machine learning and (I-
123)FP-CIT classification, this work represents the first attempt to consider and evaluate the 
impact of classification tools in a clinical scenario, with reporters. Such investigations are 
vital for moving machine learning technology towards clinical use and the positive results 
add weight to the arguments in favour of clinical translation. In answer to the original 
research question, the results summarised above demonstrate that this form of CADx is 
highly effective for assisting (I-123)FP-CIT reporting. 
 
However, although machine learning had been considered here in the clinical context, 
generating new and important information related to likely algorithm performance, the initial 
approach had arguably been naïve. There was still a long way to go before the developed 
classification tools could be used routinely in hospitals. Notwithstanding the need to 
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generate more robust statistics through collection of more data, testing of more reporters 
and perhaps even conducting a prospective clinical trial, it was demonstrated that there are 
many other psychological, economic, legal, management as well as technical issues that 
needed to be addressed on the path to widespread clinical translation. Although other 
authors have suggested that clinical translation is often not adequately addressed by the 
research community, these issues were perhaps more wide ranging than has yet been 
described in the literature. The scale of the translation challenge is substantial, affecting all 
machine learning applications in radiology, not just for (I123)FP-CIT imaging.  
 
Frustratingly, many researchers are either unaware of these issues or choose to ignore 
them. Consequently, clinical use of machine learning tools remains disappointingly low in 
medical imaging. Undoubtedly a new research approach is needed, focusing more on the 
translation gap than continual development of the technologies themselves. As shown by 
this thesis, even well-established machine learning algorithms are already sufficiently mature 
to offer real benefits to clinical care. Making sure such technology can and does thrive in the 
clinic should be a greater priority. It is hoped that the research community will in future take 
heed of this suggestion. 
 
The second half of the thesis considered aspects of the translation burden in relation to 
(123)FP-CIT classification software, to improve the prospects for future clinical uptake. 
Given the limited remaining time and resources it was decided that the final chapters would 
focus on addressing one of the most pressing and most significant technical barriers, namely 
heterogeneity of the clinical environment. Specifically, it is known that gamma camera 
imaging characteristics vary between systems in different hospitals, which could lead to 
variability in (123)FP-CIT classifier output. Investigations are needed to measure this 
variability to establish whether classification software is likely to be successful outside of the 
hospital in which it was developed. Without performing such tests it is unlikely that 
classification / CADx tools would be turned into commercial, clinical products. 
 
With so little previous consideration given to the challenges of clinical translation in the 
literature, there is little available guidance on how clinical heterogeneity might be addressed. 
Clearly, repeated scans of patient uptake patterns, under different acquisition conditions are 
likely to be required. Performing these tests using phantoms rather than real patients is likely 
to be more viable (due to financial and ethical considerations). However, as shown in 
chapter 6 there isn‘t yet a suitable phantom technology for this task. 
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Thus, the main focus of the second half of this thesis was on creating novel technologies 
and strategies that would facilitate investigations into the effects of different acquisition 
conditions on classifier / CADx performance. 
 
The new objectives for chapters 6 and 7 were to: 
 
 A)  Examine and develop phantom technology to provide a toolset that can be 
adapted to simulate a range of realistic (I123)FP-CIT image appearances.  
 B): Use the toolset to demonstrate the influence of heterogeneity by: 
 Analysing and prioritising the individual imaging parameters that may affect 
classification software performance.  
 Performing sensitivity tests to measure the impact of different imaging 
parameters on developed classification tools 
 
Therefore, the targets for the remaining research effort were both ambitious, going beyond 
the scope of the original research question and far beyond the vast majority of machine 
learning investigations, but they were also necessary given the huge translation challenges 
that remained. 
 
Chapter 6 provided results from development on a new (I123)FP-CIT phantom based on 
sub-resolution sandwich phantom technology. A series of investigations demonstrated that 
this flexible method of phantom manufacture was practical, controllable and repeatable. A 
fully assembled phantom based on an idealised anatomical template produced image 
features that were reflective of a cohort of patients. 
 
A strategy for prioritising and selecting image acquisition parameters for sensitivity tests was 
developed by examining relevant guidelines, and considering the potential for control in the 
clinical environment. The two highest priority factors were found to be: camera-collimator 
design and non-standard positioning.  
 
Sensitivity analysis was conducted according to these priority areas, using the idealised SSP 
anatomical template. For the single classification algorithm that was tested it was shown that 
use of different image acquisition equipment, from a different manufacturer, can have a 
substantial impact on algorithm output. This would be likely to preclude the algorithm from 
being widely used. The impact from using non-standard positioning was found to be smaller. 
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Although only the simplest of the developed algorithms was tested (that based on SBR 
features), the investigations demonstrated the suitability of developed processes and 
technology for assessing classification software. The same methodology could in future be 
applied to any (I123)FP-CIT classification algorithm once more patient specific anatomical 
templates had been optimised. 
 
Thus, objectives A, B (part 1 and 2) were largely completed, providing a basis for further 
work to address the remaining translation gap.  
 
In summary, this thesis has contributed several novel and important findings to the literature: 
 
 Direct, comprehensive comparison between semi-quantification and machine 
learning tools for classification of (I123)FP-CIT images, demonstrating the superiority 
of machine learning algorithms 
 Evaluation of machine learning software in a clinical (I123)FP-CIT reporting scenario, 
showing the positive impact on inter-reporter reliability and accuracy, and the ability 
of machine learning software to match human performance 
 Distillation and analysis of the wider barriers to adoption for all machine learning 
classification tools, that extend far beyond the scope of most machine learning 
studies 
 Development and demonstration of a new, flexible, controllable and repeatable 
phantom technology, facilitating phantom-based sensitivity analysis of (I123)FP-CIT 
classification software (which was not previously possible using the Alderson system) 
 Creation of a new prioritisation strategy for investigating the impact of different 
acquisition conditions 
 Sensitivity analysis results, demonstrating that differences in camera equipment and 
acquisition protocols can have a substantial impact on machine learning classification 
software performance 
8.2 Future work 
Although a lot has been achieved in this work, there remains a number of avenues that 
deserve further attention, particularly in relation to the remaining translation gap, which I 
believe is the most significant problem for machine learning in radiology. The next steps set 
out below seek to address some of the more immediate questions and issues that have 
arisen following investigations of automated (I123)FP-CIT classification tools. These ideas 
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for future work consider both the technologies specifically developed in this thesis but also 
the wider picture related to translation of machine learning technology. 
8.2.1 Mapping out a pathway from initial research to clinical adoption 
This work has highlighted the barriers that would prevent immediate widespread adoption of 
the developed algorithms in clinic. However, only one of these barriers (heterogeneity of the 
clinical environment) has been partially addressed so far. The necessary steps required to 
navigate all the other identified hurdles are not clear. What is needed, ideally, is a blueprint 
for how researchers and other stakeholders could create a clinically successful automated 
classification or CADx tool. To maximise impact, such a model should ideally be relevant to 
any application. As a first step towards meeting these goals a workflow diagram was 
developed, which maps a pathway from initial research idea to clinical adoption for CADx 
systems. This draft document is introduced below. 
 
In order to create a model for algorithm development, a specific endpoint needs to be 
defined. One possible choice would be to target inclusion within current clinical guidelines for 
the specific disease area such that clinical departments wishing to achieve accreditation, or 
to demonstrate high quality patient care, are incentivised to adopt the technology. However, 
with numerous national bodies producing clinical guidelines for different areas in medicine, 
most of which do not have clear criteria for accepting protocols or technologies into 
guidelines, this would be impractical for creating a generally applicable development model. 
 
A more well-defined endpoint would be achieving NICE approval through either the Medical 
Technologies Evaluation Programme (MTEP) or the Diagnostic Assessment Programme 
(DAP). These programmes aim to accelerate the adoption of technologies which have the 
potential to improve patient outcomes, reduce costs or provide benefits to the healthcare 
system. Although approval through these routes does not guarantee widespread uptake, it 
does provide a seal of approval that is likely to dramatically increase pressure on hospitals to 
invest in the technology. 
 
NICE approval has a list of requirements and assessment processes as set out in relevant 
guidance documents (135), which provides a basis for creating a pathway to adoption. 
NICE evaluation covers device regulations, clinical evidence and health economics. 
Evaluation panels also receive input from multiple different stakeholders. Therefore, many of 
the barriers to clinical adoption already identified in chapter 5 are also considered as part of 
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NICE approval procedures. Much of the work undertaken in this thesis (particularly in 
chapters 2-4) could contribute towards the evidence based requirements of these processes. 
 
Based on the requirements of NICE approval in the context of CAD I produced a peer 
reviewed publication (5), setting out the main considerations for any new algorithm aiming 
for clinical adoption. Using the NICE requirements as a target, I also produced a workflow 
diagram, mapping the whole development pathway, from initial research idea to NICE 
submission (see Figure 8-1). Although this has not yet been subject to peer review, it could 
potentially be used by other researchers in future to help ensure that future CAD projects are 
conducted with clinical translation in mind.  
 
 
Figure 8-1 CADx development workflow 
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The workflow is designed for both CADe and CADx applications and is linear, suggesting 
that steps be taken one after another. Five distinct stages are identified, with each 
generating additional evidence towards the final goal. Given that it is difficult to know a-priori 
which technology will work best, it is assumed that multiple possible algorithms will be 
selected to solve the clinical problem in the early stages. However, only one algorithm will be 
selected to progress through clinical and economic evaluations (due to the high cost of 
performing these tasks). The workflow was designed such that early stages are less 
resource intensive, enabling initial investigations of potential software solutions with minimal 
outlay. Due to the significant demands of the NICE approval it is anticipated that very few 
CAD systems would progress through every stage without being rejected. 
 
At each stage a decision must be made as to the sufficiency of performance given the 
metrics generated from different tests. Should performance be deemed unacceptable the 
algorithm is either abandoned or updated. Such are the requirements from NICE with 
regards to compelling empirical evidence, the first stage of the workflow (the preparation 
phase) involves an assessment of the potential for CAD to have a clinical or economic 
impact, the implication being that projects should only be undertaken if there is the potential 
for significant improvements to the current status quo. If standard reporting is quick, 
inexpensive and effective then there is little point investing time in creating an automated 
classifier. This strict, impact-focused approach contrasts strongly with much of the current 
machine literature, where studies are often driven by the availability of data, rather than the 
potential for improvements to care or efficiency. 
 
Stages 1 and 2 of the workflow involve assessments of standalone performance and 
analysis of the ability of the algorithms to cope with data derived from different (but realistic) 
acquisition scenarios. Although these procedures are not specifically referenced in NICE 
processes they are, as shown by previous discussions related to heterogeneity of the clinical 
environment, necessary for understanding baseline performance. If such results are not at a 
sufficiently high level (for example they are lower than human performance unaided) then it 
is unlikely that clinical investigations will achieve the outcomes necessary to encourage 
clinicians to adopt the technology. Stage 2 permits adjustments to the algorithm to be carried 
out (assuming they do not adversely impact on standalone performance) or other 
compensatory mechanisms to be instigated, including additional pre-processing of data, in 
order that performance figures are maintained at a high level with the widest possible scope 
of application.  
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Stage 3 of the workflow involves the collection of clinical study data through comparison of 
the performance of standard care procedures (usually radiologists performing visual 
analysis) and radiologists working with CAD support. This process has been subdivided into 
a pilot study and a main study, in a similar way to chapter 4. Ideally the main study should be 
conducted as part of a multicentre trial, whereby a wide range of radiologists can be included 
in the results, such that results are representative of general clinical usage.  
 
Stage 4 involves analysis of the direct costs of the CAD intervention (including costs of 
software licences, infrastructure, maintenance, staffing and training) as well as the indirect 
costs that would result in relation to changes to the patient pathway (for example the 
additional number of secondary care consultations that may result per patient). A health 
economic analysis is then conducted to predict the overall system impact from introduction 
of CAD. It is assumed here that results from clinical evaluations can be extrapolated to 
estimate the effects on the patient pathway. The uncertainties of this approach are likely to 
be higher than for a full clinical trial which examined patient outcomes over the longer term 
following diagnostic assessment with and without CAD. However, the costs to the developer 
are likely to be much lower using this simplified technique. 
 
Through each stage of the workflow it is assumed that evaluation methodologies are chosen 
such that uncertainties are minimised. For example, that tests conducted with radiologists 
use randomly selected patient images, thus minimising recall bias, and that investigations of 
standalone performance use large databases of images, covering most expected image 
appearances. Methodological errors that are likely to bias estimates of algorithm 
performance, such as those highlighted in recent literature (93,94), should be avoided. 
Maintaining high standards in data collection is crucial, as highlighted by a recent review of 
the MTEP programme, which showed that the 3 main reasons for technologies failing to 
progress to guidance development were a lack of evidence, insufficient/uncertain benefit to 
the NHS and insufficient/uncertain benefit to the patient (136). In addition to maintaining high 
standards in methodology, it is assumed that patient data used is always anonymised such 
that data protection and ethical issues are reduced. 
 
The workflow does not make assumptions about who should be responsible for each stage 
of the process. However, it is assumed that the individuals or groups working on the project 
are aiming towards the same goal. It is possible that some aspects of the workflow could be 
carried out by external parties, or could be derived from previous literature. For example, the 
selection and testing of different algorithms in stage 1 could be largely derived from the 
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results of ‗grand challenges‘ such as those run each year at the Medical Image Computing 
and Computer Assisted Intervention (MICCAI) conference. Here, databases of images are 
made freely available to researchers from around the world. Participants submit their created 
algorithms for evaluation on a (usually held back) test set. Algorithm details are then 
published and each is ranked according to chosen metrics. Thus, consideration of these 
results (if available) could be an efficient and cost effective way of comparing the 
performance of multiple candidate algorithms. 
 
Regulatory authorisation (particularly CE marking) needs to occur once the system design is 
finalised, which is likely to be after the clinical evaluations are completed. However, 
compliance processes could instead be completed after the system impact of CAD has been 
predicted. Thus, the CE marking stage is not strictly tied to either stage 3 or 4 in the 
workflow. It is also assumed that research publications would be produced at each stage of 
the workflow, cumulatively adding to the evidence base for the technology. 
 
This model for algorithm development represents my first attempt at trying to create a 
plausible pathway to help guide researchers on the tortuous path towards clinical translation. 
Bourne out of a frustration with the current disconnect between the rapidly expanding, 
exciting machine learning research arena, and the stubbornly low clinical use of machine 
learning technology, this model undoubtedly has limitations. For instance, the workflow 
provides no guidance on what type of expertise is required at each stage in order to meet 
the multidisciplinary challenges presented. Furthermore, there is no guidance on specific 
processes required in order to meet regulatory requirements (i.e. CE marking), and no 
consideration of what might be done if prevailing professional and public opinions were 
largely negative. The model needs to be presented to and critiqued by other experts, and 
possibly altered, before it can be put forward as guidance for researchers and developers. 
This would be a priority for future work. However, it undoubtedly offers a useful starting point 
for driving conversation in the machine learning community towards a more clinic-focused 
approach. 
8.2.2 Development of realistic anatomical templates 
The ability to conduct sensitivity tests for more complex (I123)FP-CIT machine learning 
algorithms is currently hampered by a lack of realistic anatomical template patterns for use 
with the SSP production method. Given that the most successful machine learning 
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algorithms developed in this thesis cannot yet be tested with SSP technology, this problem 
needs to be addressed.  
 
One possible route to creating more realistic templates for (I123)FP-CIT imaging would be to 
select images from patients who had already undergone both MRI acquisitions and 
(I123)FP-CIT SPECT within a short time window. The shape of the anatomical template 
could be defined by segmenting the MRI scan. After setting an assumed count density 
pattern, printing and scanning, the resultant reconstructed projections could be compared to 
the patient‘s real gamma camera images. By taking the difference between the simulated 
uptake pattern and the real image, on a voxel-by-voxel basis, an update can be made to the 
design template to iteratively bring it closer to the patient‘s underlying uptake pattern. The 
process could be repeated as many times as required. This methodology was adopted by 
Holmes et al. for the creation of realistic brain perfusion scans (119). Once such templates 
have been created, sensitivity tests can be conducted for the PCA-based machine learning 
algorithm used in chapter 4, to add further evidence of its suitability for clinical use. Algorithm 
adaptations could then be investigated if required. 
8.2.3 Evaluation of a (I123)FP-CIT screening tool 
As suggested following the clinical study in chapter 4, the performance of developed 
classification technology was so high (at or above the level of experienced reporters) that the 
algorithm could perhaps be better exploited as an independent diagnostic device than a 
CADx tool. It is likely that using such technology as a screening tool (removing the most 
obviously normal cases from the reporting list) would be the lowest risk and most acceptable 
way to perform automated, independent image analysis, at least initially. Indeed the US 
Food and Drug Administration (FDA) recently granted regulatory approval to the first 
machine-learning based medical image analysis tool which works independently from 
humans (named IDx-DR), designed to screen out retinal images showing mild or no disease 
(137). However, no clinical studies have yet been carried out according to this reporting 
scenario for (I123)FP-CIT imaging and so the potential benefits are not yet clear.  
 
A number of fundamental questions need to be addressed, in particular, what probability 
value should be used as a cut-off for deciding on whether an image should be shown to a 
radiologist of not? This could be investigated, in the first instance, through retrospective 
studies. The available clinical data already extracted from the archives at Sheffield could be 
split into two halves, the first used for retraining a classification algorithm and the second half 
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for determining a cut-off in algorithm output that is able to achieve 100% specificity (with a 
suitable, additional error margin). This could be calculated, for example, from Receiver 
Operator Curve analysis. The algorithm could then be used in a prospective study, whereby 
it is applied to all new (I123)FP-CIT scans acquired in the department, working alongside 
conventional reporting practices. The clinical reports could be compared to the algorithm 
output to confirm whether the selected cut-off was sufficient for ensuring that all abnormal 
cases continued to be displayed to reporters, and for quantifying the proportion of studies 
that could potentially be removed from reporting lists. Such information would be vital for 
evidencing potential improvements in efficiency and for justifying further algorithm 
development. 
8.2.4 Understanding perceptions of machine learning classification technology 
If automated classification software is to achieve widespread clinical adoption, particularly if 
used as an independent screening system, health professionals and patients need to be 
accepting of this new approach to radiological reporting. In particular, NICE committees 
which evaluate new medical technologies (such as the Medical Technologies Advisory 
Committee), take evidence from patient groups as well as relevant clinicians (136), whose 
opinions of the technology are likely to have a strong bearing on the final decision. Indeed, 
the developed pathway to translation (see section 8.2.1) explicitly includes evidence of 
public and professional opinions. 
 
Although the opinions of such individuals cannot be predicted it is useful to understand 
whether there are commonly held beliefs which may hamper clinical uptake. The use of 
machine learning and artificial intelligence in all aspects of life is a topic that is frequently 
visited in media reports. Such coverage is often negative. For example, the recent data 
sharing agreement between the Royal Free Hospital in London and Google Deepmind for 
development of machine learning algorithms was severely criticised in multiple publications. 
The Information Commissioner‘s Office deemed that the clinical trial had failed to comply 
with data protection law (138). It could be that such reports may naturally cause people to be 
more sceptical about machine learning in general, no matter what the empirical evidence 
that is presented. 
 
A separate Ipsos MORI survey commissioned on behalf of the Wellcome Trust (139) was 
conducted to assess public views on commercial access to health data. This is of relevance 
here as machine learning tools rely on patient data for adequate training and testing. It was 
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found that the general public and health professionals are often concerned and sceptical 
about the use of health data by private companies, in part due to lack of transparency. A 
significant minority think that health data should never be shared with commercial institutions 
under any circumstances. This could have implications for the work presented in this thesis if 
it was ever decided that software should be developed by a private company. 
 
The perils of not fully understanding the opinions of stakeholders in relation to digital 
technology are shown by the recent, high-profile failure of the care.data initiative in the NHS, 
which was designed to create a central database of primary care records. One of the key 
reasons identified for the failure was the lack of adequate information provided to the public 
on how their data would be used (140). 
 
As part of the promotion strategy for (I123)FP-CIT classification software, in the push 
towards clinical translation, it would therefore be advantageous to seek out clinical and 
patient opinions of automatic diagnosis in relation to Parkinson‘s Disease. These could be 
gathered through structured focus groups.  
 
A pilot study was conducted to provide initial data on public perceptions, and to assess the 
suitability of developed questions for a larger study. Four individuals from the Sheffield 
Parkinson‘s Disease society group volunteered to attend the focus group. Initial questions 
presented to the volunteers assessed current understanding of technical terms such as 
artificial intelligence and machine learning. Different scenarios were described, highlighting 
the use of computer software to augment or replace human work. These were discussed as 
a group, with questions posed to elicit views on acceptability. 
 
The main themes identified from discussions with the volunteers were: 
 
 Humanity in medicine (and elsewhere) should always been maintained i.e. there 
always needs to be some human interaction between patients and healthcare 
experts 
 Machines and software should augment what a human does, not replace or 
downgrade human work 
 Trust is important. If a patient trusts a doctor then the fact that CADx or classification 
software is used to inform their PD diagnosis is a minor consideration. 
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 Acceptance of automated diagnostic software is likely to increase as it is used more 
routinely. 
 Some patients may expect the latest technology to be used on them. These 
individuals may be disappointed if machine learning wasn‘t used to inform their PD 
diagnosis. 
 
The findings were somewhat contradictory in that there was a universal desire to maintain 
and protect human functions and skills, but that use of automated diagnostic algorithms 
could be tolerated or even desired so long as the patient‘s main clinical contact was with a 
human that they trusted. This suggests that marketing and promotion of any classification 
tool needs to be conducted carefully, emphasising the benefits of algorithms to clinicians and 
the patient. It may also be easier to induce positive opinions of classification tools if used as 
part of a CADx system, rather than as a screening tool where human input is removed. 
 
A larger scale qualitative study is needed to confirm these findings and to further explore 
where the boundary of acceptability lies between human and software based diagnosis. 
Ideally this would include interviews with radiologists and neurologists too, whose work 
would be directly affected by new (I123)FP-CIT classification software, and whose opinions 
are likely to have a substantial impact on whether such technology will flourish or not. 
Findings from such work would also be valuable to researchers and developers working in 
other areas of machine learning in medicine. 
 
The four suggested areas for further work described above need to be prioritised. Of these 
projects, perhaps the highest priority should be given to creation of an accepted 
development workflow, mapping the pathway from initial CAD research to clinical translation, 
as such a document could have a big impact. Also of high priority is the need to develop 
realistic anatomical templates for the newly developed phantom. Without such work the 
momentum behind the work completed in early chapters of this thesis would be lost. 
Evaluating a screening tool for (I123)FP-CIT and performing more in-depth qualitative 
analysis of public / professional perceptions are topics that are arguably less urgent, 
particularly as the latter relies upon a viable clinical tool being in place first. 
8.3 Conclusion 
At the beginning this thesis focused on assistive reporting technology in (I123)FP-CIT 
imaging. The main research question asked how effective was a CADx tool, based on 
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established machine learning algorithms, for assisted (I123)FP-CIT image reporting. 
Validation test results showed for the first time that machine learning tools outperform a wide 
range of semi-quantification approaches in terms of binary classification performance, and 
that a CADx tool built on such algorithms offered increased consistency between reporters 
and increased accuracy. Thus, in answer to the research question, machine learning for 
CADx in (I123)FP-CIT imaging proved to be highly effective. 
 
However, following a realisation that the path to clinical translation would be highly 
challenging, both for this application and others in medical imaging, there was a subsequent 
shift in focus towards addressing translation barriers. Driven by a desire to prevent 
developed technologies from being forever confined to the literature, wider questions related 
to heterogeneity of the clinical environment were considered. As a result, new phantom 
technologies and new strategies were created, which facilitated sensitivity testing. 
 
The suggested future work also focuses on wider considerations in relation to clinical 
translation, for both (i123)FP-CIT imaging and other machine learning applications in 
radiology. I hope that other researchers will also come to the realisation that in order for 
machine learning to make an impact in clinic, these areas need to be more of a priority. 
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10 Appendix 1 – handouts provided as part of the pilot 
reporting study 
Computer aided diagnosis (CAD) for DaTSCAN SPECT imaging 
John Fenner, Jonathan Taylor 
 
Introduction 
Welcome to the SPECT / CAD lab exercise. This brings together many facets of the taught 
material in the FRCR course: 
 
 Ionising radiation and dose 
 Gamma camera 
 Diagnostic protocols 
 Tomographic reconstruction (SPECT) 
 Image interpretation 
 Image quantification  
 Diagnostic performance 
 New techniques 
 
The session will last 2.5 hours and involve diagnosis of brain scan images, after an initial 
period of training.  
 
Learning objectives: 
 Consolidation of SPECT imaging 
 Introduction to DaTSCAN and its clinical rationale 
 Training in how to interpret DaTSCAN images 
 Introduction to quantitative aids in diagnosis 
 Practical exposure to CAD diagnosis and its implications for diagnostic practice 
 Introduction to metrics of diagnostic performance 
 
Timetable: 
 Part 1 (14:00-15:00) 
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 The exercise will start with a reminder of SPECT techniques and an introduction to 
DaTSCAN imaging.  
 You will be trained, as a group, to recognise the appearances of normal and 
abnormal DaTSCAN images using a series of 15 training datasets.  
 After training you will each be asked to interpret a series of 30 further patient images, 
displayed automatically on a computer. Interpretation will be in the form of a score, 
from 1-5, representing the degree to which you think the particular image is normal or 
abnormal.  
 
Break for coffee (15:00-15:15) 
 
Part 2 (15:15-16:15) 
 
 The reporting exercise will be repeated but this time the opinion of the computer 
aided diagnosis software will also be displayed for each of the 30 datasets (the CAD 
output will be displayed in terms of a probability value).  
 At the end of the exercise summary statistics on your performance will be provided 
(and compared to that of experienced reporters).  
 Discussion about diagnosis and the use of CAD for assisted reporting.  
 
This work is contributing to quantitative image developments within the department of 
Nuclear Medicine 
 
DaTSCAN background information 
 
The following information is largely taken from the GE website (md.gehealthcare.com). 
 
Indications 
 
DaTSCAN (Ioflupane I 123 Injection) is a radiopharmaceutical indicated for striatal dopamine 
transporter visualization. Single photon emission computed tomography (SPECT) brain 
imaging is used to assist in the evaluation of adult patients with suspected Parkinsonian 
syndromes (PS). In these patients, DaTSCAN may be used to help differentiate essential 
tremor from tremor due to PS (idiopathic Parkinson's disease, multiple system atrophy and 
  
207 
 
 
progressive supranuclear palsy). In addition, DaTSCAN is also used to differentiate between 
dementia with Lewy Bodies and other forms of dementia.  
 
Patient pathway (Sheffield) 
 
Approximately 2 patients per week are referred for DaTSCAN tests at Sheffield Teaching 
Hospitals. This represents approximately 1% of the department‘s total workload. Most 
referrals are from Neurologists based in secondary care in the local region. Approximately a 
quarter of referrals come from primary care. 
 
Clinical pharmacology – mechanism of action 
 
The active drug substance in DaTSCAN is N-ω-fluoropropyl-2β-carbomethoxy-3β-(4- [ 123 
I]iodophenyl)nortropane or ioflupane I 123. In vitro, ioflupane binds reversibly to the human 
recombinant dopamine transporter (DaT). Autoradiography of post-mortem human brain 
slices exposed to radiolabeled ioflupane shows concentration of the radiolabel in striatum 
(caudate nucleus and putamen). Parkinsonian syndromes reduce DaT availability, enabling 
DaTSCAN to be used as a tracer to detect these conditions.  
 
DaTSCAN also accumulates in other parts of the body, particularly the liver and lungs. Over 
time the tracer is washed out of the body, mostly via urinary excretion (60% over 48 hours). 
 
Dosage and administration 
 
The recommended DaTSCAN dose is 111 to 185 MBq (delivered intravenously). Images 
should be acquired between 3 and 6 hours post-injection (when tracer binding is maximised 
and stable). 
 
The Effective Dose resulting from a DaTSCAN administration (activity of 185 MBq) is 3.94 
mSv in an adult 
 
Physical characteristics 
 
Iodine 123 is a cyclotron-produced radionuclide that decays to 123 Te by electron capture 
and has a physical half-life of 13.2 hours. The most abundant emission is a gamma ray at 
159keV, which is used for imaging. 
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The first half-value thickness of lead (Pb) for iodine 123 is 0.005 cm. The half-value 
thickness in soft tissue is approximately 5.0 cm 
 
Imaging parameters (Sheffield) 
 
3D SPECT images provide a map of the concentration of radioactive tracer within the body. 
DaTSCAN images are reconstructed from multiple 2D projections, taken from different 
angles around the patient. This is a tomographic reconstruction technique in which images 
are acquired for 30s per projection with a matrix size of 128 x 128. Each of the 2 detector 
heads of the gamma camera are positioned 180 degrees apart, on opposite sides of the 
patient. Each detector acquires 60 images, with 3 degrees rotation between each, in a 
circular orbit around the patient‘s head such that the detector gantry rotates 180 degrees 
over the course of the scan. An energy window of 159keV (+/- 10%) is used. Total imaging 
time is approximately 35 minutes. Once the scan is finished the projection data are 
converted into a tracer concentration map through iterative reconstruction. This form of 
reconstruction has advantages over more traditional filtered back projection algorithms, often 
leading to reduced noise and improved contrast 
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Figure 1. Circular orbit of gamma camera heads 
 
Image interpretation 
 
Determination of whether an image is normal or abnormal is made by assessing the extent 
(as indicated by shape) and intensity of the striatal signal. Image interpretation does not 
involve relating the striatal image appearance with clinical signs and/or symptoms. 
 
Normal: In transaxial images, normal images are characterized by two symmetric comma or 
crescent-shaped focal regions of activity mirrored about the median plane. Striatal activity is 
distinct, relative to surrounding brain tissue (Figure 2).  
 
Abnormal: Abnormal DaTSCAN images fall into at least one of the following three 
categories (all are considered abnormal).  
 Activity is asymmetric, e.g. activity in the region of the putamen of one hemisphere is 
absent or greatly reduced with respect to the other. Activity is still visible in the 
caudate nuclei of both hemispheres resulting in a comma or crescent shape in one 
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and a circular or oval focus in the other. There may be reduced activity between at 
least one striatum and surrounding tissues (Figure 3). 
 Activity is absent in the putamen of both hemispheres and confined to the caudate 
nuclei. Activity is relatively symmetric and forms two roughly circular or oval foci. 
Activity of one or both is generally reduced (Figure 4).  
 Activity is absent in the putamen of both hemispheres and greatly reduced in one or 
both caudate nuclei. Activity of the background with respect to the striata is more 
prominent (Figure 5). 
 
      Figure 2    Figure 3 
 
          Figure 4               Figure 5 
 
Visual interpretation is inherently qualitative. More objective image analysis is available with 
the use of quantitative software, based on region of interest (ROI) tools. This is useful in 
quantifying tracer uptake and can be a helpful aid to diagnosis.   
  
Reduced uptake 
in R putamen 
Reduced uptake 
in R + L putamen 
Reduced / absent 
uptake in putamen 
and caudate on both 
sides 
Normal uptake 
in putamen and 
caudate on both 
sides 
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Semi-quantification with an ROI tool 
 
Semi-quantification refers to the measurement of a particular quantity within one region of 
interest in an image relative to that of a standard. In DaTSCAN imaging, tracer uptake within 
the striatum (or subregions of the striatum) is measured with respect to a reference. The 
European Association of Nuclear Medicine (EANM) procedure guidelines recommend that 
semiquantitative analysis is performed to objectively assess striatal DaT binding, in addition 
to visual interpretation. It is now used routinely in many UK hospitals. 
 
Commonly, regions of interest are defined on DaTSCAN images, over left and right 
putamena and caudates, with an additional region drawn over the visual cortex or 
cerebellum as a reference. ROIs may be determined automatically or may require user 
intervention. Semi-quantitative figures are derived by dividing detected counts within striatal 
regions by those measured in the reference area. Comparison with normal ranges enables 
an objective assessment of the presence or absence of disease. 
 
 
Figure 5 Typical regions of interest used to measure tracer uptake 
 
 
Figure 6 Example semi-quantification output (relative tracer uptake in the striatum as 
compared to a normal database) 
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Quantification and semi-quantification are becoming more common in many other areas of 
imaging. For instance, cardiac ejection fraction is routinely derived from MRI, CT, Ultrasound 
and Nuclear Medicine data by drawing regions of interest at systole and diastole and 
comparing volumes. In addition, tumour volumes are regularly measured on CT or MRI data 
to enable assessment of the progression of disease. Another example is the calcium score 
(Agatston score), used to quantify the extent and severity of calcium build up in the coronary 
arteries. 
 
The DaTSCAN semi-quantification tool is a simple but robust addition to the diagnostic 
armoury, but more sophisticated methods are available. Computer aided diagnosis (CAD) is 
one example and its potential is explored in this lab exercise. 
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Computer aided diagnosis 
 
Computer aided diagnosis (CAD) software generates more than a potentially relevant tracer 
uptake value. It can be considered to be an objective assessment of an image. It generates 
a diagnostic score which is shared with the reporting clinician in order to improve reporting 
accuracy and consistency. It is an extension of simple quantification since the image data is 
analysed by an independent entity (the software) to come up with an objective output related 
to the patient‘s state of disease. It makes a decision as to whether the patient is likely to 
have a particular disease or not. For instance, the output from a CAD algorithm may be a 
probability value related to the likelihood of disease being present. CAD algorithms can be 
more effective than quantification techniques in the detection of disease. 
 
CAD methods have been developed and refined over several decades (Doi, 2007). 
However, use in the clinic has historically been very limited. CAD for assisted interpretation 
of mammograms is one of the few areas where commercial software tools have found 
widespread uptake (prevalent in the USA). Recent technological advancements have made 
the effectiveness of CAD algorithms much greater. In several areas CAD algorithms have 
shown evidence of performance that surpasses that of human observers. With significant 
recent investment many companies are now actively developing CAD software for use in the 
clinic and these are likely to become mainstream in the future. However, currently there 
remains a significant gap in the evidence base in terms of CAD‘s impact on reporting 
performance. 
 
The aim of this lab session is to introduce you to CAD assisted diagnosis. In this study you 
will observe how a CAD system, which reports a single probability value, affects reporting 
decisions. Findings will be augmented through a feedback session, where wider implications 
associated with the software will be discussed. The output from the exercise will be used to 
inform a wider clinical study, both in terms of the CAD system design and the study protocol. 
 
Metrics of performance 
 
An important consideration when introducing new clinical tools is performance. Does the 
new tool improve diagnostic performance? Does it have adverse outcomes? What kind of 
metrics are appropriate for judging the merit of a new tool / protocol? 
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In many respects this is a cost-benefit exercise and might include simple measures such as 
time to diagnose. A rigorous approach will often incorporate the use of ROC curves, 
requiring an appreciation of true/false positives/negatives, the setting of diagnostic 
thresholds and an assessment of diagnostic impact (on the patient pathway). This exercise 
will make use of these approaches to expose the utility of CAD as a diagnostic tool. 
 
References: 
 
Doi, K. 2007. Computer-aided diagnosis in medical imaging: Historical review, current status 
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